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SUMMARY
Spontaneous sarcoplasmic reticulum (SR) Ca^^-release and propagated 
intracellular Ca '^’ waves are a consequence of cellular Ca^ "" overload in 
cardiomyocytes. We examined the relationship between the average 
intracellular [Ca^T and Ca "^ wave characteristics. Amplitude, time course 
and propagation velocity of Ca^  ^ waves were measured using line-scan 
confocal imaging of p-escin permeabilised cardiomyocytes perfused with 
10|iM Fluo-3 or Fluo-5F. Spontaneous Ca^  ^waves were evident at cellular 
[Ca^ "^ ] >200nM. Peak [Ca^H during a wave was 2-2.2|iM; minimum [Ca^H 
between waves was 120-160nM; wave frequency was -0.1 Hz. Raising 
mean cellular [Ca^ '"] caused increases in all three parameters, particularly 
Ca^ "^  wave frequency. Increased rate of SR Ca^^-release and Ca '^ -^uptake 
were observed at higher cellular indicating Ca^*-sensitive regulation
of these processes. At extracellular [Ca^H >2|j.M, the mean intracellular 
[Ca ’^'] inside the permeabilised cell did not increase above I.SpM. This 
extracellular-intracellular Ca^  ^ gradient could be maintained for periods of 
up to 5min before the cardiomyocyte developed a sustained and 
irreversible hypercontraction. Inclusion of mitochondrial inhibitors (2|iM 
CCCP and 2pM oligomycin) while perfusing with >2pM Ca^  ^ abolished the 
extracellular-intracellular Ca^  ^ gradient through the generation of Ca^  ^
waves with a higher peak [Ca^ "^ ] compared to control conditions. Under 
these conditions, cardiomyocytes rapidly (<2min) developed a sustained 
and irreversible contraction. These results suggest that mitochondrial Ca '^' 
uptake acts to delay an increase in intracellular [Ca^^ by blunting the peak 
of the Ca^ "^  wave. The Ca^ "^  dissociation constant (Kd) of Fluo-3 was
Summary
determined using confocal fluorescence microscopy in two different 
situations: (i) within the cytosol of a permeabilised cardiomyocyte and (ii) in 
an intact cardiomyocyte after incubation with the acetoxymethyl ester form 
of Fluo-3 (AM). Measurements were made on isolated rabbit ventricular 
cardiomyocytes after permeabilisation by a brief treatment with p-escin 
(0.1 mg.ml ’') and equilibration with lOpM Fluo-3. The Ky of Fluo-3 within 
the cytosol was not significantly different from that in free solution 
(558±15nM, n=6). The characteristics of spontaneous Ca^  ^ waves in 
permeabilised cardiomyocytes as characterised above indicated that the 
minimum [Ca^T reached between Ca^ "^  waves was relatively constant over 
a range of intracellular [Ca^^. After loading intact cardiomyocytes with 
Fluo-3 by incubation with the -AM, spontaneous Ca^  ^ waves were 
produced by incubation with strophanthidin (lOpM). By assuming a 
common minimum in permeabilised and intact cells, the intracellular 
Kd of Fluo-3 was estimated to be 898nM±64 (n=6). Application of this Kd to 
fluorescence records predicted Ca^ "' waves in intact cells with similar 
amplitudes to those in permeabilised cells. Stimulation of cardiac myocytes 
at 0.5Hz in the absence of stropthanthidin (room temperature) resulted in a 
transient with a maximum and minimum [Ca^ "^ ] of 1190±200nM and 
158±30nM, (n=11) respectively. Ultimately, the above data characterising 
the release of Ca^ "" from the SR and the Ky of Fluo-3 allowed investigation 
of the role of FK506-binding protein (FKBP12.6) using adenoviral-mediated 
gene transfer to over-express FKBP12.6 (Ad-FKBP12.6) in adult rabbit 
ventricular cardiomyocytes. Infection with a p-galactosidase-expressing 
adenovirus (Ad-LacZ) was used as a control. Peak-systolic intracellular 
[Ca^ ]^ (measured with Fura-2) was higher in the Ad-FKBP12.6 group
5
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(845±75nM, n=25) compared to Ad-LacZ (625±56nM, n=25, P<0.05); end- 
diastolic intracellular [Ca^T was unchanged (1Hz field stimulation at 37°C). 
The amplitude of caffeine-induced Ca^^-release was also greater 
(1360±103nM vs. 980±63nM p<0.05, n=25) indicating a higher SR Ca^  ^
content in the Ad-FKBP12.6 group. Line-scan confocal microscopy (Fluo-3 
fluorescence) of intact cardiomyocytes stimulated at 0.5Hz (20-21 °C) 
revealed a higher degree of synchronicity of SR Ca^  ^ release and fewer 
non-responsive Ca^  ^ release sites in the Ad-FKBP12.6 group compared to 
control. Ca^ "^  spark size and frequency was measured in p-escin 
permeabilised cardiomyocytes at a free [Ca^ "^ ]i of 150nM. All spark 
parameters were reduced in the Ad-FKBP12.6 group (n=9 cells) compared 
to Ad-LacZ (n=18 cells): Ca^  ^ spark peak, F/Fo 1.80±0.03 vs. 1.96±0.02; 
width, 3.15±0.07|Lim vs. 3.33±0.07pm; duration, 26.09±1.5ms vs.
29.21 ±1 .Oms", and frequency, 0.04±0.007events.pm\s'^ vs.
0.06±0.004events.pm\s\ Raising intracellular [Ca^T to 400nM in 
permeabilised cardiomyocytes, resulted in the appearance of coherent 
propagating Ca^ "^  waves in the Ad-FKBP12.6 group but only limited 
release events were recorded in the control group. In conclusion, this data 
suggests that FKBP12.6 over-expression enhances cardiac excitation- 
contraction coupling predominately by reducing diastolic Ca^  ^ leak from the 
SR, but also by increasing the synchrony of SR Ca^  ^ release. Finally Ca^  ^
sparks were examined in permeabilised rabbit ventricular cardiomyocytes 
(150nM [Ca^Hi) over-expressing an FKBP12.6 mutant, which lacked the 
ability to bind to calcineurin. This was compared to control virus, (Ad-LacZ) 
and over-expression of FKBP12.6. No differences were found between 
over-expression of the mutant and FKBP12.6 suggesting that calcineurin
6
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binding is not necessary for the observed decrease in spark size and 
frequency compared to control (Ad-LacZ).
Aims
AIMS
The general aim is to study the role of FKBP12.6 in regulating sarcoplasmic 
reticulum (SR) Ca^ "^  release in permeabilised cardiomyocytes.
(1) Initial work concerned the characteristics of spontaneous Ca^ "^  release 
from permeabilised cells. In particular, the aim was to discover the 
relationship between intracellular [Ca^T and the ability of the SR to 
generate Ca^  ^waves.
(2) The second aim was to compare the Ca^  ^ wave behaviour in 
permeabilised cardiomyocytes and Ca^ "^  wave behaviour within the intact 
cells and to use the wave characteristics in intact cells to calibrate the 
commonly used fluorescent Ca^ "^  indicator -  Fluo-3/AM.
(3) The main aim of this thesis was to study the effects of adenoviral 
mediated over-expression of FKBP12.6 on Ca^  ^ sparks and Ca^  ^ waves 
within adult rabbit ventricular cardiomyocytes.
(4) The final aim was to study sparks within cardiomyocytes over­
expressing a mutant form of FKBP12.6, which lacked the ability to bind to 
calcineurin.
Since this may be the only page that is comprehensible to them, this is perhaps the 
most important, and therefore. ..
I  dedicate this thesis to my parents, without whom, I  could not have achieved any 
o f  the things I  have done.
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Excitation-Contraction coupling and Ca^^ sparks and waves
1.1 INTRODUCTION
Ventricular cardiomyocytes are an essential component of the functional 
syncitium that forms the mammalian heart. Their main role is to contract 
during systole and relax during diastole, in a regulated manner. Each cell is 
stimulated to perform this process by electrical depolarisation, which 
ultimately leads to activation of myofilaments and cellular shortening. 
During diastole the myofilament interaction is inhibited and the cell relaxes. 
A chemical messenger - Ca^ ,^ provides the link between this electrical 
excitation and subsequent mechanical activity. Although a number of 
different ions play an important role in this process, it is the dynamic 
movement of Ca^  ^ from the extracellular space into the cell and its 
intracellular translocation between various micro-domains and organelles 
that constitutes E-C coupling (Figure 1.1). In fact without extracellular Ca^  ^
the heart does not contract because Ca^ "^  is directly required for 
myofilament activation [1]. The complete absence of Ca^  ^ is an extreme 
situation, which is unlikely to occur in vivo. However, a simple disruption to 
the tightly regulated process of cellular Ca^ '" homeostasis may lead to an 
inefficient contracting/relaxing myocardium. This is apparent within the 
clinical condition of heart failure.
This chapter aims to discuss some important aspects of EC-coupling and in 
doing so provide background information relevant to the thesis. The brevity 
of discussion on other aspects of the process is not a reflection of their 
relative importance in regulating Ca^  ^homeostasis.
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Figure 1.1 The dynamic movement of Ca2+
Ca enters the ventricular cardiomyocyte, is transported between various compartments 
and organelles, reversibly activates the myofilaments and is finally transported out of the 
cell This process ensures that Ca^* influx is equal to Ca^* efflux under normal conditions. 
(NCX, NaVCa^* exchange; ATP, ATPase; PLB, phospholamban; SR, sarcoplasmic 
reticulum). (Figure taken from Bers (2002) Nature  415, 198-205).
1.2 entry into the ventricular cardiomyocyte
The driving force for entry into the cell is largely due to a concentration 
gradient across the cell membrane and the membrane potential relative to 
the Ca^  ^ equilibrium potential. However, Ca^  ^ does not 'flood' into the 
cardiomyocyte and the intracellular resting [Ca^H remains low (150nM) 
while the extracellular [Ca^H is high (1.5-2.0mM). In fact, if the resting 
[Ca^ "^ ] reached mM levels, irreversible activation of the myofilaments would 
occur together with enzymatic events which would lead to cell death. How 
then does intracellular [Ca^ "^ ] rise in a controlled manner in order for
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myofilaments to be reversibly activated?
There are two sources of Ca^ "^  that could lead to a rise in myoplasmic [Ca^T 
(the Ca^  ^ transient). Firstly the pool of extracellular and secondly, 
intracellular Ca^ "^  stores. The extracellular pool has access to the interior of 
the cell via invaginations of the cell surface membrane (the sarcolemma). 
These extensions are known as transverse tubules (T-tubules). They 
account for approximately 3.6% of the cell volume and from 21 - 64% of the 
sarcolemma, the variation attributed to species differences [2-5]. Although 
their name implies a transverse arrangement, recent developments in two- 
photon microscopy have allowed visualisation of a more complex tubular 
network [5]. Entry of Ca^  ^ from this extracellular pool into the interior of the 
cell via the T-tubules is mainly by voltage dependent Ca^ "^  channels, 
namely L-type Ca^  ^ channels (LCCs) (T-type Ca^  ^ channels do exist in 
cardiomyocytes but their role in E-C coupling is not thought to be 
significant). That these channels are voltage dependent is of vital 
importance in terms of the timing and control of Ca^  ^ entry. Electrical 
excitation of the sarcolemma creates an action potential, which passes as a 
wave of depolarisation along the membrane down the T-tubules 
subsequently activating LCCs located here. LCCs are activated at negative 
membrane voltages (-40mV). The consequential current ( I c a )  is a product 
of the open probability of the channel and single channel conductance ( ic a ) .  
Between -40mV and +10mV, Ica increases to a maximum. Over this 
voltage range the decrease in electrochemical driving force for Ca^ "^  entry is 
compensated for by the increase in channel open probability. However, 
even though the open probability continues to increase as the membrane
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voltage rises to +60mV, the electrochemical drive for Ca^  ^ entry further 
decreases. Ica therefore decreases resulting in a bell shaped current 
voltage relationship [6] (Figure 1.2 Panel A(i)). The LCC shows relatively 
slow inactivation (60 - 200ms - hence Long (L-type) lasting current), which 
is voltage and dependent.
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Figure 1.2 Voltage dependence of the L - type Ca^* current
Panel A(i) shows an inverted bell shaped relationship between peak L-type Ca^ "^  current 
and m em brane voltage (where V  (volts) also refers to the E m ) .  Panel A(ii) shows the 
corresponding voltage dependence of the Ca^^ transient. Panel B shows the normalised 
relationship between L-type Ca^^ current, Ca^^ transient and contraction. (Panels adapted 
from (A) Beuckelmann et a i  (1988) J. Physioi 405 233-255), (B) Bers (2001) Excitation- 
Contraction Coupling and Cardiac Contractile Force, 2™^  edition, Kluwer Academic, 
Dordrecht, Netherlands).
The influx of via LCC from the extracellular Ca^  ^pool is insufficient to 
result in activation of the myofilaments in most mammalian species. This is 
due to an inadequate quantity of Ca^ ,^ the buffering of Ca^^ by intracellular
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binding sites and diffusion [7]. In terms of the quantiity of Ca^ '" required for 
activation of the myofilaments it has been calculated that when using 
steady state Ca^ "^  loading conditions, approximately 60 - 70|xmol/L cytosol 
is required to activate a normal ventricular twitch vwhich is thought to be 
approximately 40% of maximal force at 25-30°C [8]. This would correspond 
to an increase to approximately BOOnM free Ca^^from a diastolic of 150nM 
assuming a cytosolic buffering of 100:1 (boundifree Ca^ )^ [9]. The total 
Ca^  ^ influx due to LCC is dependant upon many factors. Species 
dependency is an important factor. The total amount of Ca^  ^which enters 
the cell due to this channel in the rabbit is only approximately 12pmol/L 
cytosol which may even be reduced to 6pmol/L cytosol due to inactivation 
of the channel by Ca^ "^  [10]. Other reports suggest 21 p,mol/L cytosol for the 
rabbit and 14pmol/L cytosol for the rat using voltage clamped cells and 
action potential waveforms [11]. These values may be unexpectedly high 
due to the use of lOmM EGTA that would have suppressed Ca^  ^
inactivation. It can be seen therefore that in the rabbit, L-type Ca^ "^  influx 
can only account for approximately 23% of the total Ca^ "^  required to 
activate the myofilaments during a normal twitch [12]. Where does the 
remainder of the Ca^‘" required to activate the myofilaments come from?
1.3 induced release (CICR) from the sarcoplasmic reticulum
In experiments involving the removal of the sarcolemma from Purkinje 
fibres using meticulous micro-dissection together with microprocessor- 
induced rapid changes of [Ca^ "^ ], Fabiato (1985) showed the second source 
of Ca^ "^  to be the sarcoplasmic reticulum (SR) [13-15]. Rapid exposure of 
Ca^ "" (approx. 1ms) to the SR, triggers release of its stored Ca^ "^  and the
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development of myofilament tension, a mechanism referred to as Ca^  ^
induced Ca^ "" release (CICR). It is conceivable that the natural origin of this 
simulated Ca^ "^  trigger comes from the extracellular Ca^" pool, the quantity 
of which is insufficient to cause a twitch in itself. This importantly implies 
that the process of CICR is able to amplify a small Ca^ "^  influx.
1.4 The sarcoplasmic reticulum (SR)
The SR is an intracellular organelle, which is intricately wrapped around the 
myofilaments [16]. Some of the SR lies adjacent to the T-tubules in 
expanded sacs known as junctional SR (terminal cisternae) and depending 
on their arrangement are termed dyadic or triadic junctions where triadic 
implies that two terminal cisternae lie either side of a T-tubule. There can 
also be junctions with the remaining sarcolemma (surface sarcolemma) or 
unattached SR expansions (corbular SR). That there is a higher proportion 
of the sarcolemma involved as a dyad in the rat (6.5-7.7% surface, 40-48% 
T-tubular) than rabbit (4.6 % surface, 20.6% T-tubular) [3;9] is of functional 
relevance. The rat twitch is more dependent on triggered SR Ca^  ^ release 
during CICR than on exposure to external Ca^ "", unlike the rabbit whose 
external Ca^  ^contribution is greater than the rat.
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Figure 1.3 Characteristics of CiCR in skinned purkinje fibres
As pCa trigger increases so does the amplitude of tension -  (amplification). Above a 
supra-optimal [Ca^^j, tension declines. Data is also shown for differing rates of application 
of trigger [Ca^^]. Small filled black circles showing highest values are triggers induced by a 
very rapid micro-injection and subsequent aspiration of the solution, other rates are values 
are achieved by the mixing of high and low [Ca "^ ]^ solutions to vary rate of change of free  
[Ca^^j (t=1-50m s). Overall it can be seen that S R  Ca^^ release is dependent on both the 
size of the trigger and its rate of [Ca^^ change -  (graded response). (Figure taken from  
Fabiato, (1985) J.Gen. Physiol. 85 247-289).
As demonstrated by the pioneering work of Alex Fabiato, there are two 
main features of CICR in cardiomyocytes - amplification and the associated 
graded nature of the process. Application of increasing amounts of trigger 
Ca^^, results in greater SR Ca^^ release, inducing a larger contracture 
(Figure 1.3). However if increasing supra-optimal amounts of Ca^  ^ are 
applied then tension begins to decrease. Additions of higher [Ca^H (lOpM)
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to a skinned cell immediately after initiation of Ca^  ^ release results in almost 
complete inactivation of SR Ca^  ^ release. CICR also depends on how fast 
trigger Ca^  ^ is reached (time dependency). A faster trigger (-1ms  
compared to 50ms) leads to greater maximum tension development and an 
increase in the optimal amount of Ca^" above which tension decreases 
(Figure 1.3). Therefore the Ca^ "" inactivating effect occurs at lower [Ca^ "^ ] 
when the trigger [Ca^^ takes longer to be reached [14].
1.5 Identifying the source of the simulated Ca^* entry during CICR
The trigger Ca^  ^ was simulated in the above experiments [14] by rapid 
solution changes. Is there a natural influx of Ca^  ^ that acts as a substitute 
for this simulation in the cardiomyocyte? There are many dyadic junctions 
in cardiomyocytes putting LCCs in the vicinity of the SR terminal cisternae. 
Located on these SR structures are the Ca^ "^  release channels/ryanodine 
receptors (RyRs). Many investigators have looked at the role of CICR in 
intact cardiomyocytes in particular the role Ca^"” entry via LCC plays in 
triggering CICR.
A B
Extracellular (TT) space 
Cytoplasm
sub-space
Figure 1.4 Location of LCCs and RyRs
Panel A shows a cut section of the T-tubule above which are located the 
LCC/Dihydropyridine receptors (DHPRs). These are in close apposition to the RyRs
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located on the SR terminal cisternae. The close proximity of these two surfaces however 
forms a cleft/sub space as seen in panel B. The arrows in panel B denote routes of Ca^  ^
flux into and out of this cleft during CICR. (Figure taken from Sobie et al. (2002) Biophys. 
J. 83, 59-78).
The most compelling evidence that L-type influx is the trigger for SR 
Ca^  ^ release is demonstrated by the similarity between the relationship of 
(a) voltage dependence and L-type Ca^  ^current, (b) SR Ca^ "^  release (Ca^  ^
transient), and (c) contraction [9; 17-20] (Figure 1.2 Panel B). Proof that 
CICR occurs in intact cardiomyocytes is reinforced by the finding that the 
influx of Na  ^or Ba^  ^current through the LCC does not elicit a Ca^  ^transient 
even though there is still Ca^  ^ within the SR [21]. More technical 
approaches to demonstrate CICR in intact cardiomyocytes have involved 
the use of photolabile Ca^ "^  chelators. These have been performed in 
skinned cardiomyocytes [22], rat cardiomyocytes without voltage clamp [23] 
and with voltage clamp [24;25]. Cannell et al (1987) showed that LCC tail 
currents could elicit Ca^  ^ transients and cellular contraction [26]. This 
particular study also raised the possibility of an Em dependence on CICR 
since Ca^  ^ transients were smaller when early repolarisation was induced. 
Several observations from various studies including: (1) the similarity 
between voltage dependence in L-type Ca^  ^current and Ca '^’ transient [17], 
(2) that caged Ca^  ^can trigger SR Ca^  ^ release independent of membrane 
potential [25], (3) the methods using prevention of Ica at different potentials 
equivalently suppress Ca^ "^  transients [27] all suggest that Em dependence 
is not important during CICR and it is sarcolemma! entry of Ca^  ^ that 
triggers SR Ca^  ^release.
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1.6 Problems associated with the theory of CICR
CICR implies in its title that a single trigger of Ca^ "^  can induce the release 
of SR Ca^ "^ . In theory, this initial release of SR Ca^ "" could act as an 
independent trigger. This would stimulate further SR Ca^  ^ release and 
generate a positive feedback loop. This mechanism would be inherently 
unstable since there would be no negative feedback event to stop the 
cascading release of SR Ca^ "^ . However, under normal circumstances this 
does not happen. As described above, in intact cells, SR Ca^ "" release is 
tightly controlled by L-type Ca^  ^ entry, i.e. they follow the same voltage 
dependent bell shaped relationship. Ca^  ^ entry via LCC stimulates a SR 
Ca^ "^  release that does not continually produce more and more Ca '^'. RyR 
mediated SR Ca^ "^  release is controlled by the LCC such that if the 
cardiomyocyte is repolarised to the holding potential or the Ca^ "^  reversal 
potential for LCC during the rising phase of the Ca^ "^  transient, SR Ca^  ^
release is suppressed [26]. How then does L-type Ca^ "" current control 
CICR and prevent positive feedback?
1.7 Preventing positive feedback
Fabiato (1985) showed that the process of CICR was inactivated at high 
[Ca^ "^ ] and proposed a model whereby the process of CICR could be 
controlled [14]. The model was that the trigger Ca^ "^  activated binding sites 
on the SR Ca^  ^ release channel with a relatively low affinity but high on 
rate. These sites acted to stimulate Ca^  ^ release. However, the same 
trigger Ca^ "^  would also inactivate SR Ca^ "" release by binding to a second 
type of site with higher affinity but slower association constant. Application 
of supra-optimal amounts of Ca^  ^ would therefore inhibit Ca^ "" release by
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overcoming the slower on rate to the inhibitory binding site. Unfortunately 
no intact cardiomyocyte work has provided evidence for Fabiato's 
inactivation model enabling prevention of a positive feedback response. In 
fact, the opposite has been observed. Nabauer et al (1990) used flash 
photolysis of caged Ca^  ^during the rising phase of contraction in order to 
reproduce Fabiato's model of inactivation but showed an increase in 
contraction (it is possible that the release of Ca^  ^ by photolysis might not 
have been sufficient to result in inactivation however) [24].
Cannell et al (1987) also suggested that Fabiato's inactivation model is hard 
to reconcile with current experimental evidence [26]. If the cell is rapidly 
repolarised during the Ca^  ^ transient's rising phase the peak of the Ca^ "^  
transient is depressed. Using Fabiato's model, one possible explanation is 
that during the very short time taken to deactivate LCCs by repolarisation, 
the influx of Ca^  ^by LCC is increased due to the increased electrochemical 
drive. This could inactivate further SR Ca^ "" release. However Cannell et al 
(1987) calculated that the repolarisation performed in this study from -24mV 
to -54mV could not increase the Ca^ "" entry by more than 20% [26]. This 
entry of Ca^ "” was not sufficient in time or quantity to account for the marked 
suppression of the Ca^  ^ transient. Furthermore Fabiato's inactivation 
theory was even harder to reconcile with experiments showing 
depolarisations inducing larger Ca^ "^  entry and thereby increasing the 
amplitude of the Ca^  ^ transient when by Fabiato's model, they should result 
in more suppression [26].
Cannell et al (1987) also suggested that perhaps the termination of Ca^ "^
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entry via the LCC during repolarisation decreases the binding of Ca^  ^ to the 
activator site and prevents autonomous SR Ca^  ^ release [26]. However, 
SR Ca^ "^  release is much larger than LCC entry, which suggests that the 
activation site will not deplete of Ca^ "" [26].
One final important observation in intact cells that is hard to reconcile with 
the model of Fabiato is the asymmetrical nature of the bell shaped 
relationship between L-type Ca^  ^ current and Ca^  ^ transient peak (Figure
1.2 Panel B). If for instance an equivalent normalised Ica current is 
examined at both positive and negative Em, a larger Ca^ "^  transient is 
observed at the negative cell membrane potential [9;17]. Fabiato’s theory 
of CICR has no explanation of this phenomenon since the same trigger 
Ca^ "^  ( Ic a )  should release the same amount of SR Ca^ "^  independent of how 
that trigger is achieved.
1.8 A model of CICR that begins to fit the experiments
Authors who had attempted to devise mathematical models of CICR also 
found it hard to reconcile the experimental evidence for CICR in intact cells 
and that of Fabiato's work in skinned cells. A theoretical paper by Stern 
(1992) however established a theory that enabled the intrinsic positive 
feedback effect of CICR to be overcome and the potential for SR Ca^ "^  
release to be graded by the L-type Ca^  ^ influx [28].
Previously, the intact cardiomyocyte was conceived as a 'common pool' 
model. This implies that trigger Ca^ "^  reaches the SR via the same cytosolic 
Ca^  ^ pool into which the SR Ca^  ^ is released [29]. However by using this
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type of model, CICR cannot achieve an amplification of trigger Ca^  ^ while 
still being able to prevent regenerative SR Ca^  ^ release. There is such a 
small window whereby both parameters are viable before instability arises. 
This is not thought to be a realistic way to regulate such a vital body 
system.
SR Release 
Pool
SR Uptake 
t L  Pool
 [C a ^  ] cytosolic
■ Î- ■OÎ-Na/Ca 4  
Exchange
Figure 1.5 ‘Common pool' model for CICR
Ca^ "^  that leaves enters and leaves the cell does so via the sam e pool of cytosolic Ca^^ (Ui 
= Ca^^ entry via LCC). (Figure taken from Stern (1992) Biophys. J. 63  497-517).
Stern (1992) therefore looked at the ultra-structure of the cardiomyocyte 
[28]. Using the knowledge that in skeletal muscle the LCC lies in direct 
apposition to the Ca^* release channel (RyR) [30], Stern devised a 'local 
control' as oppose to a 'common pool' model. The local control model relies 
on the ability of the LCC to have privileged access to the RyR. Due to the 
location of these components the sensitivity to Ca^  ^ can be lower. 
However, regeneration in these local control models does not occur 
because of the all-or-none nature of the single channel openings and the 
short diffusion times in the cleft between the channels. Firstly Stern 
devised a 'Ca^  ^ synapse' model, which involves a scenario whereby each 
SR release channel is immediately opposite and controlled by a
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sarcolemma! LCC. The termination of Ca^^ release from the RyR can 
either be random, which if long enough allows the Ca^  ^ in the vicinity to 
diffuse away, or Ca^^ dependent in which the channel will still close at a 
finite rate and again the Ca^^ diffuses away from the cleft region between 
the LCC and RyR.
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Figure 1.6 Local control theory for CICR
‘synapse model’ would suggest that each RyR is controlled by Ca^ "^  released by one 
LCC. (Figure taken from Stem  (1992) Biophys. J. 63 497-517).
Both of these mechanisms are considered equivalent and prevent positive 
feedback. This model has characteristics enabling the amplification of 
trigger Ca^^ and for amplified Ca^  ^ release to be graded by LCC. However 
the system requires an unreasonable conductance for a single SR Ca^^ 
release channel. A way around this problem is to have a number of SR 
Ca^  ^ release channels (a cluster) each channel having a smaller 
conductance but all channels in the cluster being governed by a single 
LCC. This is referred to as a 'cluster bomb' model. Within a cluster, Ca^^ 
release can be regenerative; however a single cluster cannot trigger 
release in an adjacent cluster because they are separated from one
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another. This model therefore allows for amplification of trigger [Ca^T 
(since one LCC activates a number of SR Ca^  ^ release channels) and 
provides a mechanism for SR Ca^  ^ release to be graded (since the trigger 
can recruit varying numbers of clusters).
LCC
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Bulk Cytosolic Space
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Figure 1.7 ‘C lu s ter b om b ’ m odel
The release of Ca^ "^  from a single LCC induces release of Ca^ "^  from a cluster of RyRs  
which is discreetly spaced from the adjacent cluster of RyRs. (Figure taken from Stem  
(1992) Biophys. J. 63 497-517).
Although the clusters are spatially discreet and prevent positive feedback, 
positive feedback does exist within an individual cluster and its termination 
is essential. This will be discussed later.
1.9 Evidence for local control of CICR
Evolving technological advances in the ability to resolve temporal and 
spatial changes in intracellular [Ca^^ (especially line-scan confocal imaging 
(LSCM)) revealed evidence for local rises of [Ca^T thought to originate from 
clusters of RyR as proposed by Stern (1992).
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Figure 1.8 Ca * Sparks
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Panel A(i) shows a line scanning confocal image of Ca^* sparks with corresponding line 
profiles of these sparks in panel A(ii) top and bottom. Panel B shows a characteristic 3D  
plot and contour map of a Ca^* spark. (Figure adapted from Terentyev et al. (2002) Cire. 
Res. 91, 414).
Cheng et al (1993) visualised these events for the first time in 
cardiomyocytes [31]. The events are termed Ca^'' sparks and provide 
some experimental evidence for Stern's mathematical modelling.
1.10 sparks - a more complete picture of CICR
Ca^  ^ sparks are local spontaneous increases in cytosolic [Ca^H, 
approximately 200nM, 2pm in diameter (confocal section), with a half-time 
decay of 25ms (compared to Ca^  ^ transients which can have a half-time 
decay of 164ms [31]. These events occur at a low rate at resting [Ca^ ]^ 
(approx 150nM) with a frequency of 100 sparks/cell/s. Cheng et a! (1993) 
showed that the Ca^  ^ flux of the Ca^  ^ spark is 2 x10'^^mols.s"\ which is 
equivalent to approximately a current of 4pA. Due to this flux estimate the 
Ca^  ^ spark was thought to originate from a single RyR [32]. However at
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present this is not thought to be the case, a point that will be discussed 
later. The Ca^  ^ spark originates from the SR and can be blocked by 1pM 
ryanodine. Lower concentrations of ryanodine (100-300nM for 1-3min) 
increase the frequency of Ca^  ^ sparks by approximately >2.2 fold although 
spark morphology remains unchanged. This is in line with the 
understanding that ryanodine increases the open probability of RyR at low 
concentrations and very high concentrations block the RyR. Intermediate 
concentrations can induce sub-conductance states that appear in a line- 
scan image as sparks with long durations >1s but with a consistent 
amplitude, suggesting that the local SR is not depleted of Ca^  ^during such 
long releases.
The discovery of local Ca^  ^ sparks without regenerative propagation 
provides physical evidence for the ‘cluster bomb’ theory [28]. It is still 
possible that all-or-none responses occur within a cluster of RyRs, however 
since clusters have a low sensitivity to trigger [Ca^ "^ ] and are more than 
likely spatially discreet, Ca^  ^ release by a cluster can still be localised. 
However, if external [Ca^T is raised then the frequency of Ca^  ^ sparks 
increases. If a certain threshold is reached macro-sparks are produced. 
These are thought to be due to summation of a number of Ca^  ^sparks and 
have accumulatively larger amplitudes (approx. 500nM). They usually 
occur at the beginning of Ca^  ^ waves, which are spontaneous releases of 
[Ca^ "^ ] that propagate from one end of the cell to the other. Since ryanodine 
increases the frequency of localised Ca^ "^  sparks but does not lead to 
propagating Ca^ "^  waves, an additional factor must be involved in producing 
Ca^ "^  waves other than a simple increase in spark frequency. This is now
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thought to be the regulation of RyR by SR [Ca^ ]^ content [33]. Ca '^" waves 
can be inhibited by high concentrations of ryanodine and therefore are also 
a result of SR Ca^" release [31].
1.11 Why are sparks helpful in understanding EC-coupling
The production of Ca^* sparks result from spontaneous SR Ca^ "" release at 
resting [Ca^T levels in the cardiomyocyte; however sparks can also be 
triggered by electrical depolarisation.
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Figure 1.9 Depolarisation duration effects on the Ca * transient
Panel A from top to bottom shows, spatial averaged Ca  ^ transients, corresponding 
confocal linescan image, membrane potential and membrane current. This cell is 
depolarised for 50ms leading to a uniform release of SR Ca^^. Panel B follows the same 
format as a Panel A. The LCC is activated for 3ms and then terminated abruptly by further 
depolarisation to +80m V for 80ms. Repolarising the cell to -9 0 m V  then produces the tail 
current. The abruptly terminated SR Ca^* release is sparse whereas the tail current 
produces a more uniform release of SR Ca^*. (Figure taken from Cannell (1995) Science
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268, 1045-1049).
Cannell et al (1995) developed this concept in a key study [34]: As 
discussed (section 1.5), the Ca^  ^ transient is a combination of the Ca^  ^
entry via LCCs (and possibly Na /^Ca^  ^ exchange) and SR Ca^  ^ release. It 
is the Ca^  ^ influx via the LCC, which regulates the transient in a strict 
manner. Ca^  ^sparks are also a result of SR Ca^ "^  release and Cannell at al 
(1995) were able to identify the link between the Ca^ "^  transient, Ca^ "^  spark 
and the way they are both controlled by Ca^  ^ influx via LCCs. Cannell et al 
(1995) [34] repeated some experiments performed in 1987 [26] using the 
technique of voltage clamp but this time while imaging Ca^  ^ using confocal 
line-scan imaging. When cardiomyocytes are depolarised for 3ms from - 
40mV to +10mV the Ca^  ^ released from the SR can be abruptly terminated 
before the peak [Ca^H by further depolarising the cell to +80mV. 
Repolarising the cell back to -90mV produces a tail current. The tail current 
produces a synchronous release of SR Ca^ "^  albeit with a lower amplitude. 
(The tail current occurs since when the cell is depolarised to +80mV the 
Ca^  ^ channel opens but the driving force for Ca^  ^ entry is small, hence 
when repolarised to -90mV the driving force for Ca^  ^ increases such that 
the influx of Ca^  ^ through the open channels occurs before they can 
deactivate). However, if the initial abruptly terminated Ca^ "^  release is 
observed using confocal line-scan imaging it can be seen to occur at 
sparse points along the cell. These points change each time the protocol is 
performed (Figure 1.9 Panel B). The events resemble Ca^  ^ release at 
discreet sites. It was this observation that provided an indication that LCCs 
could trigger Ca^  ^sparks.
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1.12 Evidence that Ca^* sparks are triggered by LCCs
Individual Ca^ "^  sparks can be triggered if short periods of depolarisation are 
performed from -40mv to -5mV for 0.75ms [34]. Further more, Ca^ "’ sparks 
are also triggered if the cell is depolarised from -50mV to -35mV albeit with 
a latency of <2ms. The Ca^  ^ sparks evoked have the same morphology as 
those occur during spontaneous Ca^  ^ sparks. The latency associated with 
the appearance of these events at more negative potentials but with similar 
morphology to Ca^ "^  sparks at more positive potentials (and spontaneous 
Ca^ "^  sparks), suggests that the latency is associated with a lower 
probability of LCC opening. This also suggests that the size of the Ca^  ^
spark is independent of Ca^ "^  entry via LCC and is a function of RyR. It 
follows from these observations that Ca^  ^ sparks are triggered via Ca^" 
influx associated with LCC and that large influxes of Ca^ "^  can lead to the 
production of a large number of sparks which when temporally and spatially 
combined produce the Ca^  ^ transient. Further evidence that suggested that 
the Ca^  ^ transient is a result of the temporal-spatial summation of Ca^  ^
sparks can be seen when the LCC current is reduced via L-type channel 
antagonists [31;35] or low [Ca^T [36] whereby Ca^  ^ sparks are easier to 
resolve.
1.13 The use of sparks to explain Ca^* transient characteristics
With knowledge that the Ca^  ^ transient is the result of Ca^  ^ sparks, an 
explanation for the larger Ca^  ^ transients seen at more negative potentials 
and hence the asymmetry of the relationship between the L-type Ca^  ^
current and Em discussed earlier can be provided. At more negative 
voltages the probability that a single LCC is open is lower than at more
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positive potentials, however when a single LCC does open there is a larger 
flux of Ca^^ through it due to a higher electrochemical drive (Figure 1.10 
panel A). The electrochemical driving force for Ca^^ entering the cell falls at 
more positive membrane potentials. Santana et al (1996) described the Em 
dependence of a single channel ica and showed that the spark probability 
normalised to Ica follows the same relationship as ica (Figure 1.10 Panel B) 
[37]. Hence there is a greater influx of Ca^^ through an open channel at 
more negative potentials than at positive potentials, which in turn is more 
likely to trigger RyRs. This could not have been accounted for by Fabiato's 
work, which would have predicted the same release of SR Ca^  ^
independent of how the trigger was achieved.
To trigger a Ca^  ^ spark by Ca^ "^  entry via LCC requires at least SpM [Ca^T 
within a distance of <20nM. This can only be achieved by the close 
apposition of the LCC and RyR cluster [26].
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Figure 1.10 Asymmetrical voltage dependence of the Ca transient
Panel A  shows the relationship between normalised peak Ica and the amplitude of the 
normalised Ca^ "^  transient. It is noted that at the sam e Ica the Ca^^ transient is larger at 
more negative membrane potentials. Panel B takes the data from Panel A  and calculates
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the gain in relation to the membrane voltage. This follows the same relationship between 
membrane voltage and the probability of Ca^  ^ sparks occurring. Figures taken from Bers 
(2001) Excitation-Contraction Coupling and Cardiac Contractile Force, 2"  ^ edition, Kluwer 
Academic, Dordrecht, Netherlands adapted from data by Beuckelmann et al. (1988) J. 
Physiol. 405 233-255 (Panel A) and Santana et al. (1996) Cire. Res. 78, 166-171 (Panel 
B).
This close proximity is critical since [Ca^T in this small cleft will decrease 
rapidly when Ica influx terminates due to diffusion of Ca^ "^  out of the space 
formed between the two channels [9]. This is a further indication that only a 
single LCC can activate a cluster close to it within the cleft and not one 
further away. This principle leads to the localisation Ca^ "^  sparks.
1.14 How many LGGs are required to trigger a cluster of RyRs?
If the LCC is really the trigger for SR Ca^  ^ release then the rate of spark 
production should be related to the voltage dependence of the L-type Ca^'’ 
current. If a cell is slowly depolarised from -70mV to -40mV i.e. over a 
range of voltages where the probability of channel opening is very low and 
opens by chance, Ca^ "" sparks within the same cell also activate 
stochastically. Furthermore, between -70mV to -40mV, the Ca^  ^spark rate 
increases exponentially to the same extent as the activation curve of LCC 
[34]. This observation provides evidence that a single LCC opening can 
trigger a Ca^  ^ spark [34]. Many subsequent papers have confirmed this 
[35;37;38]. It must be noted however that these experiments were carried 
out using protocols that reduced the probability of Ca^  ^ spark production. 
However, a recent study by Inoue et al (2003) uses a protocol that does not 
block LCC (i.e. by low external [Ca^T or antagonists) a factor which 
increases the likelihood that a single LCC activates a single Ca^  ^ spark
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[39]. The study firstly establishes the probability with which Ca^ "^  sparks are 
evoked by an action potential (AP) shaped voltage command using 2mM 
EGTA in the pipette solution. The probability that a Ca^  ^ spark appears 
with each AP is approximately unity (events being activated 2-6ms after the 
peak). Using unitary current recordings of LCC by voltage clamp, the 
authors also establishes that the probability of a single LCC opening at 
least once within 2-6ms after depolarisation is approximately 0.87, i.e. 
much lower than the spark probability. Therefore from this data Inoue et al 
(2003) suggests that at least 3-11 LCCs are required to produce a Ca^  ^
spark at the beginning of an action potential with a probability of 
approximately unity. Anatomical observations also suggest that this may 
be the case [40]. Wang et a! (2001 ) acquired direct visualisation of a single 
LCC Ca^  ^ influx (Ca^ "^  sparklet) concurrent with Ca^  ^ spark measurements 
[41]. This meticulous work reinforces three principal ideas involving local 
control of CICR. Firstly, the visualised Ca^  ^ sparklet can be used as a 
representative measure of LCC unitary current ( ic a )  and under loose voltage 
clamp conditions the proportion of sparklets able to trigger a Ca^  ^ spark 
(LCC-RyR coupling fidelity) is 0.71, i.e. less than unity. Secondly, where a 
Ca^ "^  spark is successfully triggered the ability of the second sparklet to 
produce another Ca^  ^ spark is reduced, showing therefore use-dependent 
inactivation or adaptation of RyR (a point that will be discussed later). 
Thirdly, abolition of the sparklet during depolarisation by 2pm nifedipine or 
substitution of Ca^  ^in the pipette with 20mM Ba^  ^suggests that the sparklet 
is necessary for Ca^ "^  spark production and not merely changes in 
membrane voltage.
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1.15 How many RyRs contribute to a Ca^* spark?
Originally Cheng et al (1993) suggested that a Ca^  ^ spark was due to the 
flux associated with a single RyR (4pA x 10s) [31]. However, since it is now 
recognized that the Ca^  ^ flux through a single RyR is approximately 0.35- 
0.6pA [42] the Ca^  ^spark must be a product of a number of RyRs. Wang 
et al (2001) using visualisation of the sparklet and Ca^  ^ spark showed that 
the rate of rise of the sparklet is seven times lower than Ca^ "^  sparks and 
from this the Ca^ "^  spark flux is calculated as approximately 2.1 pA [41]. 
This is in agreement with other studies (2-1 OpA) [31;43;44]. Hence a 
sparklet [41] is thought to trigger 4-6 RyRs to generate a Ca^ "" spark. 
Various studies produce results that resemble these numbers of RyR (6-20) 
[45;46]. Large numbers of RyRs (90-267) in a dyadic junction have been 
revealed using micrographs [47]. On average there are thought to be 100 
RyRs [48]. In summary, functional studies suggest that various numbers of 
RyRs are in a functional cluster. These estimates are all less than 
ultrastructural micrographs measurements would suggest.
1.16 How do Ca^* sparks contribute to the graded amplified nature of 
CICR
Entry of Ca^  ^ via LCCs only acts as a trigger for Ca^  ^ sparks. The spark 
size does not get larger if a greater amount of Ca^  ^ comes through LCC. 
How then is the trigger graded and amplified? The graded nature of CICR 
is a result of altering the probability of Ca^  ^ spark production. This explains 
the complex relationship between Ic a . ic a , Ca^ "' transient amplitude, and E m  
discussed earlier. It must be remembered though that the Ca^" spark is a 
function of the RyR and although whether it is elicited, depends on the
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above parameters, once triggered, is independent of them. How then is 
trigger amplified? Cannell et al (1995) discussed how amplification comes 
from two mechanisms [34]. Firstly, the conductance of the RyR (2.2pA - 
see NB. below) [49] is greater than the LCC (0.3pA) [50]. Secondly, since 
RyRs are thought to be clustered and governed by a single or smaller 
number of LCCs, the conductance will be further increased [28;51]. This is 
referred to as analogue gain. (NB. Cannell et al (1995) had suggested that 
the flux associated with a single RyR was 2.2pA using a study by Rousseau 
et al 1989 [49]. While this value agrees with the flux associated with a Ca^ "" 
spark (2.1 pA) it does not agree with recent estimates of the unitary Ca^  ^
associated with the RyR (0.35-0.6pA) [42]). The final conclusions about 
analog gain are not changed however since the flux from the whole cluster 
producing the spark is still much larger than ica)- Thirdly, once triggered by 
LCC the cluster of RyRs will produce Ca^  ^ release that is regenerative but 
unable to reach the next cluster (as discussed above). The duration of this 
type of release is longer than the release associated with a LCC. This type 
of amplification has been referred to as digital 'pulse stretching' gain [34] 
(Figure 1.11).
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Figure 1.11 The analog and digital gain of CICR
A schematic to illustrate digital and analog gain. Both of these processes contribute to the
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amplification factor applied to a small trigger [Ca^ "^ ] via the dihydropyridine receptor/LCC, 
which opens (O) and closes (C). The product of the analog and digital gain represents the 
overall gain of CICR. (Figure taken from Cannell et al. (1995) Science 268,1045-1049).
1.17 How is a spark terminated?
So far the discussion has focused on how Ca^ "^  sparks are triggered. 
However, once triggered the RyR cluster releases Ca '^' independent of the 
entry of Ca^ "^  via LCC. In fact Cannell et al (1990) showed that the 
intracellular [Ca^ ]^ during a transient continues to rise for approximately 
10ms after Ica has terminated [34]. This suggests that once triggered the 
Ca^ "^  spark continues to rise due to the intrinsic function of the RyR cluster. 
The spatial separation of the clusters, which is thought to be present, 
prevents a global all-or-none response. However, within a cluster the 
response is very much a positive feedback event that requires a 
mechanism to terminate. This is essential if the [Ca^ "^ ] in the cleft is to 
diffuse away and thus be ready again for initiation on the next stimulation. 
How does termination therefore occur? There are various theories.
Before Ca^" sparks were visualised. Stern (1992), had suggested several 
mechanisms for RyR cluster termination [28]. One such mechanism is 
stochastic attrition. This would suggest that at any particular moment 
after being triggered a proportion of RyRs within a cluster could close at the 
same time by chance. This would lower the threshold for further 
regenerative release and the remainder of the RyRs in the cluster would 
close. However while this mechanism certainly holds true for 3-6 RyR this 
becomes harder to accomplish if more RyR receptors are involved in the 
cluster, in fact if 10 RyR are involved then the cluster tends to ‘latch open’
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[28]. Since the number of RyRs in a cluster is controversial and may be as 
high as 100 [52] this mechanism is not likely to be the sole reason for Ca^ " 
spark termination.
Fabiato (1985) proposed a model whereby Ca^*-dependent inactivation of 
RyR could prevent an all-or-none response (discussed above). This 
particular mechanism has not been observed in intact cardiomyocytes, in 
fact the opposite has been observed when simulated by caging compounds 
[24]. The mechanism has been observed in isolated SR vesicles, however 
the [Ca^T required to inactivate the channel was in the mM range 
(approximately lOmM) whereas the [Ca^^ thought to be in the vicinity of the 
RyR cluster is 10-100|iM [53]. Physiological solutions also result in shifts of 
the [Ca^ ]^ dependence of release far to the right of Fabiato’s work 
[54][13;15;551 Using confocal imaging and the use of Ca^  ^ spikes, Sham 
et al (1998) demonstrated that use-dependent inactivation of RyRs is the 
main mechanism for Ca^  ^ spark termination, while ruling out stochastic 
attrition or depletion of local SR Ca^  ^ [56]. LCC triggers are able to 
produce Ca^  ^ spikes but when repeated or prolonged are unable to 
reproduce those spikes. Furthermore, tail currents are also unable to 
reactivate the Ca^  ^ spikes. This is described as absorbing inactivation 
since the RyR cannot open again until it recovers. A problem with this 
experiment however was the use of high concentrations of EGTA (4mM) to 
produce Ca^  ^ spikes which may hide the real mechanisms occurring since, 
(1) additional buffering may decrease the ability of RyR to activate other 
RyRs within a cluster and therefore alter Ca^ "^  spark morphology, and/or (2) 
reduced activation of adjacent RyRs may indirectly reduce inactivation,
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and/or (3) additional cell buffering may decrease Ca^  ^ uptake by SERCA 
leading to SR Ca^  ^depletion [9]. It is therefore unknown how important this 
potential mechanism is in Ca^  ^spark termination. Wang et al (2001) using 
visualisations of sparklets and Ca^ "^  sparks showed that the coupling fidelity 
between the two events is 0.71 on the first trigger but decreases to 0.30 if 
the stimulation occurs again at the same site [41]. This also suggests some 
kind of use-dependent inactivation however it is hard to separate this from 
local SR Ca^  ^depletion that may also aid the termination of Ca^  ^sparks.
It is also possible that RyR adaptation aids Ca^  ^ spark termination. 
Adaptation occurs when after activation of RyR the initial high open 
probability reduces gradually to a lower open probability but still maintains 
its ability to be reactivated by a sufficient trigger. However, this may occur 
too slowly and incompletely for Ca^  ^spark termination [9;57;58].
It is possible that local SR depletion occurs in the vicinity of the Ca^  ^
spark and therefore reduces the possibility that the cluster is able to release 
further Ca^ "^ . However this is hard to reconcile with observations of 
prolonged Ca^ "^  sparks (>1s) during application of low concentrations of 
ryanodine. These Ca^ "^  sparks manage to maintain constant amplitude, 
which would be hard to achieve if the local SR [Ca^ "^ ] were being depleted 
[31]. Furthermore during a Ca^ '" transient, the SR is not thought to 
completely empty of Ca^ "^  [59;60]. It could be that movement of Ca^  ^from 
different sites within the SR play an important part in maintaining a 
releasable amount of Ca^  ^while preventing full SR depletion.
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SERCA molecules within the vicinity of RyR clusters (co-localised) could 
act to terminate Ca '^" sparks by aiding faster diffusion of Ca^  ^ from the 
release sites and thereby increasing the probability that the cluster closes 
by stochastic attrition. However, no evidence exists for this theory at 
present.
It can be seen that each of the above mechanisms have evidence against 
the likelihood of it being the prime way in which Ca^  ^ sparks terminate, 
however one recent study devises a theory which fits the majority of 
experimental data [48]. Recent anatomical observations suggest that 
clusters of RyRs are arranged in arrays such that, the channels touch each 
other at their corners, with an accessory protein called FK-506 binding 
protein (FKBP) at or near the point of contact [61;62]. A model called the 
“sticky cluster model” (Figure 1.12) incorporates this concept. The “sticky” 
refers to the observed phenomenon of ‘coupling’ that exists between 
isolated RyRs due to the accessory protein FKBP, i.e. FKBP allows for 
simultaneous openings/closings of RyRs when grouped together [63].
FKBP
(RYR),
Figure 1.12 The ‘sticky cluster model’
A schematic illustrating the location of FKBP in relation to the RyRs within a cluster.
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(Figure taken from Sobie et a/.(2002) Biophys. J. 83, 59-78).
There are three major themes that underlie this model: (1) by defining 
coupling, using a cooperativity factor (1 being high, <1 - reduced coupling) 
a reduction in this parameter prolongs Ca^ "^  sparks, i.e. clusters of RyRs are 
unable to efficiently switch off and terminate the Ca^  ^ spark, (2) increases 
of sub space and SR luminal [Ca^ j^ lead to an increase in frequency of Ca^  ^
sparks, however, an increase in SR luminal [Ca^ "^ ] (while increasing Ca^  ^
spark frequency in a highly non-linear fashion) does not affect duration 
except at very low [Ca^^ where Ca^ "^  sparks terminate prematurely (3) the 
above observations are seen with a control number of 50 RyRs within a 
cluster, however the Ca^  ^ spark duration is relatively insensitive to RyR 
cluster size if between 10-100.
The process of inactivation or adaptation is not required within the model 
presented above, however, as suggested, this does not rule out the 
possibility that these mechanisms play a role in Ca '^’ spark termination. 
Stochastic attrition is however intrinsic to the above model and together 
with luminal Ca^  ^ regulation of RyR and a cooperativity factor, a good 
stable model of Ca^ "^  spark termination has been established.
One major problem with this study is the inability to match the simulated 
Ca^ "^  spark width to that found in experiments. Model Ca^ "^  sparks were 
almost half the size of those found in experiments. This could be due to 
insufficient knowledge regarding parameters associated with Fluo-3 
binding/buffering.
58
Excitation-Contraction coupling and Ca^^ sparks and waves
It seems therefore that accessory proteins associated with RyR can have 
an effect on CICR, FKBP in particular in terms of Ca^ "" spark termination. 
Ca^ "^  spark termination is essential if a local regenerative response is not to 
proceed and lead to abnormally large amounts of diastolic SR Ca^  ^ leak. 
Both of these events could be detrimental to Ca^ "^  homeostasis and 
ultimately the contractile function of the ventricular cardiomyocyte. One of 
the main aims of this thesis is therefore to examine whether or not FKBP 
does affect the size and frequency of Ca^ "^  sparks in rabbit ventricular 
cardiomyocytes, using the two techniques of cell permeabilisation and 
FKBP over-expression. There are many factors, which could affect Ca^  ^
release from the SR and therefore alter Ca^ "” spark size and frequency. 
This thesis will largely focus on the role FKBP has in altering these Ca^ "^  
sparks parameters.
When attempting to measure Ca^  ^ sparks in permeabilised cells, as this 
thesis sets out to do, there are perhaps two further questions that must be 
considered.
1.18 Can Ca^* sparks and waves be measured in permeabilised 
ventricular cardiomyocytes, and if so, are they the same as those in 
intact cells?
Gyorke et al (1999) has established that spontaneous Ca^  ^ sparks and 
waves can be observed within permeabilised ventricular cardiomyocytes 
and have the same characteristics as those measured in intact cells [64]. 
Manipulations performed in intact cells can also be performed in 
permeabilised cells, e.g. applications of caffeine, intracellular buffers
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(EGTA), as well as drug manipulations not able to be performed in Intact 
cells due to being membrane impermeable, e.g. application of cytosolic 
adenosine diphosphate-ribose (cADPR) and calmodulin [64].
Perhaps the most important aspect when comparing and quantifying Ca^  ^
waves is ensuring that cellular conditions are kept the same between two 
populations of cells. The main advantage of the permeabilised cells is that 
this can be done with a high degree of accuracy not achieved by 
measurements in intact cells due to easier access to the intracellular 
environment. This is very important in regards to the following question:
1.19 What are the effects of intracellular [Ca^T and SR [Ca^T on Ca^* 
sparks?
Under normal conditions these two parameters are probability interrelated 
in that increases in intracellular [Ca^ ]^ lead to increases in SR [Ca^H- 
However both parameters can affect Ca^  ^sparks and waves independently.
1.20 Regulation of Ca^* sparks by [Ca^*] within the SR lumen
Satoh et al (1997) established much of the initial investigations. In rabbit 
ventricular cardiomyocytes a decrease in SR [Ca^^ content leads to a 
reduction in spark frequency, even when intracellular [Ca^ ""] remains 
unchanged, the converse is also true in that increases of SR [Ca^ ]^ lead to 
increases of Ga^  ^ spark frequency, until macro-sparks are formed and 
eventually Ca^ "^  waves [31 ;65]. The relationship between intracellular [Ca^ ""] 
and spark frequency is the same as for SR [Ca^T content. The amplitude 
of Ca^ "^  sparks has also been found to increase with greater SR [Ca^ ]^ [65]. 
During post rest decay in rabbit ventricular cardiomyocytes a gradual decay
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in SR [Ca^T content occurs and a concurrent decrease in the frequency of 
Ca^ "^  sparks [65]. The same study also provided evidence for time- 
dependent recovery of Ca^  ^ spark events during rest after periods of 
stimulation when SR [Ca^ "^ ] and intracellular [Ca^ "^ ] were not changed in rat 
cardiomyocytes, and in rabbit cardiomyocytes, where Ca^  ^ extrusion from 
the cell was prevented by inhibiting NaVCa^ "^  exchange.
The effect of increased SR [Ca^ "^ ] content on the frequency of Ca^  ^sparks 
and eventually the production of Ca^ "^  waves could reflect an increase in 
sensitivity to Ca^ "^  of the RyR by cytosolic activation or a more direct 
activation by luminal SR [Ca^ ""]. The use of the local anaesthetic, tetracaine 
has provided much information on luminal regulation of RyR [33]. 
Tetracaine has a biphasic effect on the RyR. Firstly, the drug inhibits RyR, 
decreasing the frequency and amplitude of sparks and the frequency 
of Ca^ "^  waves, but secondly, and rather paradoxically, then goes on to 
produce late potentiation of RyR mediated Ca^ "^  release increasing the 
frequency of these events. This only occurs at intermediate concentrations 
of the drug (0.25-0.75mM). At higher doses (>1.25mM) RyR mediated Ca^ "" 
release is terminated. The late potentiating effect of tetracaine has been 
shown to occur because of a gradual increase in SR [Ca^^, (while RyR 
Ca^  ^ release is inhibited); eventually overcoming RyR inhibition and 
perhaps activating the channel by direct luminal activation. There are a 
number of studies suggesting a role for luminal SR [Ca^ "^ ] in regulating RyR 
Ca^ "^  flux. Work has been performed using isolated RyR channels [66], and 
molecular mechanisms altering the Ca^ "^  sensing sites on the luminal 
surface [67]. One study however has shown no significant effect of partial
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depletion of SR Ca '^' content on Ca '^’ sparks [68].
1.21 RyR activity and SR Ca^* ieak
The leak associated with Ca^  ^ sparks at rest on SR Ca^  ^ content in some 
studies is thought to be significant factor in Ca^  ^ homeostasis [33;46;69-71] 
and in others, however not [60;72].
Finally, Ca^  ^ transport mechanisms can have an effect on Ca^  ^ spark 
morphology. For instance, when the main Ca^ "^  removal mechanisms are 
inhibited (SERCA and NaVCa "^^  exchange) Ca^ "^  spark decline is decreased 
by 26% together with increases in spatial spread. The converse is 
observed when SERCA uptake rate is increased. This indicates the 
importance of removal mechanisms perhaps in aiding spark termination 
[73].
It can be seen that there is much evidence for the regulation of Ca^  ^ spark 
frequency and morphology by cytosolic and SR [Ca^ "^ ]. It is therefore 
essential that these are considered when performing Ca^  ^ spark and wave 
measurements and this concept underlies much of the thought behind the 
development of experimental protocols within this thesis.
1.22 Other sources of entry
Work previous to Stern's (1992) theoretical paper had also suggested the 
importance of cardiomyocyte ultra-structure in regulating EC-coupling [28]. 
In fact together with observations made by Cannell et al (1987) (that 
substantial Ca^  ^ transients could be triggered with minimal L-type Ca^  ^
currents) other routes of Ca^ "^  entry able to trigger Ca^ "^  transients were
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Investigated [26].
u_
Intracellular
space
Figure 1.13 The fuzzy space’
A schematic illustrating the location of the restricted space envisaged to enable entry of 
Ca^^ via the NaVCa^^ exchange. The NaVCa^^ is located on the sarcolemma denoted by 
the doubled line. (Figure taken from Lederer (1990) Science  248, 283).
Leblanc and Hume (1990) showed that the Na^/Ca^^ exchanger could 
contribute to contraction during EC-coupling in the absence of an L-type 
Ca^  ^ current [74]. This contraction is TJX (tetrodotoxin) sensitive, i.e. it 
relies on influx of Na^ to raise intracellular [Na^ levels such that the 
Na^/Ca^^ exchange works in reverse in order to bring Ca^  ^ into the cell and 
trigger SR Ca^  ^release.
Lederer et al (1990) suggested though that the concentration of [Na^ could 
only be achieved if a micro-domain was present between the sarcolemma 
and the SR Ca^  ^ release channel [75]. This was termed the 'fuzzy space' 
(Figure 1.13). However, this result was contested by Sipido et a! (1995) 
and others due to possible discrepancies in SR Ca^^ load or the actual cell 
voltage [76].
There is however another way in which influx of Ca^^ can arise on the
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NaVCa^^ exchanger. Em drive such that the membrane voltage increases 
above the reversal potential, e.g. during the rapid depolarisation of the 
action potential [77] can lead to Ca^  ^ influx [78]. At more positive potentials 
with higher intracellular [Na ]^ the bell shaped curve of voltage dependence 
on contraction becomes skewed such that there is a greater contraction at 
more positive potentials. This suggests that more Ca^  ^ enters the cell via 
the NaVCa^ "^  exchange as membrane potential increases. Sipido et al 
(1997) again contested this [79]. A normal bell shaped relationship was 
observed in this latter study using high intracellular [NaT (20mM) in the first 
20ms of the change of intracellular [Ca^T but the skewed relationship 
described by Litwin at al (1998) was seen at longer times (250ms) [78]. 
Sipido at al (1997) concluded that the NaVCa^ "^  exchange was four times 
less efficient at triggering SR Ca^  ^ release due to the relatively long delay 
associated with Ca^  ^ influx using the exchanger compared to LCCs [79].
Other possibilities of Ca^  ^entry include, T-Type/TTX sensitive Ica, and entry 
of Ca^  ^through Na  ^channels 'slip mode conductance'. Other authors have 
suggested that CICR is not required in cardiomyocytes and the source of 
the Ca^ "^  transient is driven by voltage dependence or aided by inositol 
1.4.5-triphosphate (IP3) -induced SR Ca^  ^ release. These mechanisms are 
reviewed elsewhere [9], and evidence for and against these mechanisms is 
out with the scope of this thesis since this study mainly concerns itself with 
permeabilised cells in which the function of sarcolemmal Ca^  ^ entry is 
bypassed.
CICR triggered by LCCs is the most favoured mechanism thought to
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activate the myofilaments, with the possibility that the process is aided by 
Ca^  ^entry via the NaVCa^ "^  exchanger [6].
1.23 Cardiomyocyte relaxation
Ca^  ^ dependent activation of the myofilaments results ultimately in cellular 
shortening and/or tension development. Ca^  ^ binds to troponin C that in 
turn increases its association with troponin I, thereby removing the 
molecule from the actin filament. Troponin T and tropomyosin as a 
complex are shifted to enable exposure of the actin filament to the myosin 
filament resulting in cellular shortening. To allow the heart to refill with 
blood and efficiently maintain cardiac output, filament relaxation must occur 
such that the filaments return to their original length. There are four main 
routes (presented below) by which Ca^ "^  can return to diastolic levels in 
order for this to occur.
1.23.1 SR mediated Ca^* uptake
In most mammalian species, this is the main route whereby Ca '^’ is 
removed from the myoplasm during a transient although the relative 
contribution differs from species to species. In rabbit, the fraction of Ca^ "^  
transported by the SR during relaxation is 70% whereas, in the rat is 92% 
emphasising the dominance of the SR in ventricular contraction and 
relaxation in this species [80]. Uptake of is mediated via a SR Ca^ "" 
ATPase pump also referred to as the sarco(endo)plasmic reticulum Ca^ -^ 
ATPase (SERCA). Two Ca^  ^ are transported in exchange for one ATP 
molecule [81]. Phospholamban is an endogenous inhibitor of the SR Ca^ "^  
ATPase pump but its inhibition can be relieved by phosphorylation by 
cAMP-dependent protein kinase (PKA). Uptake of Ca^  ^ into the SR can
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also be prevented by the application of thapsigargin which binds to SERCA 
and prevents further cycling of this enzyme [82;83], or cyclopiazonic acid 
[84].
1.23.2 Ua*ICa^* exchange
This route contributes to 28% in the rabbit and 7 % in the rat [85]. This 
route is reversible with a stoichiometry of 3 Na  ^ to 1 Ca^  ^ During diastole, 
this mechanism works in the forward mode to extrude Ca^ "". However, this 
exchanger may work in the reverse mode to bring Ca^  ^ into the cell and is 
therefore a potential source of Ca^  ^entry during CICR [75].
1.23.3 Sarcolemmal mediated Ca^* extrusion
Ca^  ^ extrusion is mediated via a Ca^  ^ ATPase pump and contributes less 
than 2% and 1% in the rabbit and rat respectively [80]. Ca^ "^  extrusion can 
be further enhanced via this route by Ca^^-calmodulin and PKA dependent 
phosphorylation. One Ca^ "^  is transported per molecule of ATP hydrolysed 
and maybe linked to proton influx [86]. This pathway for Ca^ "^  extrusion 
together with mitochondria can be regarded slow since it would take 
approximately 60s for relaxation to occur after a Ca^  ^ transient had been 
triggered if all other pathways were blocked [87].
1.24 Mitochondria
Even though this organelle occupies 35% of the cell volume, the role of the 
mitochondria in Ca^  ^ handling on a beat-to-beat basis is not thought to be 
significant. Its relative removal contribution is the same as Ca^  ^ extrusion 
via the sarcolemmal Ca^  ^ ATPase pump. However mitochondria have a 
considerable potential for Ca^  ^ uptake, which can be further enhanced in
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the presence of inorganic phosphate and subsequent precipitation into 
insoluble Ca^ "^  phosphate (matrix loading). If mean cellular Ca^ "^  is raised 
sufficiently Ca^  ^ uptake by this route on a beat to beat basis does become 
significant and under these circumstances, the accumulation may act to 
preserve cell function [88].
1.24.1 uptake into mitochondria
Two pathways exist which allow Ca^ "^  uptake into the mitochondria. The 
first is the Ca^  ^ uniporter. The interior of the mitochondria has a largely 
negative potential such that Ca^ "" is driven into the organelle by this 
electrochemical gradient [89]. Carbonyl Cyanide m-
Chlorophenolhydrazone (CCCP) is a protonophore which inhibits the proton 
motive force and therefore inhibits the uniporter. The second route for Ca^ "” 
uptake is the rapid uptake mode. This mode is again dependent upon the 
large electrochemical gradient and may be related to the Ca^  ^ uniporter 
[90].
1.24.2 Inhibiting mitochondriai uptake
When attempting to prevent uptake of Ca^  ^ into the mitochondria, 
ionophores such as CCCP can be used. However it is important that 
oligomycin is also included. Oligomyocin is an antibiotic, which acts by 
inhibiting the Fo component of the H^-ATP synthase [91]. It inhibits 
therefore oxidative phosphorylation and minimises the mitochondrial ATP 
consumption during exposure to CCCP [87].
1.24.3 Ca^* efflux from mitochondria
Efflux of Ca^ "" from the mitochondria is thought to exist via two main routes.
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The first is the Na  ^ independent pathway. Ca^  ^ is exchanged for against 
an electrochemical gradient. The second is the Na  ^ dependent pathway. 
This relies on a NaVCa^^ exchanger. The stoichiometry is thought to be 
3Na"^  for each Ca^  ^[92].
A final route in which the mitochondria may use to exchange substances to 
and from the cytosol is the Permeability Transition Pore (mPTP). This may 
allow the free permeation of low molecular weight solutes under certain 
conditions [90].
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General methods
2.1 Rabbit ventricular cardiomyocyte isolation
Cell isolation was performed by one of two experienced technicians (Ann 
Ward and Aileen Rankin) with additional assistance provided by myself.
2.1.1 Isolation procedure
The procedure is based on the principle that cells within the intact heart can 
be isolated by gradual removal from their associated connective tissue and 
cellular syncitium. Before isolation can begin thorough cleaning of 
perfusion equipment was carried out. 2-31 of double distilled water was 
perfused through the system followed by 1-21 of sterile water. New Zealand 
White rabbits (2-2.5kg) were given an intravenous injection of 500U heparin 
together with an overdose of sodium pentobarbitone (lOOmg/kg). The 
hearts were rapidly excised, weighed and cannulated onto a Langendorff 
perfusion column via the aorta. The hearts were perfused in a retrograde 
fashion at a rate of 25ml.min-1 (37°C), initially with 150ml of Krebs 
Henseleit solution with the following composition (mM): 120 NaCI, 20
HEPES, 5.4 KCI, 0.52 NaH2,P0 4 , 3.5 MgCl2.6H20, 20 Taurine, 10 Creatine,
11.1 Glucose; pH 7.4 with NaOH at 37°C. [Ca^T within this solution is in 
the order of 6-7|liM  due to Ca^ "" contamination. This solution aids in 
washing away blood and reduces the probability of clot formation. Taurine 
may aid in cardio-protection against Ca^  ^ paradox [93;94]. Thereafter, the 
hearts were perfused for 1 min with Krebs Henseleit solution supplemented 
with 1.4 mg mb'* collagenase (type 1, Worthington Chemical Co.), 0.1 mg 
m|-1 protease (type XIV, Sigma Chemical Co.) and a further addition of 
SOpM CaClg to activate the enzymes. After a time, such that the enzyme
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solution had fully perfused the heart and equipment the enzyme containing 
solution was re-circulated for a further 6min. The heart was then perfused 
with a 0.1% Bovine Serum Albumin (BSA) Krebs Henseleit solution with the 
addition of 62pM CaCI^. The BSA containing solution provides extra
substrate for superfluous enzyme. The atria were removed and discarded 
whereas the right and left ventricle was kept for experiments.
2.1.2 Cells required for permeabilisation experiments
If cells were required for permeabilised cell work then the chosen ventricle 
was carefully cut into small pieces and placed into a culture flask containing 
20ml of the Krebs Henseleit solution. The flask was gently shaken at room 
temperature for 30-60min. After the appropriate time the cell suspension 
was filtered using 250p,m mesh and the filtrate centrifuged. The pellet was 
re-suspended in Krebs Henseleit solution. The cell concentration was 
approximately lO^^ cells.ml \
2.1.3 Cells required for intact cell experiments
If cells were required for intact cell work then the chosen ventricle was 
carefully cut into small pieces and placed into a culture flask containing 
20ml of the 0.1% BSA containing Krebs Henseleit solution described 
above. This solution also contained 0.125mM CaCb. The suspension was 
gently shaken for 30-60min. After the appropriate time the supernatant was 
removed and the cells re-suspended into 0.1% BSA containing Krebs 
Henseleit solution containing 0.25mM CaCb- This process was repeated in 
the same solution containing increasing amounts of CaCb (0.5mM and 
ImM CaCb). This gradual increase in [Ca^ ]^ is thought to prevent the Ca^ ^
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paradox and subsequent damage to cellular membranes [94;95]. The 
Langendorff perfusion system was then cleaned using 21 of boiling water, 11 
of 100% ethanol and 10-121 of double distilled water.
2.1.4 Primary ventricular cardiomyocyte culture
Isolated rabbit ventricular cardiomyocytes were prepared as above under 
sterile conditions, with some subtle changes to the methods. All solutions 
had previously been filter sterilised and prepared with sterile water and 
autoclaved glassware. Perfused tissue was cut down and placed in a 
solution containing 0.1% BSA in sterile glassware and the tissue finely 
chopped using autoclaved instruments in a laminar flow hood. The 
chopped tissue was then placed in tissue culture grade sterile flasks and 
gently shaken at room temperature for 30-60min. The following steps were 
performed using aseptic technique in a laminar flow hood. The supernatant 
was removed and placed into sterile 15ml centrifuge tubes. The cells were 
allowed to sediment by gravity. The supernatant was removed and the 
pellet re-suspended in Krebs’ solution containing 125|iM CaCb. Again the 
cells were allowed to sediment by gravity, the supernatant removed and the 
pellet re-suspended in Krebs’ solution containing 250)iM CaCl2. This step 
was repeated twice more and successively raised the extracellular Ca^  ^ to 
500p,M and then ImM. The cells were counted using a haemocytometer, 
the cells subjected to gentle centrifugation and the pellet re-suspended in 
M l99 medium (supplemented with 312.5mg Taurine, 500mg D,L Carnitine, 
327.5mg creatine, 5ml penicillin/ streptomycin per 500ml) to a concentration 
of 1x 10® cells.ml'\
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2.2 The use of recombinant adenovirus to transfect adult 
cardiomyocytes
Recombinant adenovirus vectors are genetically modified forms of natural 
adenoviruses, which can be used to express a protein of choice within adult 
cardiomyocytes. If the DNA sequence codes for a naturally occurring 
protein, this protein is over-expressed. This technique can be used 
therapeutically in cases where the protein is absent due to a defective 
gene, i.e. gene therapy. The technique can also be used to study the 
function of a protein. A major part of this thesis concerns itself with the 
functional consequences of over-expressing FKBP 12.6 within adult rabbit 
cardiomyocytes. This is achieved by the construction of an adenovirus, 
which acts as a vector for the FKBP12.6 DNA sequence. This sequence 
(under the control of incorporated promoters) leads to the enhanced 
production of the protein within the cardiomyocyte. Within this thesis, three 
such viruses have been used: Ad-FKBP12.6, Ad-FKBP12.6 mutant lacking 
a calcineurin binding site and a control virus that over-expresses p- 
galactosidase (Ad-LacZ). In this way the function of FKBP12.6 and the 
mutant can be investigated and compared to a control (Ad-LacZ) virus. The 
work involved in constructing and propagating the adenovirus vector was 
meticulously performed by Dr Tim Siedler and Dr. Jurgen Prestle from the 
University of Goettingen and Dr. Debbie Reynolds from the University of 
Glasgow. The amount of work and variety of molecular techniques used to 
create these viruses is out with the scope of this thesis which essentially 
only concentrates on the functional consequences of their subsequent 
transfection into cardiomyocytes. However a brief over view will be 
presented below:
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2.2.1 Adenovirus
Adenoviruses are double stranded DNA viruses with an icosahedral capsid 
approximately 80nm in size (Figure 2.1). The virus is assembled in the cell 
nucleus and exists as several serotypes in most host species. To gain 
entry to the host cell the virus is adsorbed to the cell membrane and 
endocytosed. Once inside the cell the virus leaves the endosome and is 
released into the cytosol.
Hexon
Figure 2.1 The capsid of a typical adenovirus
The capsid is icosahedral with 252  capsomeres. There are 12 points of five-fold 
symmetry. The polypeptides that form the hexon and penton are distinct. (Figure and text 
description adapted from University of Glasgow, Veterinary School, U.K. virology notes. 
Prof. Oswald Jarrett).
The virus particles make their way to the nuclear pores where their DNA 
genome is released and passed into the nucleus. The replication of the 
virus occurs in two stages: early and late events (Table 2.1).
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2.2.2 Generation of the Ad-FKBP 12.6 virus
This following description follows the methods of Becker et al (1994) that 
have been adapted by the above co-workers for FKBP12.6 [96]. 
Essentially two plasmids are formed. The first plasmid (circular DNA) 
contains the cDNA of FKBP12.6. The second plasmid is called a shuttle 
vector, which contains a cytomegalovirus (CMV) early promoter to drive 
transcription of the cDNA of interest. The shuttle vector also contains 
fragments of the adenovirus (type 5) genome and an ampicillin resistance 
gene. The two plasmids are linearised by restriction enzymes 
{EcoRI/Hindlll) and purified. The first plasmid can therefore be inserted into 
the shuttle vector within E.coli bacteria. Bacteria, which have this combined 
vector, can then be selected according to their resistance to ampicillin 
(Figure 2.2).
Transcription Function
map area
E1a First gene to be transcribed and this activates other early genes.
E2 Encodes enzymes and proteins necessary for DNA replication.
E3 Encodes genes unnecessary for replication in vitro but aids virus growth
in vivo by interfering with host immune response.
E4 Dispensable Ibr growth vif/o but important for replication rnv/vo.
encodes genes that shut down host ceil protein synthesis and regulates 
late gene synthesis.
Late genes Encode for structural proteins.
Table 2.1 The function of various regions of the transcriptional map of a typical 
adenovirus
The adenovirus genom e consists of double stranded D NA approximately 36kb long. Viral 
replication is divided into early and late events. (Figure and text description adapted from  
University of Glasgow, Veterinary School, U.K. virology notes. Prof. Oswald Jarrett).
To allow amplification of this combined plasmid the circular DNA is co­
transfected into HEK 293 cells with another plasmid (pJM17), which is
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derived from the adenovirus (type 5) genome with the E1 region of the 
genome (which is essential for viral replication) deleted. The absence of 
this region makes it possible to allow site-specific recombination and 
subsequent insertion of oDNAs. The E1 function is complemented in HEK 
293 cells thus allowing propagation. Co-transfection of pACCMV.pLpA and 
pJM17 is followed by homologous recombination to generate a functional 
adenovirus with the FKBP12.6 cDNA incorporated (Figure 2.2).
2.2.3 Infection with adenovirus
Adult rabbit cardiomyocytes were infected with Ad-FKBP 12.6, Ad- 
FKBP12.6 calcineurin mutant, or Ad-LacZ. The infectivity of each virus had 
been assayed and expressed as a plaque forming unit.mM (pfu.ml'^) by Dr 
Tim Siedler from the University of Goettingen and Dr. Debbie Reynolds 
from the University of Glasgow who had also constructed the viruses. The 
methods involved with this procedure are out-with the scope of this thesis
[96]. Virus infection took place using a multiplicity of infection (MOI) of 100. 
This essentially means that 100 virus particles were used to infect each 
cell. After 48hrs of culture this resulted in at least 90% of the cells 
transfected (originally established by the workers above). Over-expression 
levels of these proteins were thought to be approximately 5 fold. In order to 
use permeabilisation techniques in these cultured cells the [Ca^T in the 
M199 culture medium/cell suspension was diluted three-fold and ImM 
EGTA added.
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Figure 2.2 Construction of Ad-FKBP12.6
Refer to text for detailed description. (Figure taken from Debbie Reynolds’ doctoral thesis 
2003 with permission).
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METHODS
Cell Permeabilisation and Laser Scanning Confocal Microscopy
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2.3 Cell permeabilisation of cardiomyocytes
The ability to equilibrate an extracellular solution with the cell interior has 
been pivotal in elucidating cardiomyocyte function. Various techniques 
have been used to by-pass the sarcolemmal barrier. Mechanical removal 
(‘skinning’) of this membrane by meticulous micro-dissection was used to 
first identify the process of CICR within cardiomyocytes [14;95]. On cells as 
small as ventricular cardiomyocytes this is by no means an easy task and 
hence simpler techniques have been investigated. Winegrad (1971) 
attempted to use chemicals such as EDTA to skin strips of frog ventricle
[97]. However, whether this was actually achieved has been debated [98]. 
Therefore, non-ionic detergents such as Brij58 and Triton x -100 were used 
to skin cardiomyocytes. However, while myofilaments remain unaffected 
by such treatments the SR may be damaged [99]. Since this thesis 
investigates spontaneous Ca^  ^ release from the SR, the above agents are 
not helpful. However, one agent, discussed below is currently used to 
successfully permeabilise cardiomyocytes.
2.3.1 p-escin
The source of p-escin is the Horse Chesnut tree {Aesculus 
hippocastanum). The tree seeds contain an active triterpene saponin 
mixture known as escin [100]. p-escin is therefore related to saponins, 
which are glycosides of triterpenoids or steroids (acetal form of glucose) 
[101]. The saponin molecule consists of a non-carbohydrate component 
(aglycone/sapogenin) and a carbohydrate component (sugar chain/s 
attached via glycoside/ester linkage), p-escin is based on the aglycone 
protoescigenin [102].
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2.3.2 Mechanism of action
The mechanism of action involves formation of complexes with
sterols/cholesterol located on the sarcolemma and subsequent lateral
displacement with the formation of aqueous pores (8-15nm) [103]. The 
agents are not thought to disrupt the SR since the relative content of 
cholesterol on this organelle membrane is very low (<2% of SR lipid 
content). Within this thesis, this possibility is further prevented by a very 
careful acute exposure of the permeabilisation agent to cardiomyocytes. 
This results in a functional SR which produces not only Ca^ "" waves but also 
produces Ca^ "^  sparks that required the coordinated release of Ca^  ^from a 
cluster of RyRs. This would be hard to achieve if the SR had been
damaged (in fact the production of Ca^ "^  sparks cannot occur if the
permeabilisation agent is left on for too long).
2.3.3 Minimum effective concentration
The concentration of p-escin used within this thesis to permeabilise 
cardiomyocytes was lOOpg.ml"  ^ for 0.5-1 min. The use of this 
concentration was elucidated by two independent assays (Ca^  ^ contraction 
assay and tryptan blue assay) within this laboratory. The above studies 
were carried out by Elspeth Elliott (BSc project). Some of the data 
produced in this report has been reproduced with permission in Figure 2.3. 
P-escin has a minimum effective concentration of lOOpg.mM that is, 95% of 
cells are permeabilised within 2min of exposure to the agent.
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Figure 2.3 Minimum effective concentration of p-escin
A known number of cardiomyocytes were exposed to p-escin for 2min at concentrations as 
denoted. This was performed in both a <1nM [Ca^"] solution (5m M EGTA) and a 20|iM  
[Ca^^] solution (5m M  EGTA) which resulted in contraction if cells were permeabilised. 
The minimum effective Ca^* concentration is the concentration of agent required to 
permeabilise 95%  of the population of cells. (Figure taken from Elspeth Elliott (BSc 
honours thesis) with permission).
However it is also clear from these studies that permeabilisation occurs 
over a concentration range of Ipg.ml'^ to lOOpg.ml'^ with 50% cell 
permeabilisation occurring at 8.3±1.1pg.m r\ The danger is to leave the 
permeabilisation agent on for too long. With this information in mind, 
lOOpg.ml"  ^ was the concentration of choice to permeabilise 
cardiomyocytes. The time of exposure to this chemical was variable but 
was approximately 0.5-1 min. Cell permeabilisation was performed 
simultaneously with confocal microscopy and a mock intracellular solution 
(see section 3.2.4) containing lOpM Fluo-3/5F and 150nM [Ca^'’].
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Permeabilisation of the cells was ascertained by a rise in intracellular 
fluorescence relative to the extracellular solution (see section 3.2.4) and the 
appearance of Ca^  ^ sparks. As soon as permeabilisation of the cell under 
study was achieved, the p-escin was immediately removed by subsequent 
perfusion with a solution of choice. Leaving the agent on for any longer 
may result in SR disruption. It is therefore not acceptable to perform ‘blind’ 
permeabilisation to measure Ca^ "^  sparks and waves, whereby cells are 
permeabilised as a batch and permeabilisation agent removed after a 
specific time period. This will result in some cells being rendered 
impermeable and (perhaps more detrimental) SR damage in others. It has 
been argued that saponin and not p-escin should be used for studying SR 
function, however these experiments were performed in skeletal muscle 
fibres with exposure times of 30min which would result in SR damage 
[1041.
2.3.4 Other uses for permeabilisation agents
Permeabilisation agents are not only used to equilibrate external and 
internal solutions. They can also be used to introduce exogenous 
molecules into the cytoplasm, e.g. antibodies [105] and antisense 
deoxynucleotides [106]. Enzymatic systems, exocytosis, and direct 
measurements of intracellular [Ca^ ]^ have also been investigated in 
permeabilised cell systems [105; 107]. Finally, since intracellular [Ca^T is 
known, the permeabilised cell system can be used to calibrate fluorophore 
characteristics (as described in section 3.2.4). This is harder to perform 
accurately within intact cells.
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2.3.5 Other permeabilising agents
Recently bacterial toxins have been used to permeabilise cardiomyocytes. 
The main bacterial toxin used in cardiomyocytes is Streptolysin-0 (SLO), a 
57kDa oxygen-labile prototype of the cholesterol-binding ‘thiol-activated’ 
cytolysin family [108; 109]. This is a pore-forming toxin produced by some 
gram-positive bacteria including Streptococci, Clostridia, and Listeria spp. 
The toxin targets cholesterol molecules within biological membranes. The 
binding is rapid (<1min). Pore formation involves the formation of an 
aqueous trans-membrane pore that displaces the lipid laterally. Pore 
formation is ATP independent and therefore the energy is derived from the 
conformational changes in the toxin molecules [110]. Essentially there is 
oligomerisation of toxin monomers to form partial or fully circularised protein 
complexes. Pores are very large (SOnm) and theoretically large enough to 
permit SLO to enter the cytoplasm, but this is probably rare since toxin 
molecules rapidly bind to and are trapped in the plasma membrane. The 
main problem with SLO seems to be the large pore sizes. This could lead 
to loss of intracellular components. One way around this problem could be 
the use of tetanolysin which is very similar to SLO but has the ability for 
pore sizes to be determined depending on the concentration of toxin used. 
Staphylococcal alpha-toxin is another pore-forming toxin that is also a 
single chain polypeptide. It is the most researched pore-forming toxin and 
hence is used as a model to which other toxins are compared. Alpha-toxin 
binds to an unidentified receptor. Receptor binding only occurs at low 
concentrations (<50nM). At higher concentrations (>200nM), the binding is 
indiscriminate to lipid bi-layers. This factor may limit its use within rabbit 
cardiac cardiomyocytes since the receptor within the sarcolemma has yet to
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be identified and the use of higher concentrations would lose the ability of 
the toxin to be sarcolemmal specific. In terms of pore formation the alpha- 
toxin is similar to SLO. The pore itself is selective for mono-valent ions and 
not a rapid flux of Ca^  ^ ions. This has obvious limitations in the 
measurement of intracellular [Ca^ ]^.
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2.4 Laser scanning confocal microscopy (LSCM)
Almost all the functional experiments presented in this thesis have been 
performed using Laser Scanning Confocal Microscopy (LSCM). The 
technique has been essential in enabling alterations in [Ca^ ]^ within 
ventricular cardiomyocytes to be dynamically tracked through space and 
time. The following is a brief account of the principles behind LSCM and 
the experimental set-up used within this thesis.
2.4.1 Tracking the dynamics of [Ca^*] within ventricular 
cardiomyocytes
In order to track Ca^  ^ the use of a specific probe for this ion is needed. The 
conventional probes used to track Ca^  ^ are called fluorophores. The two 
main fluorophores used within this thesis are Fluo-3 and Fluo-5F, the 
particular characteristics of which are extensively covered in chapters 3 and 
4 and will not be discussed further here. As the name suggests, 
fluorophores rely on the principle of fluorescence. Fluorescence is a type 
of luminescence in which light is emitted from a molecule for a very short 
period of time (10® to 10®s) following the absorption of light [111]. 
Fluorophores can absorb high-energy photons (e.g. from a LASER source) 
and achieve an excited state. Some energy is lost internally within the 
molecule but eventually fluorescence emission occurs with the release of a 
photon and a return of the molecule to the ground state. The photon 
emitted has less energy than the one absorbed. In practical terms this 
means that when using Fluo-3/5F the excitation wavelength may be blue 
(488nm) however the emitted wavelength that is collected is longer 
(>518nm) and appears green. The specific nature of the fluorophore for
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ensures that the higher the [Ca^T within the cell the greater the degree 
of binding to this molecule. This subsequently results in a greater amount 
of fluorescence produced. In this way the dynamic movement of Ca^  ^ and 
its concentration can be monitored over time. An accurate assessment of 
the [Ca^T within ventricular cardiomyocytes can only be achieved through 
thorough calibration with solutions of known [Ca^ ""] and dye characteristics 
(Refer to chapters 3 and 4).
2.4.2 How do we measure cell fluorescence?
The technique used to both excite the fluorophore and collect the emitted 
photons is LSCM. A laser source is used to excite the cellular medium 
containing the fluorophore. The excitation light is passed by a series of 
dichromatic mirrors. The dichromatic mirrors reflect light shorter than a 
determined wavelength, and pass light longer than that same wavelength. 
The laser then hits scanning mirrors, which continually rotate back and 
fourth in an arc in order to direct the laser across an area of the sample at a 
speed determined by the user. The laser then passes through the objective 
lens to the sample. The laser excites the dye and the emitted fluorescence 
is then collected by the same objective lens. This is referred to as epi- 
fluorescence. The emitted light is de-scanned by the same rotating mirrors 
and since it is of a longer wavelength, it is able to pass back through the 
same dichromatic mirrors to a detector called the photo multiplier tube 
(PMT).
2.4.3 How is the confocal principle achieved?
It is clear from the above description that that the excitation light excites an
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area of the cell which is determined by the user. However fluorescence is 
being produced from that entire area at the same time. The highest degree 
of fluorescence will be produced at the focal plane, however other areas of 
the sample above and below that plane will also be excited and contributing 
to the fluorescence collected. This makes the tracking of Ca^  ^ ions within a 
ventricular cardiomyocyte very difficult. In order to eliminate out of focus 
light a pinhole is placed before the detector, positioned such that only light 
being emitted from the focal plane is able to pass through this hole to be 
detected. Out of focus light is therefore rejected. Since the focal point of 
the objective lens forms an image where the pinhole is located, the two 
points are conjugate. Thus the LSCM acquires its name from both the use 
of the confocal principle (since the pinhole is conjugate to the focal point of 
the objective lens), and the use of scanning mirrors to direct excitation and 
emission light, to and from the sample.
2.4.4 Image formation
Essentially the basis of LSCM is to reject out of focus fluorescence however 
a complete image of the whole of the sample is never achieved at any one 
time. The scanning mirrors direct the laser, point by point across the 
sample. The data is then acquired on a pixel-by-pixel basis {Laser Sharp 
software, BioRad). The conventional image collected is a 512 x 512 pixel 
array and since the usual scanning speed used is 500 lines per second, the 
time taken to cover the whole of the sample is approximately 1 s. It follows 
from this that if the user scans a smaller area of the sample, faster 
acquisition times can be achieved. This can be further aided by the use of 
bi-directional scanning. Confocal systems can image up to 40pm in depth.
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This is ideal for cardiomyocytes, which are only approximately half this 
depth (~20pm).
2.4.5 What if events occur with frequencies greater than 1s?
Due to their high frequency Ca^ "^  sparks and waves can be missed if the 
LSCM scanning speed is 1 frame/s. Hence a particular method has been 
used throughout this thesis, which ensures enough temporal and spatial 
resolution of these events. This technique is referred to as line-scan 
imaging. Essentially, instead of using the LSCM to scan over the whole 
sample to create a 512 x 512 pixel image, the LSCM repeatedly scans 
across a single line across the sample, the position of which is determined 
by the user. This same line is repeatedly scanned at 500 lines per second. 
To image the data collected, each of these scanned lines (512x1 pixels) is 
placed on top of each other to create a 'waterfall' image whereby time is 
expressed on the vertical axis and distance across the sample is expressed 
on the horizontal.
2.4.6 Data recording and analysis
Confocal line-scan images were recorded using a BioRad Radiance 2000 
confocal system. Fluo-3 (or Fluo-5F) in the perfusing solution (or when 
loaded within cardiomyocytes using and acetoxymethyl ester -AM form of 
the drug) was excited at 488nm and measured above 515nm using epi- 
fluorescence optics of a Nikon Eclipse inverted microscope with a Fluor 
60X water objective lens (NA 1.2). The higher the numerical aperture of a 
lens the greater its light collection efficiency [112].
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Figure 2.4 Line-scan confocal imaging
Top panel shows a 512 x 512 pixel image of a permeabilised cardiomyocyte and the 
positioning of the line-scan by the user. By repeatedly scanning this line an image is 
formed as in the lower panel where distance across the cell is expressed on the horizontal 
axis and time on the vertical. The extracellular signal has been cropped from the image.
Iris diameter was set at 1.9 providing an axial (z) resolution of about 0.9pm 
and X-Y resolution of about 0.5pm based on full width half maximal 
amplitude measurements of images of 0.175pm fluorescent beads 
{Molecular Probes). Prof. Godfrey Smith carried out these latter 
measurements in order to obtain the resolution of the confocal microscope. 
The principle behind these measurements is that due to diffraction, a point
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source of light cannot be imaged as a single intense point. The point 
source is spread out in 3-dimensions. The spreading of which can be 
quantified using the point spread function (PSF). Hence fluorescent beads 
which are 0.175pm provide an almost point source of fluorescence. Due to 
diffraction, these beads will not appear 0.175pm in size but appear with the 
dimensions stated above. This is the actual resolution of the microscope 
and is a measure of the PSF. Another calibration method used, involved 
calculating the edge spread function in order to establish the resolution at 
the Ca^ "^  transient/Ca^^ wave front. This involves taking a broken glass 
cover slip, which formed an almost perfect straight edge, and laying this on 
top of another cover slip, which formed the base of a 300pl bath. Within the 
section of the bath formed by the broken cover slip a glycerol solution 
containing the fluorophore Fluo-3 (10 pM) was added. Using LSCM the 
edge of the broken cover slip was imaged with one half containing the 
fluorophore and one half with the absence of fluorophore due to the 
presence of the glass. A line scan image of this was then taken and 
analysed. A fluorescence line profile was obtained of this image and 
subsequently differentiated to obtain the width at half maximal 
fluorescence. This is another indication of the PSF and correlated well with 
the results above. Experimental data was acquired in line-scan mode at 
2ms/line; pixel width was 0.29pm (512 pixels/scan; zoom=1.4). In the 
majority of cases, unless stated, the scanning laser line was oriented 
parallel with the long axis of the cell and placed approximately equidistant 
between the outer edge of the cell and the nucleus/nuclei, to ensure the 
nuclear area was not included in the scan line.
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2.4.7 Perfusion of cardiomyocytes
The perfusion system and rig that houses the LSCM was constructed with 
the assistance of Prof. Godfrey Smith, Perfusion of cardiomyocytes was 
achieved by a series of 50ml syringes, which allowed the various solutions 
to be applied. This was a gravity fed system with the incorporation of 
solenoid valves. The solutions entered a 300pl cell bath made from 
Perspex via a system of silicone rubber tubing. Isolated cardiomyocytes 
settled onto a glass cover slip (#1.5), which formed the base of this bath 
without the need for additional adhesives. The removal of solutions was 
achieved using a peristaltic pump and a microelectrode glass pipette. The 
perfusion rate for all experiments (unless otherwise stated) was 1.5ml.min'\ 
Inflow was within 500pm of the cell to facilitate rapid solution change.
2.4.8 Disadvantages of confocal microscopy
There are some problems associated with LSCM that must be considered 
when calibrating [Ca^ "^ ] in live cells:
1. Quenching is the reduction of fluorescence intensity due to the 
physicochemical modification of a fluorophore in the excited state [111]. It 
can be caused by a variety of reasons including the presence of other 
fluorophores, oxidising agents and heavy metal salts. No major problems 
with fluorophore quenching were observed within this thesis. Any decrease 
in fluorescence due to quenching can be rectified by the application of 
calibrated compensation.
2. Bleaching is due to excessive illumination of the fluorophore. This
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can result in changes in the emission spectrum of the dye. This is 
characterised by a gradual decrease in fluorescence obtained on a signal 
that should be constant. Decreasing the intensity of the laser source and 
reducing the time the cell is exposed to it can minimise this phenomenon.
3. The maximum depth the LSCM should be used for is 40pm, above 
which spherical aberration can often degrade image contrast [112]. Since 
cardiomyocytes are only approximately 20pm thick this technique is ideal. 
However for multi-cellular cardiac preparations a two-photon microscope is 
required.
4. Photo-toxicity can also be a problem due to the physicochemical 
changes within the cell due to the laser source. This can alter the binding 
characteristics of the dye. This is characterised by an increase in a 
fluorescence signal that should be constant. In our hands the laser power 
needs to be set at a laser power of 12% (3mW laser) for Ca^ "^  wave 
measurements and can be as high as 16% for Ca^  ^ sparks measurements 
since these protocols are shorter. The maximum time under which the cell 
should be exposed to these laser powers should be <5min.
5. The non-ratiometric properties of the fluorophores used, means the 
concentration of the dye within the cell alters the fluorescence signal 
produced. Movement artefact therefore can increase the concentration of 
the dye although the actual [Ca^T might not have changed. These 
problems have been overcome and are discussed in the appropriate place 
(section 3.2.4).
92
General methods
2.4.9 Analysis programs used
Analysis was performed using a variety of different computer programs. 
The use of interactive data language (IDL) for Ca^  ^ spark analysis will be 
extensively reviewed later. The analysis of Ca^  ^waves and stimulated Ca^  ^
transients relied on programs such as Metamorph {Universal imaging 
corporation) and Laserpix {BioRad) to bring in images created on line by 
LSCM. These convert images were then appended together using a 
program written by Dr. Francis Burton {Nbands). The data files from such 
amalgamations were then analysed on a graph analysis package called 
Origin v6.1 {OriginLab). Macros written by Prof. Godfrey Smith enabled 
averaged waves and transients to be produced along with integration and 
differentiation programs to subsequently analyse these events in detail.
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2.5 Automated spark detection method
Originally, the mean Ca^  ^ spark shape and freqeuncy were measured by 
accumulating the data from a number of line-scan events. Ca^ "^  spark 
detection used to be performed ‘by eye’ [113; 114]. A study by Cheng et al 
(1999) emphasised the subjective nature of this method and the bias of the 
results that arose as a consequence [115]. Cheng et al (1999) therefore 
created an automated detection algorithm that has been adopted as a 
standard. This algorithm is coded in the image-processing language - 
Interactive Data Language (IDL) - Research Systems, Boulder, CO. and 
provides an objective and more efficient way to detect Ca^  ^ release events 
from cardiomyocytes when dispersed in a noise signal. Although the 
subjective method of ‘eye detection’ has a sensitivity and reliability 
comparable to computer detection the distribution histogram produced from 
each method is different [115]. The reasons why they are different will be 
discussed below. Care must be therefore taken when interpreting Ca^  ^
spark characteristics from data ascertained by eye detection’ [113;114].
2.5.1 Summarisation of Ca^* spark detection programme
The IDL code used within this thesis was originally written by Cheng et al 
(1999) for use in intact cardiomyocytes and has therefore been adapted for 
use in permeabilised cardiomyocytes by Godfrey Smith (Appendix 2.1) 
[115]. The basis of this programme is the detection of conjoined areas of 
fluorescence that are above a signal noise level (via input of a certain 
threshold -  a criterion).
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The four main stages to enable Ca^  ^spark detection are as follows:
Input -  The raw 512 x 30000 pixel BioRad line-scan image (*.pic) is 
converted to a (*.tiff) image file. The image contains both the intracellular 
signal, which is required, and the extracellular signal, which is cropped. 
Normalisation -  Each of the 512 bands (30000 points) is averaged to 
provide a mean value. This produces a fluorescence baseline. At this time 
Ca^  ^ sparks are included. Using the mean value in each of the 512 lines 
the image is normalised to 1 and the mean (m) and standard deviation (a) 
of this whole image is calculated. Using this normalised image, pixels that 
are greater then m+2a are excised and the whole process is repeated 
again. Pixels, which exceed the set deviation from the noise signal, are 
possible spark areas. This second estimate of background is used to 
provide the final normalisation of the data.
Detection -  Two images are created. The first is the binary image at the 
level of m+2a and the second is a binary image at the level of m+Cria, 
where Cri (criterion) is a constant, which the user can input to determine the 
threshold for Ca^  ^ spark detection. Ca^  ^sparks are identified as regions 
in the m+2a image that contain values above m+Cria. The m+2cr image is 
then used to delineate the continuous area bounding the Ca^  ^spark. 
Measurement - The number of Ca^  ^sparks is determined together with the 
peak, full width at half maximum (FWHM) and full duration at half maximum 
(FDHM) (Figure 2.5).
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Figure 2.5 Computer automated Ca^* spark detection
Flow diagram showing the various stages in Ca^^ spark detection using an algorithm from 
Cheng e t a l 1999. (Figure taken from Cheng a t a! (1999) Blophys. J. 76, 606-617).
2.5.2 Sensitivity and specificity
As the criterion is increased the sensitivity of detected events (percentage 
of sparks detected) decreases while the specificity (100% minus 
percentage of detections that are false) increases. Cheng et a! (1999) 
suggests that a Cri of 3.5 is the most favourable compromise between 
these two parameters [115]. A Cri of 4.0 was used in the results presented 
in this thesis. This choice of Cri was based on the results of some simple 
measurements carried out in permeabilised cells described below;
(1) Ca^^ sparks were measured and detected at 150nM [Ca'^T as discussed2+1
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in section 6.3.5.
(2) The same cell was then perfused for 5min with 2.5|xM thapsigargin and 
10p,M ryanodine to completely block Ca^  ^ release from the SR. Ca^  ^spark 
calibration and detection was then performed on this image as above.
(3) Amplitude histograms of both images were performed. Since this latter 
image (Figure 2.6B) contains only noise and not Ca^  ^sparks, the frequency 
of events in this histogram can be subtracted from the former image (Figure 
2.6A), which contains Ca^  ^sparks and noise (Figure 2.6C),
The cumulative amplitude histograms in Figure 2.6 are data from 4 freshly 
dissociated cells at 150nM [Ca^^. As can be seen from the histograms 
data, where the SR has been blocked (Figure 2.6B) a number of events are 
detected which are attributable to noise. However at a Cri of 4.0 this 
number is minimal. This was therefore the Cri used in subsequent 
chapters.
2.5.3 spark detection from line-scan confocal images
It is clear that while spontaneous Ca^  ^sparks are produced throughout the 
cell interior, the intrinsic nature of line-scan confocal imaging prevents the 
simultaneous imaging of all these events at any one time. It follows from 
this that Ca^  ^ sparks observed in a line-scan image originate at and a 
variable distance from the confocal plane (line-scan). Therefore even if 
Ca^ "^  sparks, are stereotypical in size, distribution amplitude histograms of 
these events will appear otherwise [115].
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Figure 2.6 A m p litu d e  h is to g ram s o f Ca^* sparks
Amplitude histograms are presented for four cardiomyocytes analysed with a criterion of 
3.5 (left 3 panels), 3 .8  (middle 3 panels), and 4 .0  (right 3 panels), in the presence of 
1 SOnM [Ca^T (panels in A) and in the presence of SR  inhibitors (panels in B). Panels in 0  
are the subtraction of data from panels B from A.
2.5.4 What should the amplitude distribution for Ca^* sparks look like?
There are two considerations when establishing a theoretical distribution 
histogram for Ca^  ^spark amplitudes. Firstly the Ca^ "" spark is imaged as an 
increase in fluorescence signal that originates from a point source. Due to 
diffraction, the confocal cannot detect this signal as a point source and is 
optically blurred in three dimensions. This can be quantified in terms of the 
point-spread function (PSF). The second, which follows from this, is that, 
although the line-scan confocal images are at a particular focal plane, Ca^^ 
sparks originating out of that plane of focus due to their PSF, which will
1 2  3
Spark Peak F/Fq
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encroach into the focal plane being measured. However the amplitude of 
these events will not be as high as those within the focal plane. Since 
these out of focus events are more numerous (due to a larger volume of the 
cell out of focus than in focus) it follows that there will be a larger quantity of 
small events compared to larger amplitude events. The amplitude 
distribution is therefore monotonic/non-modal [115]. This is in contrast to 
histograms produced as the result of ‘eye detection’, which show a 
Gaussian distribution. This is due to human bias against these small 
events. The theoretical non-modal distribution of Ca^ "^  spark amplitudes is 
confirmed by the use of the above automated detection algorithm [115] and 
is also seen in Figure 2.6. It can be seen from Figure 2.6 that as Cri is 
increased the monotonie relationship between Ca^  ^ spark amplitude and 
frequency of events begins to become modal but not to any great degree. 
There is therefore the possibility that an undercounting of low amplitude 
events occurs at Cri of 4. However the distribution is not dissimilar from the 
distribution produced at a Cri of the recommended 3.5 by Cheng et al 
(1999) [115] and is certainly not Gaussian (‘eye detection’ method). 
Therefore a Cri of 4.0 has been used within this thesis.
2.5.5 What should the width and duration distribution of Ca^* sparks 
look like?
No detailed study has been produced on Ca^ "^  spark width and duration 
distributions, but these characteristics will be under the same 
considerations as for Ca^ "^  spark amplitude histograms with the addition that 
Ca^  ^ spark width would be expected to have a greater spatial dispersion 
when originating out of the plane of focus.
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2.5.6 Calculation of Ca^* spark width
The width distribution of sparks requires careful consideration. To 
determine the width of the detected Ca^  ^spark, the algorithm determines a 
2-dimensional relationship between the number of pixels and their 
corresponding intensity (Figure 2.7A). In this example, the width is 
measured at full width at half maximal peak. Therefore if the peak of the 
spark is 6 then any pixels above 3 are included in the width measurement. 
In Figure 2.7A, this corresponds to a Ca^ "^  spark width of 4 pixels (0.29pm 
per pixel). There is a criterion within the algorithm that enables the user to 
change the distance searched either side of the pixel with the highest 
intensity (width search distance (WSD)). Figure 2.7B demonstrates a 
possible problem when this parameter is set too large i.e. 5pm either side of 
the peak pixel. The same Ca^  ^ spark will be detected as in Figure 2.7A 
with a width of 4 pixels. However, since the WSD is now larger two 
additional sparks are now detected with this one. However the peaks of 
these sparks (intensity of 7) are larger then the original spark (intensity of 6) 
and since the algorithm uses the highest intensity pixel from which to look 
for sparks to measure the width from, it is the width of these sparks that are 
measured and not the central spark. Since they are only partially within the 
WSD the widths of these events are recorded to be much smaller then in 
reality they actually are. The width distribution therefore results in a sub­
population of events at the left of the distribution because WSD is too large 
(Figure 2.80). Figure 2.8A shows what happens to the width distribution if 
WSD is too narrow, i.e. 2.0pm. Any Ca^  ^ sparks larger then 4pm (i.e. 2 x 
WSD) are piled up to the right of the distribution since the programme
recognises all sparks larger than this to be 4pm. As a compromise, this
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thesis uses a WSD value of 2.5pm, which prevents sub-population of 
events on either side of the width distribution (2.8B).
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Figure 2.7 Adjustment of width parameters within the algorithm
Figure 2 .7A  shows a  schem atic to illustrate how the algorithm calculates the Ca^* spark 
width. Panel A  shows a schematic illustrating what happens when the width search  
distance is adjusted correctly and Panels B, when the search width distance is too large. 
Refer to text for discussion.
2.5.7 Is the Ca^* spark a stereotyped event
Cheng et al (1999) demonstrated theoretically that a monotonie non-modal 
amplitude distribution would result if all Ca^^ sparks were the same size or 
were of different sizes [115]. To determine whether or not Ca^^ sparks are 
therefore stereotyped the amplitude distribution histograms cannot be used. 
However if the Ca^^ sparks are all the same size and are just at various 
distances from the in focal plane then Ca^^ spark amplitude will be 
negatively correlated with Ca^ "" spark width.
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Figure 2.8 Effects of varying width search distance on width distribution
Panel A, B, and C  shows the width frequency distribution when the width search distance 
is set to 2 .0 , 2.5, S.O^iM respectively. Refer to text for discussion.
This is thought to be because of an increased spatio-temporal spreading 
when sampled off centre. However a very weak positive correlation was 
found by Cheng et al (1999) suggesting that Ca^  ^ sparks may be different 
sizes. This is far from certain though and further work is needed on this 
fundamental concept [115].
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CHAPTER THREE
The relationship between intracellular [Ca^*] and Ca^* wave 
characteristics in permeabiiised cardiomyocytes from the rabbit.
wave characteristics at different intracellular [Ca *]
3.1 INTRODUCTION
3.1.1 The discovery of waves
In the early 1970’s several authors described a phenomenon whereby 
isolated adult cardiomyocytes were seen to “beat” spontaneously 
[95;116;117]. Fabiato (1972), demonstrated that this was due to cyclical 
release and uptake of Ca^ "^  from the SR. This oscillation occurred in 
circumstances where the SR was overloaded with Ca^  ^ [95]. Originally, 
oscillations had been observed using light microscopy and tension 
measurements. However, the development of more sophisticated Ca^ "" 
indicators and fluorescence microscopy confirmed the original hypothesis 
that these events were due to dynamic changes in [Ca^ ]^ [118]. This latter 
study was one of the first to observe the ‘wavelike’ changes in fluorescence 
using Fura-2 [118]. The dynamic changes in [Ca^ "^ ] accompanied the 
propagating local contractions and were subsequently called Ca^  ^ waves. 
Intracellular Ca^  ^waves arising from Ca^  ^ release from internal stores have 
been observed in a range of mammalian cell types [119]. In many cases, 
the Ca^ "' waves constitute a physiological signal that triggers downstream 
cellular processes [120].
3.1.2 How do Ca^* waves propagate?
In cardiomyocytes, Ca^  ^ waves arise from local spontaneous releases of 
SR Ca^  ^ (Ca^  ^sparks/macrosparks) [121]. Ca^  ^waves are also composed 
of the spatial and temporal summation of Ca^  ^ sparking events similar to 
Ca^  ^ transients. However, unlike Ca^  ^ transients the Ca^  ^ sparking events 
are not produced synchronously, but rather the rise in intracellular [Ca^T
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propagates from one area of the cell to the remainder, producing a global 
Ca^ "^  event [121-125]. The mechanism by which Ca^  ^ propagates from one 
region of the cell to another is still under debate.
3.1.3 Mathematical modelling
Cheng et al (1996) showed that the resolved image of a Ca^  ^wave consists 
of Ca^  ^ sparks which are arranged at regular distances apart (~2|im) [121]. 
This correlation between Ca^  ^ sparks during a Ca^  ^ wave and the regular 
array of T-tubules, which are separated by a distance (~2|im), suggest that 
Ca^" propagates from one site to another in a saltatory fashion. This was 
mathematically modelled by Keizer et al (1998) who showed that Ca^  ^
waves propagate with a speed that is proportional to the diffusion 
coefficient of Ca^ "" [126]. The mathematical model incorporates Ca^ "^  
release sites, which release Ca^  ^(fire) when a threshold is reached. Once 
fired it cannot fire again. The model also incorporates a distance between 
release sites that mimics the regular array of T-tubules. Hence Ca^  ^ fires 
from one release site and diffuses continuously to the next release site in 
which it raises the Ca^ "^  threshold there to initiate firing of this second site. 
This is therefore termed a fire-diffuse-fire model [127]. Interestingly, it was 
suggested that since Ca^  ^waves often occur under extreme conditions the 
arrangement of T-tubules may actually function to inhibit Ca^ "^  waves 
occurring, by making sure that propagation failure occurs under normal 
physiological conditions [127].
3.1.4 Factors involved in wave propagation
There are three main mechanisms, which may contribute to Ca^  ^ wave 
propagation.
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(1) Induced Ca^* Release (CICR)
It has been proposed that Ca^  ^ release is triggered by cytoplasmic Ca^  ^
acting at the cytoplasmic face of the SR [122]. This would suggest that 
there would always be an elevation in the Ca^  ^ concentration at a site 
before a Ca^ "^  wave. This is often observed, but not always [31]. That a 
mechanism such as CICR solely underlies Ca^  ^ wave propagation is hard 
to reconcile with the knowledge that Ca^ "^  sparks are local events, which do 
not propagate. If cytoplasmic [Ca^ "^ ] was the only stimulant for SR Ca^ "^  
release then why do Ca^ "^  sparks not propagate? Clearly another factor is 
in play.
(2) SR overload
Since the Ca^  ^ spark frequency is proportional to the SR Ca^  ^content, Ca^  ^
waves could be the result of Ca^ "^  overload within the SR [65;121;122;128]. 
It is possible that the Ca^  ^within the SR initiates a Ca^  ^wave via a lumenal 
Ca^  ^detector site, which senses when a certain [Ca^H threshold is reached 
[66;67]. This mechanism would rely on release of Ca^  ^ from the SR and 
subsequent uptake into another overloaded SR terminal cisternae. There 
are two observations that may accompany such a theory. Firstly, since the 
SR Ca^  ^ content is higher when overloaded, it is likely that Ca^  ^ release is 
expected to be greater in amplitude than the Ca^  ^stimulated Ca^  ^ transient 
(discussed further in section 4.4.6). This larger SR Ca^  ^ release would 
inevitably aid propagation of Ca^  ^ throughout the cell. Secondly, unlike the 
former theory, it is not necessary for the [Ca^ ]^ prior to the Ca^  ^wave to be 
increased.
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(3) Combination of CICR and SR Ca^* overload
This mechanism involves an overloaded SR, which sensitises the RyR2 to 
cytosolic [Ca^T therefore allowing the Ca^  ^wave to propagate via CICR. It 
is known that if SR [Ca^ "^ ] content is increased a smaller trigger can elicit 
the same response as a larger trigger [60; 129]. Together with the finding 
that an increased SR [Ca^ "^ ] content leads to the production of Ca^  ^waves 
[65; 130] it is plausible that both these factors contribute to Ca^  ^ wave 
propagation.
3.1.5 Inactivation of SR Ca^* release
A final point that must be considered is the intrinsic inactivation of SR Ca^ "^  
release and the time taken for its subsequent recovery. This limitation on 
the positive feedback of CICR (as discussed in section 1.7) has obviously 
been superseded during the Ca^  ^ wave by the factors discussed above. 
However there is evidence that inactivation is not completely abolished 
during a Ca^ "^  wave. For example when ventricular cardiomyocytes are 
stimulated immediately after a Ca^  ^ wave has occurred, there is a time 
delay before RyRs recover from prior activation/inactivation during the Ca^ "^  
wave and subsequent stimulation can lead to further Ca^  ^ release [121]. 
Furthermore when two Ca^  ^ waves approach each other, the two waves 
annihilated each other. This could be due to incomplete recovery from 
inactivation [131]. It could be that wave propagation relies not only on an 
increase in SR Ca^ "^  content and cytoplasmic activation, but also an 
increase in the sensitivity of RyR2 such that the channels refractoriness is 
shortened.
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3.1.6 Are there different forms of Ca^* waves?
Spontaneous Ca^  ^waves occur during the diastolic period and have been 
linked to generation of arrhythmic electrical activity [132]. Previous studies 
have suggested that spontaneous Ca^ "^  waves are beneficial in: (i) 
minimising diastolic tone [133] and (ii) stimulating Ca^  ^ extrusion from the 
cell [69]. These studies have suggested that increasing cellular [Ca^ "^ ] 
leads to Ca^  ^ waves of uniform amplitude but increasing frequency. In 
contrast, a more recent study monitoring Ca^  ^ waves in intact rat 
myocardium using rapid confocal imaging identified three distinct types of 
Ca^  ^waves differing in frequency, time course and amplitude depending on 
the cellular Ca^ "^  load [134]. Apart from these two studies [69; 134] no other 
has addressed the specific issue of Ca^  ^ wave characteristics at varying 
cellular Ca^ "^  load. Furthermore, these previous studies arrive at quite 
different conclusions.
3.1.7 The aim of this chapter
The present study within this chapter is designed to address this dichotomy 
by examining the characteristics of spontaneous Ca^  ^ waves under 
standardised intracellular conditions using permeabiiised cardiomyocytes.
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3.2 METHODS
3.2.1 Cell isolation and permeabilisation
Cell isolation was performed as described within the general methods 
section (section 2.1.1). The cells were allowed to settle onto the cover-slip 
which formed the base of a small bath, p-escin (Sigma) was added from a 
freshly prepared stock solution to the cell suspension to give a final 
concentration of O.lmg.ml'^ for 0.5-1 min. To assess permeabilisation, cells 
were examined using a confocal microscope. When intracellular 
fluorescence increased above extracellular fluorescence the cell was 
deemed permeabiiised and the p-escin subsequently removed by perfusion 
with a mock intracellular solution (see below).
3.2.2 Solutions
Permeabiiised cells were perfused with a mock intracellular solution with 
the following composition (mM): 100 KCI, 5 NazATP, 10 Na2Creatine 
Phosphate, 5.5 MgCl2, 25 HEPES, 0.05 K2EGTA, pH 7.0 (20-21 °C). The 
[Ca^*] in the perfusing solution was varied by the addition of known 
amounts of 1M CaCl2 stock solution (BDH). Fluorescent Ca^ " indicators 
Fluo-3 or FIU0-5F (Molecular Probes) were added to the solution to give a 
nominal final concentration of 10p.M. All other chemicals were supplied by 
SIGMA (UK).
3.2.3 Data recording and analysis
Confocal line-scan images were recorded using a BioRad Radiance 2000 
confocal system (the details of which are found in section 2.4.6). Data was
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acquired in line-scan mode at 2ms/line; pixel width was 0.3pm (512 
pixels/scan; zoom=1.4). The scanning laser line was oriented parallel with 
the long axis of the cell and placed approximately equidistant between the 
outer edge of the cell and the nucleus/nuclei, to ensure the nuclear area was 
not included in the scan line. As illustrated in Figure 3.4A, the LaserScan 
(BioRad) software saved the data as a series of image files each containing 
30,000 line-scans (i.e. Imin of continuous recording). An experimental 
record was typically comprised of 4-5 line-scan image files; these were 
reviewed off-line and a single intracellular region (20 voxels wide) was 
selected on the basis of the earliest events in the majority of Ca^ '' waves (as 
indicated in Figure 3.2A). This ensured that any movement artefact following 
the increase in [Ca^l did not affect the estimation of peak [Ca^H- Wave front 
was taken to be the mid-point of the upstroke. Using a 50-voxel region 
flanking the 20-voxel region, the gradient was used to calculate wave 
velocity. An average velocity (5-10 waves) was calculated for each cell.
3.2.4 Calibration of fluorescence indicators
The Ca^  ^sensitivity of the fluorescence dyes was measured using a series 
of Ca^  ^ buffered solutions based on the mock intracellular solution 
containing lOmM EGTA. The equilibrium concentrations of metal ions in 
the calibration solutions were calculated using a computer program with 
known affinity constants for H ,^ Ca^  ^ & Mg^  ^ for EGTA [135] and for ATP 
and CrP [136]. Corrections for ionic strength, details of pH measurement, 
allowance for EGTA purity and the principles of the calculations are detailed 
elsewhere [137]. Under these conditions the apparent affinity constant of 
Fluo-3 for Ca^ '" was 558±14nM (n=6); that of Fluo-5F was 1035±16nM
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(n=4). To establish the behaviour of the dyes in the permeabiiised
cardiomyocytes, simultaneous fluorescence measurements were made
from a 6pm (x) by 0.5pm (y) by 0.9pm (z) volume (20 voxels) within a
cardiomyocyte and in the solution adjacent to the cardiomyocyte. In these
calibration experiments, SR Ca^  ^ uptake was inhibited by prior treatment
with thapsigargin (10pM, 20min). Figure 3.1 A (i) and (ii) shows that a
higher fluorescence was recorded from within the cell compared to an
equivalent region in free solution suggesting either: (i) a higher Fluo-3
concentration within the cell or (ii) differing Ca^  ^affinity of the dye within the
cytosolic space. Rapidly increasing [Ca^ "^ ] perfusing the cell from 150nM
(50pM EGTA, lOpM Fluo-3) to 1.12pM (lOmM EGTA, lOpM Fluo-3) caused
proportionate changes in fluorescence in both regions implied by the almost
constant ratio of intracellular /extracellular fluorescence ( F ic / F e c ; Figure
3.1A(ii)). Similarly, reducing [Ca^T in the perfusing solution to <1nM (lOmM
EGTA) caused a proportionate decrease in fluorescence but no change in
F ic/ F e c . Using the fluorescence at 1.12pM and <1nM as calibration values,
the [Ca^'’] inside the cell and in the extracellular solution can be calculated
assuming the Fluo-3 Ca^  ^affinity is the same in both compartments. This
yields a value that indicates an equivalent [Ca^T (~150nM) in both
compartments prior to the solution change (Fig 3.1 A (iii)). In a number of
calibration experiments Fic/Fec was measured in solutions containing ~
150nM Ca^ "^  and on rapid application of solutions containing 375nM or
1.12pM Ca^ .^ The Fic/Fec value in 375nM Ca^  ^was 0.99±0.4 (n= 8) of that
in ~150nM Ca^  ^ while the Fic/Fec value in 1.12pM Ca^  ^ was 1.01 ±0.06
(n=4) of that in ~150nM Ga^ .^ This constancy of Fic/Fec values over a wide
range of [Ca^ "^ ] indicates that Fluo-3 inside the cardiomyocyte has a Ca^ ^
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affinity indistinguishable from that of free solution. While the Fic/Fec value 
was constant over a range of [Ca^ ]^ in any one preparation, absolute value 
varied between cells, on average the fluorescence within a cardiomyocyte 
was 140±9% (n=14) of that in free solution. Similar behaviour was 
observed for the lower affinity dye Fluo-5F. Figure 3.1 B(i) shows the 
fluorescence signal from a cardiomyocyte (in the absence of thapsigargin) 
perfused with a [Ca^ "^ ], that was sub-threshold for Ca^ "^  waves. Calibration of 
both intracellular and extracellular signals was performed by perfusing with 
375nM Ca^  ^ in the presence of lOmM EGTA to clamp the [Ca^T in both 
compartments. Minimum fluorescence values were obtained by perfusion 
with a [Ca^T of <1nM (lOmM total EGTA). Thus the [Ca^ ]^ could be 
calculated assuming an identical affinity of Ca^" for the dye in both 
intracellular and extracellular compartments (Fig 3.1B(ii)). With 50pM 
EGTA present, the was identical in both regions, additional noise in 
the intracellular signal is attributable to local release of Ca^  ^ from the SR 
(Ca^ "^  sparks).
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Figure 3.1 Line-scan epi-fluorescence imaging of cardiomyocytes
A (i), line-scan epi-fluorescence image of a single permeabiiised cardiomyocyte after 
incubation with thapsigargin (lOpM for 10min). The brighter central region is due to the 
presence of the fluorophore Fluo-3 in the cell; dimmer flanking signals are from the Fluo-3 
in the perfusing solutions. The calculated [Ca^*] in the perfusion solution is shown above 
the trace; control solutions contained a total concentration of EG TA ([EGTA]) and Fluo-3 of 
50pM and 10pM, respectively. [Ca^^] marked by * indicates solutions containing a total 
[EGTA] of lOmM. A (ii), mean fluorescence signal of a 20 voxel region from the 
intracellular (1C) and extracellular compartments (EC); these regions are indicated by
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dashed lines in A (i). The ratio of 1C fluorescence/EC fluorescence (F ic/F ec) is plotted 
above (see right-hand axis). A (iii), 1C and EC signals converted to [Ca^ "^ ] on the basis of 
the signals in 1.12pM and <1nw Ca^\ B (i), mean fluorescence signals from within a 
cardiomyocyte (1C, grey trace) and a similar region outside the cell (EC, black trace) on 
raising the external [Ca^^] from 40nw to 170nM (in SOpM EGTA, 10pM Fluo-3). At the points 
indicated above the trace, the solution was switched to one containing 375nM C a^, then 
<1nM Ca^ "^  (10mM EGTA). B (ii), 1C and EC signals converted to [Ca^^] on the basis of the 
signals in 375nM and <1 nivi Ca^ "".
3.2.5 Statistics
The relationship between extracellular [Ca^T and Ca^ "’ wave parameters 
was investigated using linear regression. The best-fit gradients are 
expressed with the asymptotic standard error (a measure of the uncertainty 
of parameter estimates). Where appropriate, curve fits were compared using 
an F-test, based on the sum-of-squares (SSQ) difference between the fitted 
curve and data values. Student’s t-test or Anova and Tukey-Kramer Multiple 
comparisons test were used where appropriate.
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3.3 RESULTS
3.3.1 Measurement of waves in permeabiiised single myocytes
Figure 3.2A shows a section of a line-scan image recorded from a single
permeabiiised cardiomyocyte exposed to solution containing 260nM Ca^ "".
Due to the presence of Fluo-3 (10pM) in the perfusing solution, the
fluorescence signal recorded from the complete line-scan contains signals
from both intracellular and extracellular compartments. Intracellular and
extracellular areas were distinguished by (i) the higher fluorescence from
cardiomyocyte under quiescent conditions (see Figure 3.1) and the
presence of Ca^ "^  waves. As described above, the complete series of line-
scans recorded in the protocol (Figure 3.2B) were analysed by selecting a
20 voxel region from a site inside a permeabiiised cardiomyocyte and an
extracellular site -6pm away from the cardiomyocyte (the fluorescence
signals are shown in Figure 3.2C(i)). Increasing [Ca^^ in the perfusing
solution from 40 to 260nM caused an increase in Fluo-3 fluorescence at
both sites. The raised intracellular [Ca^T initiated a series of Ca^ "" waves
recorded as transient increases fluorescence at regular intervals at the
intracellular site. The delay between the increased cytosolic [Ca^ ]^ and the
first Ca^  ^ wave reflects a period of net SR Ca^ "^  uptake. The frequency of
Ca^  ^waves quickly (within 1-2 cycles) reaches a steady state suggesting a
period of 10-15s before a new steady SR Ca^ "^  content is achieved. The
average of the last 5 Ca^ "^  waves is shown in the adjacent panel (Fig
3.2C(ii)). At the point indicated, the perfusing solution was changed to one
containing 375nM free [Ca *^] (buffered by lOmM EGTA). The high [EGTA]
effectively clamped the [Ca^H, buffering Ga^  ^release and uptake by the SR.
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Figure 3.2 Analysis of confocal line-scan images of Ca^* waves
A, line-scan image of Ca^* waves measured on perfusion of a permeabiiised 
cardiomyocyte with an extracellular [Ca^*] of ~260nM Ca^*. The sections marked with the 
dashed lines are 20 voxel wide regions within the cell (1C) and in the extracellular solution 
(EC). B, a longer record of line-scan images from the permeabiiised cardiomyocyte while 
raising the [Ca^*] in the perfusate from 40nw to 260nM (50pw EGTA, lOpM Fluo-3). The  
section marked by an asterisk is the region corresponding to the expanded trace in A.
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Subsequently; the cardiomyocyte was perfused with 375nM and <1nM Ca^* (* indicates 
total [EGTA] = 10mM, 10pMFIuo-3), as indicated above the trace. C (i), superimposed 1C 
(grey trace) and EC fluorescence signals (black trace) from the line-scan shown in B. C 
(ii), average fluorescence signal of the last five Ca^* waves (1C, grey trace) and the 
corresponding EC signal (black trace); the period averaged is indicated by the open box. D
(i), 1C and EC [Ca^*] signals calculated from the fluorescence signals obtained in 375nM 
and <1 nM C a^\ D (ii), the averaged 1C (grey) and EC (black) [Ca^*] calculated from the 
averaged fluorescence signals during the period indicated by the open box. E (i), higher- 
resolution 1C and EC [Ca^*] signals. E (ii), averaged 1C (grey) and EC (black) [Ca^*j signals 
displayed at a higher resolution during the period indicated by the open box. F (i), 
averaged Ca^* signals over 10s periods from 1C (grey) and EC (black) signals. F (ii) mean 
1C and EC [Ca^*] signals during the period indicated by the open box.
The [Ca^T was subsequently reduced to <1nM by perfusion with 10mM 
EGTA solution (no added Ca^ "^ ). Figure 3.2D shows the trace converted to 
[Ca^ "^ ]. There appeared to be a large variation in peak [Ca^ "^ ] of the Ca^ "^  
wave. Some of this variation could be due to the noise associated with the 
photo-multiplier signal combined with the low Ca^ sensitivity of Fluo-3 
fluorescence signal at high [Ca^^. A more reliable estimate of peak [Ca *^] 
can be obtained by converting the averaged fluorescence signal shown in 
Figure 3.2C(ii) to [Ca^T (Figure 3.2D(ii)). In Figure 3.2E the minimum 
intracellular Ca^  ^ signal between Ca^  ^ waves and the extracellular signal 
have been plotted on a different scale to show the relationship more clearly. 
When [Ca^ ]^ in the perfusing solution was increased the [Ca^ ]^ inside the 
cell was consistently lower than the extracellular suggesting active Ca^ "" 
uptake by the cell. Ca^  ^waves began approximately 15s after an increase 
in extracellular [Ca^T with a frequency about 0.2Hz. The minimum inter­
wave [Ca^ ]^ was maintained at approximately 140nM. To assess the mean 
[Ca^ ]^ within the cell, average [Ca^ ""] over a series of 10s periods was
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calculated for both intracellular and extracellular signals (Figure 3.2F(i)). 
Despite the presence of large amplitude waves, mean intracellular [Ca *^] 
over a 10s period was comparable to that in the extracellular space (Fig 
3.2F(ii)). In several experiments, thapsigargin (10p.M) was applied after a 
period of spontaneous Ca "^ waves. The resulting rapid inhibition of the SR 
Ca^  ^ pump abolished Ca^  ^ waves and caused both intracellular and 
extracellular signals to become superimposed (results not shown). Thus 
SR Ca^ "^  uptake and release results in a minimum inter-wave [Ca^ "^ ] that is 
considerably lower than the average value. This maintained concentration 
gradient is balanced by intermittent Ca^  ^ waves that reverse the 
concentration gradient and generate a net Ca^ "^  efflux from the cell.
3.3.2 Ca^ wave characteristics measured at high celiuiar [Ca^*]
Elevating [Ca^^ in the extracellular solution led to Ca^  ^waves arising more 
frequently (Figure 3.3A, B & C). These signals were recorded using Fluo- 
5F to ensure adequate sensitivity at higher [Ca^ "^ ]. Each panel shows 
sections of records of early and late periods (separated by -60s) of a 
continuous 90s exposure to high [Ca^ "^ ]. In Figure 3.3A, stable Ca^  ^wave 
activity was maintained with a mean extracellular and intracellular [Ca^T of 
1.3|xM. In Figure 3.38, in a separate cell, when the extracellular [Ca^T was 
increased to >2pM, larger amplitude and more frequent Ca^  ^ waves 
occurred. It was consistently observed that the mean intracellular and 
extracellular [Ca^ ]^ did not equalize over the 90s of the recording. In the 
presence of an extracellular [Ca^ ]^ of 2.12±0.08p.M, mean intracellular 
[Ca^ ]^ was 1 .46±0.06|liM (n=4, P <0.01).
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Figure 3.3 Records of Ca * waves at different values of extracellular [Ca *]
Records of EC (black trace) and 1C [Ca^T (grey trace) derived from 20 voxel regions of 
line-scan images of cardiomyocytes perfused with solutions containing 50pM EGTA, lOpM 
Fluo-SF and the following [Ca^^: A, I.Spw; B, 2.26pM; C, 3.4pM. The grey dashed line 
indicates the calculated m ean intracellular [Ca^^].
In a separate set of measurements, cardiomyocytes were exposed to an 
extracellular [Ca^T >3pM, as shown in Figure 3.3C, mean intracellular 
[Ca^T remained at ~2pM over the 60-90s period of the recording. 
Furthermore, the characteristics of waves were not constant. Over the 
period of exposure (90s) the time course of the Ca^  ^ waves slowed, peak 
[Ca^T decreased and the waves were of irregular amplitude (see Figure 
3.3C). During short periods (90-120s) at these high cellular [Ca^^, the 
cardiomyocyte retained a normal relaxed cell length.
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Figure 3.4 Effect of prolonged exposure to high extracellular [Ca^*] on Ca^*
waves in cardiomyocytes
A, series of eight sequential line-scan images recorded from a single cardiomyocyte 
perfused with 2 .6pM  Ca^* (50pM  EG TA and 10pM Fluo-5F). The gaps between images 
represent ~5 s breaks between acquisition periods. Images during perfusion with 375nM  
Ca^* (10m M  EG TA*) and 1nM Ca^* (10m M  EGTA*) are indicated above the images. B, EC  
(black) and 1C (grey) [Ca^^] signals derived from line-scan records of a hypercontracted 
cardiomyocyte during exposure to 2.6pM  Ca^* (50pM  EGTA, 10pM Fluo-5F). The grey 
dashed line indicates the calculated mean intracellular [Ca "^ ]^.
However, if the period was prolonged (>2min) cardiomyocytes developed 
an irreversible hyper-contracture (i.e. did not relax when exposed to <1nM 
[Ca^^). This phenomenon is illustrated in Figure 3.4A. Marked cell 
shortening prevented the use of the calibration signals at 375nM and <1nM
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to calculate the intracellular [Ca^"] inside the previously relaxed cell. 
However, the calibration protocol could be applied to regions of the 
shortened cell. As shown in Figure 3.4B, intracellular [Ca^T in a 
cardiomyocyte after a sustained hyper-contracture, indicated that the SR 
within the cell was capable of generating low amplitude Ca^  ^waves. Mean 
[Ca^ "^ ] measurements indicated equilibration between intracellular and 
extracellular [Ca^H at these high cellular [Ca^H-
3.3.3 Mitochondrial Ca^*-uptake affects Ca^* wave characteristics
Agents that dissipate the mitochondrial membrane potential such as CCCP 
(carbonyl cyanide m-chlorophenylhydrazone, 2pM), inhibit Ca^^-uptake by 
mitochondria. Under these conditions, the mitochondrial F1, FO ATP 
synthase can work in reverse and breakdown ATP. This ATPase is 
inhibited by oligomycin (2p.M). Figure 3.5A shows line-scan images 
recorded from two cardiomyocytes exposed to a short (90s) period of high 
(2.3|o.M) Ca^ "^ . As Figure 3.3B, 3.4A and 3.5A showed, this [Ca^ ""] normally 
produced high frequency waves that were stable over short periods. 
However, in the presence of mitochondrial inhibitors (CCCP and 
oligomycin), the cardiomyocyte initially produces high frequency waves, but 
very quickly develops an irreversible hyper-contracture. Signals recorded 
from a cardiomyocyte exposed briefly (5Q-6ÜS) to ~2.3|xM Ca^  ^ and 
subsequent calibration solutions without developing a sustained hyper­
contracture is shown in Figure 3.5B.
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Figure 3.5 Effect of mitochondrial inhibitors on Ca^* waves at high extracellular 
[Ca'1
A (I) and (ii), sequential line-scan images recorded from permeabiiised cardiomyocytes 
perfused with 2.3pM Ca^* (50pM EGTA, 10pM Fluo-5F) followed by perfusion with 375nM* 
Ca^* and 1nw* Ca^ "^  (*10mM [EGTA], 10pM Fluo-5F). The gaps between images represent 
~5s breaks between acquisition periods. B, records of EC (black trace) and 1C (grey trace) 
[Ca^" ]^ signals derived from 20 voxel regions of line-scan images of a cardiomyocyte 
perfused with 2.3pM Ca^* (50pM EGTA, lOpw Fluo-5F) under control conditions (i) and 
including mitochondrial inhibitors (+M I) carbonyl cyanide m-chlorophenylhydrazone 
(C C C P, 2pM) and oligomycin (2pM) (ii). The grey dashed lines represent the mean 
intracellular [Ca^^] over the period shown.
waves observed during mitochondrial inhibition reached higher peak 
values than that seen under control conditions (compare Figure 3.5B(i) and 
(ii)). Furthermore, the significant extracellular-intracellular [Ca^ ]^ gradient
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observed under control conditions was absent after mitochondrial inhibition. 
The effects of mitochondrial inhibitors on Ca^  ^waves were studied in detail 
at two cellular [Ca^ ]^’s. At ~400nM, a level known to allow equilibration of 
[Ca^ "^ ] between intracellular and extracellular compartments, and ~2-2.2pM 
which, as shown in Figure 3.5B normally does not result in equilibration 
unless mitochondrial inhibitors are used. The mean values (+SEM) of 
maximum [Ca^ ]^, minimum [Ca^ ]^ during a Ca^  ^ wave, wave frequency 
along with mean extracellular and intracellular values are given in Figure 
3.6A & B. At ~400nM, mitochondrial inhibition had no effect on any of the 
Ca^ "^  wave characteristics studied (Figure 3.6A). However the mean data 
shown in Figure 3.6B confirms that mitochondrial inhibition permits 
equilibration of Ca^ "^  between extracellular and intracellular compartments 
by increasing the maximum [Ca^T reached during a Ca^  ^ wave. This 
suggests that mitochondria Ca^ "^  uptake normally buffers the peak of Ca^ "^  
wave.
3.3.4 Relationship between extracellular and intracellular [Ca^*]
Figure 3.7 plots results from 15 cells using a range of extracellular [CaH. 
No Ca^ "^  waves were recorded in cardiomyocytes exposed to <200nM over 
a 90s period, but raising mean [Ca^T to approximately 240nM caused low 
frequency Ca^ "' waves with the minimum [Ca^ "^ ] between the waves reaching 
~140nM.
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Figure 3.6 Effect of mitochondrial inhibitors on [Ca^*] and Ca *^ wave parameters
Averages (± S E M ) of Ca * signals recorded from line-scan images of cardiomyocytes after 
perfusion with ~0.4pM  (A) and -2 .1  pM Ca^* (B) in the absence (Control) and presence 
(+M I) of 2pM  C CC P, 2pM  oligomycin (n = 4 in each group). For each param eter (i.e. mean 
extracellular [Ca "^ ]^ (here denoted [Ca^*]Ec), mean intracellular [Ca^*] (here denoted 
[Ca^"^]ic), minimum [Ca^^], maximum [Ca^^] and wave frequency) significant differences 
between control and the +M I conditions are indicated (B). Significant differences existed 
between all of the individual Ca^* wave characteristics measured at ~0.4pM  and ~2.3pM  
[Ca""] (P <  0 .001).
Using extracellular [Ca^'’] >200nM and <2pM, Ca"" waves with nearly 
uniform amplitude and frequency occurred. At extracellular [Ca""] >3pM,
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Ca"" wave characteristics were not stable. A common feature in 
experiments using high (>2|iM) [Ca^"] was the maintained [Ca^"] difference 
between intracellular and extracellular compartments over the 60-90s of 
recording. To examine the relationship between peak [Ca""] or minimum 
[Ca""] and the extracellular [Ca""], the values obtained between 200- 
lOOOnM Ca"" are plotted on a linear scale in panels (ii) and (iii). The 
straight lines represent the best-fit linear correlation. A similar format is 
used in Figure 3.7B to indicate the relationship between Ca"" wave 
frequency and velocity at a range of extracellular [Ca""]. Frequency was 
highly dependent on intracellular [Ca""] but no clear relationship existed for 
wave velocity (Figure 3.7B(ii) & (iii)).
3.3.5 Time-course of the Ca"" wave is influenced by the mean cellular 
[Ca""]
Figure 3.7C (i) and (ii) indicates the relationship between the rate of rise 
and rate of decline of the averaged Ca^  ^wave measured (rates measured 
at 1p.M intracellular [Ca""]). Both measurements show a weak but 
significant positive correlation indicating that the rate of release of Ca^  ^and 
rate of uptake are increased at higher extracellular [Ca""] (similar results 
were observed at 0.5 and 1.5|iM). This indicates that the time-course of 
Ca""^  waves is sensitive to the mean cellular [Ca" ]^, as a consequence, the 
duration of the Ca"" wave decreases as mean cellular [Ca""^ ] is increased.
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Figure 3.7 Relationship between various mean intracellular [Ca^*] and Ca^* 
wave parameters and mean extracellular [Ca^*]
A  (i), a log-log plot of extracellular [Ca^^] vs. mean intracellular [C a ^  from 15 
cardiomyocytes (Fluo-3: filled squares, Fluo-5F: closed squares), maximum [Ca^^ (wave  
peak), (Fluo-3: filled triangles; Fluo-5F: open triangles), minimum [Ca^"”] (Fluo-3: filled
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circles; Fluo-5F: open circles). The line indicates the unity relationship in panel A (i). A (ii), 
linear plot of extracellular [Ca^ "^ ] (300-900nM range) vs. maximum [Ca^ "^ ]. The continuous 
line is the best-fit linear correlation with gradient 0.77±0.18 (P <0.01). A (iii), linear plot of 
extracellular [Ca^^] (300-900nM range) vs. minimum [Ca^ "^ ] during a Ca^* wave. The 
continuous line is the best-fit linear correlation, and has a gradient of 0.35±0.03 (P  <0.001). 
B (i), a log-log plot of extracellular [Ca^^] vs. frequency of Ca^* waves (filled inverted 
triangles) and wave velocity (filled diamonds). B (ii), linear plot of extracellular [Ca^ ""] (300- 
900nM range) vs. Ca^  ^ wave frequency. The continuous line is the best-fit linear 
correlation, with gradient 5.5x10®±1 x 10® (waves s'^  M '\  P <0.01). B (iii), linear plot of 
extracellular [Ca^*] (300-900nM range) vs. wave velocity (no correlation). C (i), semilog 
plot of extracellular [Ca^^] vs. rate of rise of Ca^^ wave measured at Ip M  Ca^^. The line 
shows the best-fit linear correlation. C (ii), semilog plot of the rate of decline of the C a^  
wave measured at various values of extracellular [Ca^^]. The line shows the best-fit linear 
correlation.
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3.4 DISCUSSION
In this study, the permeabiilsed cardiomyocyte preparation is used as a 
simplified system to study the characteristics of propagated Ca^  ^waves. A 
simple set of measurements revealed that the fluorescence from Ca^  ^
indicators Fluo-3 and Fluo-5F was higher within permeabilised 
cardiomyocytes than in an equivalent extracellular volume. This may be 
explained by either: (i) indicator binding to structures within the 
permeabilised cell or (ii) an interaction between the cytosol and indicator 
resulting in increased fluorescence. Regardless of the cause, 
measurements in this study indicated that affinity of Ca '^’ for the dye in the 
cytosol is not significantly different to that measured in free solution.
3.4.1 Changes in Ca^  ^ wave characteristics at a mean cellular [Ca^*] 
<1.2^M.
This is the first study to report the relationship between Ca^  ^ wave 
characteristics and mean cellular [Ca^ "^ ] in single cardiac muscle cells. 
Spontaneous Ca^  ^ waves were recorded at a mean intracellular [Ca^T of 
>200nM. Below this value no spontaneous release was evident, although 
individual Ca^  ^ sparks could be detected. Since the test period was only 
90-120s, it is conceivable that at 150-180nM, propagated Ca^* waves 
occurred at frequencies less that 1-2min  ^ (-0.01s )^. However, this 
frequency is much lower than the value of 0.1 s'^  expected at 150nM Ca *^ 
based on a linear extrapolation of the relationship shown in Figure 3.7B(ii). 
In a recent study of intact rat myocardium at room temperature [134], 
“sporadic” Ca^  ^waves occurred at very low frequencies (0.02-0.2Hz) with a 
distinctly lower velocity and amplitude from those observed at higher
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cellular [Ca^^. Waves with these characteristics were not observed in the 
present study. At moderate intracellular [Ca^T (250-300nM), peak [Ca^T of 
waves observed in this study was 2.1-2.2pM. These values are higher than 
that reported by some studies [138; 139] but similar to others [122]. The 
peak of Ca^  ^ waves increased by approximately 0.4|xM (i.e. from -2.1 to 
-2.5|iM (120% increase) when cellular [Ca^T was raised from 0.3jiM to 
0.9pM (300% increase). Minimum [Ca^ ]^ increased by 200% over the same 
range of cellular [Ca^ ]^ (from -150nM to ~300nM), while Ca^ "^  wave 
frequency increased from -0.15 to -0 .45Hz (300%). Interestingly, Ca^  ^
wave velocity was constant over the entire range of cellular [Ca '^’] despite 
marked increases in the peak [Ca^ ]^ during a wave. The mean value of 
122±6|im.s‘  ^ (n=8) is similar to the values reported by other studies 
[122; 130; 134; 139; 140] and faster than others [64; 121; 138]. A positive 
correlation between peak [Ca^ "^ ] during a wave and velocity has been noted 
previously [124; 138], but these measurements were made at a constant 
cellular [Ca^ ]^ (and therefore constant minimum [Ca^H)- As shown in 
Figure 3.8, a positive correlation between velocity and Ca^  ^wave amplitude 
(peak -  minimum) was observed at each cellular [Ca^ ]^, (mean gradient of 
33.4±0.4|im.s \p M '\ n=8). Approximately parallel increases in minimum 
and peak [Ca^ ]^ occur as mean intracellular [Ca^ ]^ is increased. This 
results in a relatively constant wave amplitude (2.1±0.04|iM, n=8) over the 
range of cellular [Ca^ "^ ] 0 .2-1 .2pM. This constant amplitude may explain 
the lack of marked changes in wave velocity despite increases in the peak 
[Ca^ "^ ] during a Ca^  ^ wave. The significant correlation between maximum 
[Ca^ ]^, minimum Ca^  ^ and Ca^ "^  wave frequency and mean cellular [Ca^ ]^
1 2 9
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was confirmed when the characteristics of the Ca^^ waves were studied in a 
number of cardiomyocytes at two specific extracellular [Ca^^’s (~400nM 
and -2.1  ^ iM, Figure 3.6).
Ë
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Figure 3.8 Relationship between wave velocity and wave amplitude at different 
values of Intracellular [Ca^*]
Plot of Ca^^ wave amplitude (i.e. peak [Ca "^ ]^ - minimum [C a H ) vs. w ave velocity for a 
range of m ean intracellular [Ca^T values (here denoted [Ca^^]ic). Amplitude m easurements 
were m ade from four to six Ca^^ waves from five cardiomyocytes. Each cardiomyocyte 
was exposed to an extracellular [Ca "^ ]^ ranging from 240nM  to 796nM . The average (±  
SEM , 77=8) Ca^^ wave amplitude and velocity for cardiomyocytes exposed to <1pM  
extracellular [Ca "^ ]^ is plotted on the sam e graph (open square). The line through the data 
is the best-fit linear correlation to the data, with a gradient of 33±5pm  s'  ^ pM'^ (P  < 0.03).
wave frequency is the parameter most sensitive to mean [Ca^H; an 
increase in the frequency and to a lesser extent the minima and maxima of 
Ca^  ^ waves accounts for the equilibration of intracellular and extracellular 
compartments up to a mean cellular [Ca^^] of 1.2pM. In this study, the 
highly permeable surface membrane allows equilibration of intracellular and 
extracellular [Ca^^. In cardiomyocytes with intact membranes, similar 
mean cellular [Ca^^] is a consequence of influx and efflux of by trans-
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membrane proteins. In both situations, Ca^  ^waves serve to increase [Ca^ ]^ 
transiently and stimulate net extrusion from the cell. The resultant 
‘buffering’ of the minimum [Ca^ ""] will limit the development of resting 
contractile tone in the Ca^  ^ overloaded cardiomyocyte [69; 133]. SR Ca^* 
load was not assessed in this study, therefore it is unclear whether the 
changes in wave frequency were accompanied by increased intra-SR 
Ca^\ Diaz et al (1997) noted a higher frequency of spontaneous Ca^ "' 
release in rat cardiomyocytes at higher extracellular [Ca^T, but no change 
in either spontaneous release amplitude or response to caffeine (a measure 
of SR Ca^  ^ content) [69]. This led the authors to conclude that 
spontaneous release occurred when intra-SR Ca^  ^ reached a set-point, 
increasing cytosolic Ca^  ^ increased the rate of uptake by the SR therefore 
shortening the time to reach the set-point
3.4.2 wave time-course
As indicated in Figure 3.7C, the rate of rise and rate of decay of the Ca^  ^
wave increased as the mean cellular [Ca^ ""] increased. The cause of these 
changes in time course are unknown, an increased rate of rise of [Ca^ ]^ 
could arise from a higher intra-SR [Ca^T at higher cellular [Ca^^. But an 
increased rate of Ca^  ^ uptake is more difficult to explain simply since a 
higher intra-SR [Ca^ "^ ] would be expected to reduce SR Ca^  ^ pump activity 
[141]. This would suggest the mechanism underlying the higher Ca^ "^  
uptake rates may be based in the cytoplasm, for example via activation of a 
Ca-calmodulin kinase [142].
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3.4.3 Ca^ wave characteristics at high mean cellular [Ca^*] levels 
(>2|iM).
When the permeabilised cell was exposed to an extracellular [Ca^ ]^ close to 
the maximum [Ca^T during a Ca^ "^  wave (>2pM), the cell produced high 
frequency waves of larger amplitude, but the mean intracellular [Ca^ "^ ] 
within the cell failed to equilibrate with the extracellular space. All 
cardiomyocytes studied were able to maintain stable Ca^ "^  wave 
characteristics over a 2-3min period when perfused with 2-2.5|iM [Ca^H. 
When 3.2-3.4|xM extracellular [Ca^ ]^ was used, uniform Ca^ "" waves were 
not maintained over the 2-minute period, due to slowing in time course, a 
fall in maximum and a rise in minimum [Ca^T. Cardiomyocytes that 
developed an irreversible hyper-contracture after prolonged periods of high 
[Ca^n exhibited low amplitude oscillations of intracellular [Ca^T and 
equilibration of extracellular and intracellular [Ca^ ]^ (Figure 3.4B). The 
frequency of Ca^  ^ waves under these circumstances was variable, but not 
significantly different from that observed in cardiomyocytes prior to a 
sustained hyper-contracture. For this reason, these low amplitude Ga^  ^
waves are not consistent with the ‘agonal waves’ reported recently in intact 
rat myocardium at very high cellular Ca^  ^ loads which achieved frequencies 
of >2s'i [134]. Possible reasons for this disparity include: (i) the high 
cellular Ca^  ^ loads in intact cells would almost certainly be accompanied by 
changes in other intracellular factors (e.g. ATP and pH) which may affect 
Ca^ "’ wave characteristics; (ii) individual cardiomyocytes within the 
syncitium would not develop the same degree of hyper-contracture as an 
isolated cell.
132
wave characteristics at different intracellular [Ca
3.4.4 Mitochondrial inhibitors modify wave characteristics in high 
[Ca"1.
The absence of any significant effect of mitochondrial inhibitors on the 
characteristics of Ca^  ^ waves at low (~0.4|xM) extracellular Ca^  ^ suggests 
that mitochondrial Ca^  ^ uptake/release does not contribute to the 
characteristics of the Ca^ "^  wave at this level of Ca^  ^overload. However, in 
the continued presence of mitochondrial inhibitors, perfusion with a higher 
extracellular [Ca^T (~2|iM) resulted in Ca^  ^waves that reached significantly 
higher peak values (5.1±0.2|liM, n=4) to those observed without inhibitors 
(3.6±0.08p.M, n=4). Calculation of mean intracellular [Ca^T in the presence 
of mitochondrial inhibitors generated a value close to the extracellular 
[Ca^ "”], which indicates there was no sustained gradient of [Ca^ ]^. These 
results strongly suggest that mitochondrial Ca^  ^uptake attenuates the peak 
of a Ca^ "^  wave generated at an intracellular [Ca^T >2p,M. It is unlikely that 
this effect is due to a direct effect of CCCP and oligomycin on the SR since 
perfusion with these mitochondrial inhibitors had no effect on Ca^ "" wave 
characteristics at lower cellular [Ca^ ""]. Although this is the first report of an 
effect in cardiac muscle, previous studies of Ca^  ^ waves in acinar cells 
[143] and pituitary cells [144] have shown increases in amplitude of Ca^  ^
waves after disruption of the mitochondrial membrane potential. Isolated 
rat heart mitochondria injected into oocytes were able to blunt and slow the 
intracellular Ca^  ^ transient in response to thapsigargin application [145]. In 
the present study, it is unlikely that these effects result from altered 
intracellular metabolite levels or pH as a result of mitochondrial inhibition 
since the permeabilised cardiomyocytes were continuously perfused with a
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buffered mock intracellular solution. Previous studies have suggested that 
mitochondrial Ca^  ^ uptake and release occurs during Ca^  ^ sparks and 
waves/transients in cardiac muscle via the calcium uniporter [146; 147]. 
These measurements were made at low cellular [Ca^ "^ ] and the kinetics of 
mitochondrial Ca^  ^ efflux were rapid and unlikely to generate the net Ca^  ^
uptake. The apparent threshold for mitochondrial Ca^  ^ uptake observed in 
this study (extracellular [Ca^ "^ ] =1.5-2|iM) is in agreement with previous 
studies of the passive buffering by mitochondria in permeabilised 
cardiomyocytes [148; 149]. An estimate of total Ca^  ^ released into the 
cytosol during a Ca^  ^wave can be made using previously published values 
for passive Ca^  ^ buffering capacity of digitonin-treated rabbit 
cardiomyocytes [149]. These calculations would suggest that at an 
extracellular [Ca '^’] of ~0.4|iM, the increase of [Ca^T during a wave (see 
Figure 3.6) would result from the release of 178pmol.r^ Ca^  ^ per litre non- 
mitochondrial cell volume. At the higher cellular [Ca^ '"] of -2|iM, the Ca^  ^
wave characteristics described in Figure 6 would predict a release of only 
165pmol.M Ca^ "' from the SR (see Table 3.1). However, the larger Ca '^’ 
waves measured in presence of mitochondrial inhibitors suggest the 
amount of Ca^ '" released by the SR is actually 176pmol per litre (similar to 
that at 0.4|iM), of which -lOfxmol per litre is taken up by the mitochondria at 
every Ca^  ^wave.
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Free [CePl [Ce^ Total Buffers 1+2 CeTEGTA Ce^Fluo ^ToW [Ca^
High ICa«l (2.3pM) 
Minimum [Ca^ 0.29 115.14 90.39 21.01 3.45
Maximum 3.60 280.41 223.14 45.00 8.67 165.27
High [Ca2+] (23pM) + Ml 
Minimum [Ca**] 0.35 128.40 100.83 23.33 3.89
Maximum [Ca^ 5.12 301.95 241.43 46.38 9.03 173.56
T ab le  3.1 C a lcu la tio n  to  d e term in e  th e  to ta l am o u n t o f Ca^* (pM ) p roduced  
during  a Ca^* w ave
Using the mean data shown In Figure 3 .6  the free [Ca^T w as converted to total [Ca^T by 
summating the [Ca^T associated with each of the main buffers within a permeabilised cell 
(H ove-M adsen & Bers, 1993 Am. J. Physiol 264, C 677-C 686) without (upper panel) and 
with mitochondrial Inhibitors present (lower panel). It can be seen that the change In total 
[Ca^T Is approximately lO pM  less when mitochondrial Inhibitors are present. Calculations 
are based on a two buffer system and the following equation and constants:
CaB = ([Ca^^/K)*BT C aB Ca^^ buffer complex
(1+ [Ca^"]/K) K Association constant
[C a"1 Free [C a ^ l
B t [Buffer]
W here (pM): B u ffe rl K = 0 .42 Bt = 2 1 5
B uffer2 K = 79 Bt = 702
E G TA K = 0.4 Bt = 50
Fluo-3 K = 0.55 Bt = 10
Net mitochondrial accumulation via the Ca^^ uniporter has been 
reported in stimulated (intact) cardiomyocytes [150; 151]. In the latter study,
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net mitochondrial uptake was observed during depolarisation only 
when diastolic cytoplasmic [Ca^ ]^ exceeded 300-500nM. This value agrees 
well with the value of minimum intracellular [Ca^ "^ ] measured in this study at 
which mitochondrial Ca^  ^uptake was first evident (mean extracellular [Ca^T 
>2pM). The results in this study suggest that mitochondrial Ca^  ^ uptake is 
not maintained, since cardiomyocytes that develop a hyper-contracture 
show no extracellular-intracellular [Ca^ ]^ gradient (at >2|iM). The use of the 
single wavelength dyes (Fluo-3/Fluo-5F) allowed accurate measurement of 
intracellular [Ca^ ]^ signal before and after but not during hyper-contracture. 
On this basis it would appear that an event associated with the exhaustion 
of a mitochondrial Ca^  ^ uptake mechanism caused a rise in mean 
intracellular [Ca^ ]^ and irreversible cardiomyocyte shortening. In a series of 
cell types, cell death has been linked to the collapse of the mitochondrial 
membrane potential and the inhibition of mitochondrial Ca^ "" uptake [152]. 
Two possible causes of this event are (i) the opening of the mitochondrial 
permeability transition pore [153] or (ii) damage to the respiratory chain 
[152].
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3.4.5 SUMMARY
In summary, this study suggests at cellular [Ca^ "^ ] between 0.2-1.2pM, 
spontaneous Ca^  ^ release and the generation of spontaneous Ca^ "" waves 
can effectively buffer the minimum [Ca^ ]^ between Ca^ "^  waves in cardiac 
cells. Higher cellular Ca^ "” levels result in more frequent Ca^  ^ waves with 
only minor changes in time course. Attempts to increase intracellular 
[Ca^ ]^ >2[iM is resisted by mitochondrial Ca^  ^ accumulation occurring 
predominately at the peak of the Ca^  ^ wave. Working in this way, 
mitochondrial uptake will extend the period of time cardiomyocytes 
can maintain a low diastolic [Ca^T and resist the development of a 
sustained and irreversible hyper-contracture when exposed to high 
intracellular Ca^  ^ loads.
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CHAPTER FOUR
Measurement of the dissociation constant of Fluo-3 for Ca^* in 
isolated rabbit cardiomyocytes using Ca^* wave characteristics
The dissociation constant for Ca^* of Fluo-3
4.1 INTRODUCTION
Changes in intracellular Ca^  ^concentration ([Ca^ J^ic) play an integral part in 
the process of excitation-contraction coupling within mammalian 
cardiomyocytes. Recent developments in Ca^  ^ imaging using laser 
scanning confocal microscopy (LSOM) and fluorescent Ca^  ^ indicators 
enables the changes of [Ga^ ]^ic to be followed within sub-compartments of 
the cell. Fluorescent signals obtained from these techniques can only be 
converted into changes in [Ca^ ]^ic with accurate information concerning the 
behaviour of the dye within the cytoplasm. Aspects of the intracellular 
environment such as pH, viscosity, temperature, cell type, and the binding 
of the dye to intracellular proteins are all known to affect the affinity of the 
dye [154-161]. Fluo-3 is commonly used as a Ga^  ^ indicator in 
fluorescence and confocal studies of cardiomyocytes, yet information 
concerning the behaviour of Fluo-3 in the cytoplasm of cardiomyocytes is 
not available. Fluo-3 Ga^  ^ dissociation constants ranging from 0.4-1 .09|liM 
have been used in published work on excitable cells [109; 123; 138; 162- 
166]. These values are based mainly on the measurements of Fluo-3 
fluorescence in free solution. Only in one paper, was the Kd measured 
under conditions approximating the intracellular space [163]. This 
uncertainty leads to large differences in estimates of [Ga^^ic and the 
corresponding Ga^  ^ fluxes and buffering within the cell. This study aims to 
measure the Ga^  ^ dissociation constant (Kd) of Fluo-3 in two different 
situations; (i) within the cytosol of a permeabilised cardiomyocyte and (ii) in 
an intact cardiomyocyte after incubation with Fluo-3 AM. These Kd values 
are then used to measure dynamic changes in [Ga^^ic that occur within
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intact and permeabilised cardiomyocytes.
140
The dissociation constant for Ca^^ of Fluo-3 
4.2 METHODS
4.2.1 Cell isolation and permeabilisation
Cell isolation was performed as described within the Chapter 2: section 2.1. 
The cells were allowed to settle onto the cover-slip at the base of a small 
bath, p-escin (Sigma) was added from a freshly prepared stock solution to 
the cell suspension to give a final concentration of O.Img.mM for 0.5-1 min. 
To assess permeabilisation, cells were examined using a confocal 
microscope. When intracellular fluorescence increased above extracellular 
fluorescence the cell was deemed permeabilised and the p-escin 
subsequently removed by perfusion with a mock intracellular solution (see 
below).
4.2.2 Solutions for the production of spontaneous Ca^* waves within 
permeabilised cells
Permeabilised cells were perfused with a mock intracellular solution with 
the following composition (mM): 100 KOI, 5 Na2ATP, lONazCrP, 5.5 MgCb, 
25 HEPES, 0.05 KgEGTA, pH 7.0 (20-21 °C). The [Ca^T in the perfusing 
solution was varied by the addition of known amounts of 1M CaClz stock 
solution (BDH). An estimate of the [Ca^T in these solutions was calculated 
using a computer program (React, Smith, G.L.). For example, in the 
absence of added Ca^ "^ , and assuming ~5|xM contamination, free Ca^  ^ in 
50pM EGTA is ~40nM. Addition of Ca^  ^ to achieve a total [Ca^^ of 15pM 
generates a free [Ca^ "^ ] of ~150nM. Further addition of Ca^ "^  to achieve a 
total of 25|liM generates a free [Ca^T of -300nM. Fluorescent Ca^  ^
indicators Fluo-3 or Fluo-5F (Molecular Probes) were added to the solution
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to give a nominal final concentration of 10|iM. All other chemicals were 
supplied by SIGMA (UK).
4.2.3 Solutions for the production of spontaneous waves within 
intact cells
Intact cells were perfused with a modified Krebs solution [167] [168] with 
the following composition (mM); 140 NaCI, 4 KCI, 1 MgClz, 5 HEPES, 11.1 
Glucose, 0.3 NaH2PO4.2H20, 0.01 Strophanthidin, pH 7.4 (20-21 °C). The 
[Ca^ "”] in the perfusing solution was varied (0.1-1 mM) by the addition of 
known amounts of 1M CaCl2 stock solution (BDH). The solution used to 
obtain a maximal fluorescence reading where the indicator dye was 
saturated with Ca^  ^ (Fmax) contained the above solution with the addition 
0.02mM ionomycin (Calbiochem) and an increased [Ca^T of 20mM. To 
load cells with Fluo-3AM (acetoxymethyl ester form. Molecular Probes), the 
cells were incubated in 20|iM Fluo-3AM (Molecular probes) for lOmin at 
37°C. The cells were centrifuged (5 x g, 15s), re-suspended in modified 
Krebs solution and left for 20min before use. The perfusing solution used 
during electrical stimulation experiments was the modified Krebs described 
above with the addition of 1.8mM CaCl2 (without strophanthidin).
4.2.4 Laser-scanning confocal Fluo-3 fluorescence measurements In 
free solution and permeabilised cardiomyocytes
The Ca^  ^ sensitivity of Fluo-3 and Fluo-5 in free solution was measured
using a series of Ca^ "^  buffered solutions (lOmM EGTA) based on the mock
intracellular solution described above. The equilibrium concentrations of
metal ions in the calibration solutions were calculated using a computer
program with known affinity constants for H ,^ Ca^  ^ & Mg^  ^ for EGTA [135]
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and for ATP and CrP [136]. Corrections for ionic strength, details of pH
measurement, allowance for EGTA purity and the principles of the
calculations are detailed elsewhere [137]. The behaviour of Fluo-3 in
permeabilised cardiomyocytes was established by making simultaneous
fluorescence measurements from a 6pm (x) by 0.5pm (y) by 0.9pm (z)
volume (20 voxels) within a cardiomyocyte and in the perfusing solution
adjacent to the cardiomyocyte. In these calibration experiments, SR Ca^ ^
uptake was inhibited by prior treatment with thapsigargin (Calbiochem,
lOpM, 20min). These simultaneous measurements were also used to
examine Ca^  ^waves inside the cells in relation to the extracellular [Ca^ ]^,
but no thapsigargin was added to these cells. Confocal line-scan images
were recorded using a BioRad Radiance 2000 confocal system. Fluo-3 (or
FIU0-5F) in the perfusing solution was excited at 488nm and measured
above 500nm (HQ500LP emission filter) using epi-fluorescence optics of a
Nikon Eclipse inverted microscope with a Fluor 60X water objective lens
(Plan Apochromat NA 1.2). The 3mW Kr laser was set to 12% power, and
the gain on the photomultiplier tube (PMT) set to 25%. Iris diameter was set
at 1.9 providing an axial (z) resolution of about 0.9pm and X-Y resolution of
about 0.5pm based on full width half maximal amplitude measurements of
images of 0.175pm fluorescent beads (Molecular probes). Data was
acquired in line-scan mode at 2ms/line; pixel width was 0.3pm (512
pixels/scan; zoom=1.4). The scanning laser line was oriented parallel with
the long axis of the cell and placed approximately equidistant between the
outer edge of the cell and the nucleus/nuclei, to ensure the nuclear area was
not included in the scan line. The LaserScan (BioRad) software saved the
data as a series of image files each containing 30,000 line-scans (i.e. 1 min
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of continuous recording). An experimental record typically comprised 4-5 
line-scan image files; these were reviewed off-line and a single intracellular 
region (20 voxels wide) was selected on the basis of the earliest events in 
the majority of Ca^  ^ waves. This ensured that any movement artefact 
following the increase in [Ca^T did not affect the estimation of peak [Ca^ j^. 
The same methods were used to record and analyse the data from Ca^ "^  
waves and stimulated transients within intact cells. Cellular 
autofluorescence values (Fca) were obtained by measuring intrinsic 
fluorescence from cardiomyocytes not loaded with Fluo-3 or bathed in 
fluorescent solution. Cardiomyocytes (either intact or permeabilised) were 
bathed in a low (<50nM) Ca^  ^ solution and imaged using the same laser 
power and PMT gain setting used to make the experimental 
measurements. Average autofluorescence values were subtracted from 
the fluorescence measurements to obtain accurate values of Fluo-3/Fluo- 
5F associated fluorescence (intact cells Fca = 9.8±0.49 (n=4), permeabilised 
cells Fca = 5.29±0.43 (n=6), extracellular Fca = 3.56±0.21 (n=6).
4.2.5 Field stimulation of intact cardiomyocytes
Cells were field stimulated with 2ms voltage pulses delivered through 
parallel platinum wires, and the stimulation voltage was set to 1.5 times the 
threshold. The exact timing of electrical stimulation was marked in the 
confocal image by activating a light-emitting diode mounted above the cell 
bath for 2ms (i.e. the duration of one line-scan) 8ms before electrical 
stimulation.
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4.3 RESULTS
4.3.1 The sensitivity of Fluo-3 in free solution and in
permeabilised cardiomyocytes
A mock intracellular solution containing 10mM EGTA to buffer Ca^ "^  at a 
range of concentrations was used to ascertain the Kd of Fluo-3 and Fluo-5F 
in free solution. Figure 4.1 A shows examples of calibration measurements 
for Fluo-3 (lOpM) and Fluo-5F (lOpM). The average Kd from a series of 
individual curves was 558±15nM (n=6) for Fluo-3 and 1035±16nM (n=4) for 
Fluo-SF respectively. To establish the Kd of Fluo-3 within permeabilised 
cardiomyocytes, thapsigargin pre-treated cells were perfused with a mock 
intracellular solution (0.05mM EGTA, 150nM [Ca^H) which was rapidly 
changed to a high [Ca^T solution (lOmM EGTA, 1.12pM [Ca^ ]^) as shown 
in Figure 4.1B(i)(iii). This manoeuvre resulted in a rapid increase in 
intracellular fluorescence (F ic )  and extracellular fluorescence ( F e c ). A 
subsequent decrease in [Ca^ "^ ] as indicated by Figure 4.1B(ii) resulted in a 
rapid decrease in Fec and Fic as shown in Figure 1B(iv). These changes in 
fluorescence were proportionally equivalent, i.e. had the same Fic/Fec ratio, 
and if converted to [Ca^ "^ ] using the two standard solutions (1.12pM and 
<1nM [Ca^ ]^) the [Ca^ ]^ inside and outside the cell emerged as -150nM. In 
a number of calibration experiments the ratio Fic/Fec was measured in 
solutions containing -150nM Ca^  ^ and on rapid application of solutions 
containing 375nM or 1.12pM Ca^ .^ The F|c/Fec value in 375nM Ca^  ^ was 
0.99±0.4 (n= 8) of that in ~150nM [Ca^T while the Fic/Fec value in 1.12pM
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Figure 4.1 Establishing the Kd value for Fluo-3 in free solution and within a 
permeabilised cardiomyocyte
Panel A, examples of individual Fluo-3 (black), and Fluo-5F (grey) Ca^* calibration curves 
measured in free solution using confocal fluorescence microscopy. Calibration solutions 
with [Ca^*] ranging from 0.2nM  to GOpM (lO m M  EG TA with lO pM  Fluo-3/5F). The mean 
dissociation constant (Kd) for Ca^^-Fluo-3 and C a^'-Fluo-5F was 558±15nM  (n=6) and 
1035±16nM  (n=4) respectively. Panel B (i-ii), confocal line-scan image of a permeabilised
cell treated with thapsigargin, with the inclusion of 10pM Fluo-3. The calculated free [Ca^*]
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in the mock intracellular solution is shown above the trace and was increased from 150nM 
to 1 .12uM and back to <1nM. The EGTA concentration was O.OSmM unless marked by (*) 
in which case it was 10mM. Panel B (iii-iv), mean fluorescence signal of a 20 voxel region 
was taken from the intracellular (1C) and the extracellular (EC) compartments the position 
of which is shown by the dotted lines in B (i-ii). Panel B (v-vi) shows fluorescence traces 
shown in panel B (iii-iv) converted to [Ca^ "^ ].
was 1.01 ±0.06 (n=4) of that in ~150nM Ca^ "^ . This constancy of 
F ic/ F ec  values over a wide range of [Ca^T indicates that Fluo-3 inside the 
cardiomyocyte has a Ca^ "^  affinity indistinguishable from that of free 
solution. While the Fic/Fec value was constant over a range of [Ca '^’] in 
any one preparation the absolute value varied between cells, however, on 
average the fluorescence within a cardiomyocyte was 140±9% (n=14) of 
that in free solution. Similar behaviour was observed for the lower affinity 
dye Fluo-SF. A slower rate of rise in Fic (Figure 4.1 B (v)) when [Ca^ ]^ is 
increased is attributed to diffusion of Ca^ "^ /Ca^ "’EGTA into the permeabilised 
cell. This is confirmed by the lag in Fic due to a decrease in [Ca^ ]^ to <1 nM 
(Figure 4.1B(vi)).
4.3.2 A Protocol to produce Ca^* waves in permeabilised 
cardiomyocytes
Figure 4.2A (i) shows the routine protocol to produce and calibrate Ca '^' 
waves. Simultaneous fluorescence measurements were taken both inside 
and outside the cell using confocal line-scan imaging with Fluo-3.
147
The dissociation constant for Ca of Fluo-3
60#M * [Ca2+]
A (I)
100
i
(ii)
0^
B
225nM [Ca2+]
365nM * [Ca2+]
J  ly l n M  *  [C a 2 + ]^
20s
20s
3
0
500ms
Figure 4.2 Protocol to produce Ca^* waves within permeabilised 
cardiomyocytes
Panel A  (i) M ean 20 voxel fluorescence signals taken from a line-scan confocal im age from  
the intracellular compartment (10, grey) and extracellular compartm ent (EC , black) of a 
permeabilised cardiomyocyte (no thapsigargin added). The calculated free [Ca^T in the 
mock intracellular solution is shown above the trace. The permeabilised cell w as perfused 
with 225nM  [Ca^T (O.OSmM EG TA), which initiated a series of Ca^^ waves. The cell was  
subsequently per-fused with a series of calibration solutions containing 10m M  EG TA  
denoted by the (*) and a free [Ca^T of 365nM , <1nM , 60pM . Using the calibration 
solutions (*) the fluorescence trace can be converted to [Ca^^ as shown in A  (ii). The  
open box indicates the section of trace used to produce the average Ca^^ w ave as shown 
in panel B.
The permeabilised cell was perfused with a 225nM [Ca^^ solution, which
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triggered the production of waves. Ca^ "^  waves were seen as regular 
transient increases in fluorescence within the intracellular compartment. 
Intracellular and extracellular compartments were distinguished by both, 
higher fluorescence signal in the intracellular compartment and the 
production of these propagating waves. To enable this trace to be 
converted to [Ca^ ]^ a series of calibration solutions were used. At the point 
indicated, the perfusing solution was changed to one containing 365nM free 
[Ca^ ]^ (10mM EGTA). This [EGTA] effectively buffered Ca^  ^ uptake and 
release by the SR and was used as a reference [Ca^ ""]. The solution was 
then changed to one containing <1nM [Ca^T to enable a reading of minimal 
fluorescence (Fmin) to be made (10mM EGTA) (no added Ca^ )^. The last 
calibration solution was one containing a saturating 60jiM [Ca^T (10mM 
CaEGTA) to ascertain a maximum fluorescence reading (F m a x ). Although 
the reference solution of 365nM did not cause any noticeable change 
in cell shortening the Fmax solution caused the cell to develop a gradual 
irreversible hypercontracture. Due to the non-ratiometric characteristics of 
Fluo-3, consequent movement of the cell has an impact on fluorescence 
readings and subsequent conversions to [Ca^ ]^. This does not affect the 
Fmax reading taken in the extracellular space. Great care was taken in the 
selection of a site for recording of the intracellular compartment to ensure 
Fmax readings were taken from regions of the cell that remained 
approximately constant throughout changes in cell length. The Fmax 
reading was taken as the initial steady state fluorescence reading obtained 
after perfusing the cell with 60|xM [Ca^T solution (Figure 4.2A(i)).
149
The dissociation constant for Ca of Fluo-3
2.6
1.9
0.9
S o
0.2
E S
Hî
s o  0.1 
0.5
(lii)
(iv)
oo
0.1
0.90.2
Mean EC 
[CaM üiM)
Figure 4.3 wave characteristics taken from permeabilised cardiomyocytes
over a range of [Ca^*]
Mean extracellular (EC) [Ca "^ ]^ from 200-900nM  plotted against the wave, (i) m ean  
maximum [C a ^ l (Fluo-3: filled squares, Fluo-5F: open squares), (ii) m ean intracellular (10) 
[Ca "^ ]^ (Fluo-3: filled diamonds, Fluo-5F: open diamonds), (iii) mean minimum [Ca "^ ]^ (Fluo- 
3: filled triangles, Fluo-5F: open triangles), (iv) frequency (Fluo-3: filled circles, Fluo-5F: 
open circles). The continuous lines through these graphs (i-iv) are the best-fit linear 
correlations with gradients, (i) 0 .79±0.17; p<0.001, (ii) 0 .94±0.1; p<0.0001, (iii) 0 .35±0.05; 
p<0.0001, (iv) 6 .03x10®±1.07x1 O^waves.s V M ' \  p<0.001.
Figure 4.2A (ii) shows the trace converted to [Ca^T using Fmin and the 
reference [Ca^^. A reliable estimate of the peak of the Ca^^ wave can be 
obtained by converting an averaged fluorescence trace (of four or more 
waves) to [Ca^^] (Figure 4.2B). The [Ca^T inside the cell was consistently 
lower than the extracellular [Ca^^ during the inter-wave diastolic period
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suggesting active SR uptake, this was transiently reversed by the 
production of Ca^  ^waves. Although these dynamic changes in [Ca^ "^ ] were 
present the mean [Ca^Hic and mean [Ca^ j^ec were equal when averaged 
over 10s periods. The inter-wave diastolic [Ca^"] refers to the minimum 
[Ca^ l^ reached between waves. The peak of the Ca^  ^wave is synonymous 
with the maximum [Ca^ "^ ]. The maximum and minimum [Ca^ ]^ of the waves 
was taken from the averaged spontaneous wave record as shown in Figure 
4.2B.
4.3.3 wave characteristics in permeabilised cardiomyocytes
The three main characteristics of Ca^ "^  waves that enable a calculation of Kd 
for Fluo-3 are: (i) the Ca^  ^ wave frequency, (ii) maximum [Ca^ ]^ and (iii) 
minimum [Ca^ "^ ]. These values can be correlated with the mean 
extracellular Ca^ "" concentration ([Ca^^Ec) and mean intracellular ([Ca^"]ic) 
as shown in Figure 4.3(i-iv). This figure shows results from a series of 
permeabilised cells perfused with differing [Ca^ "^ ] ranging from 0.2 to 0.9|liM. 
The maximum [Ca^^ic, minimum, [Ca^ "^ ]ic and wave frequency have been 
plotted on linear scales in relation to [Ca^ ]^Ec- There is a positive linear 
correlation between these parameters measured and [Ca^ ]^Ec- The straight 
lines represent the best-fit linear correlation. On an approximate basis it 
was found that as [Ca^ ]^ic (and therefore [Ca '^’]Ec as shown by Figure 
4.3A(ii)) was increased from 300-900nM (i.e. 300%), the maximum [Ca^ ]^, 
minimum [Ca^^, and wave frequency increased by 120%, 200%, and 300% 
respectively.
151
The dissociation constant for Ca^  ^of Fluo-3
4.3.4 The use of waves characteristics in permeabilised cells to 
calibrate the Ky of Fluo-3 in intact cardiomyocytes.
The change in minimum [Ca^ "^ ] over a large range of mean cellular [Ca^^ is 
small (150nM -  SOOnM) in permeabilised cardiomyocytes. This reflects the 
ability of cardiac muscle SR to buffer cytosolic [Ca '^']. Assuming the 
minimum [Ca^ ]^ follows the same relationship in intact cardiomyocytes, this 
phenomenon can be used to provide a calibration point to allow the 
estimate of the Ky of Fluo-3 in intact cardiomyocytes. Measuring Fmax in 
intact cardiomyocytes after recording a period of spontaneous Ca^  ^ waves 
allow the Ky of Fluo-3 to be calculated by the following equation (assuming 
that Fmin = 0):
Kd = ((F m a x  -  F y ia ) . [C a ^ ^ y ia ) /F y ia
Where: Fmax = Fluorescence at saturating [Ca^ ]^
Fyia = Fluorescence at the minimum [Ca^T 
[Ca^^yia = [Ca^T at minimum fluorescence
Figure 4.4A shows a section of a line scan recording from an intact 
cardiomyocyte exposed to strophanthidin after Fluo-3AM incubation. The 
Ca^  ^ waves produced transient increases in fluorescence similar to those
seen in the permeabilised cell protocol (Figure 4.2A). After a period of
120s the perfusing solution was changed to one containing ionomycin and 
20mM [Ca^^. This resulted in a rapid increase in intracellular Fluo-3 
fluorescence and an irreversible hyper-contracture of the cell. The initial 
steady state fluorescence obtained in this situation was used as Fmax- 
Using the frequency of spontaneous Ca^  ^waves as an indicator of cellular 
Ca^  ^ load (in this case 0.4Hz); the relationships described in Figure 4.3
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Figure 4.4 Protocol to produce waves within intact cardiomyocytes
Panel A, M ean 20 voxel fluorescence signal from a line-scan confocal im age within the 
intracellular compartment of an intact cell treated with strophanthidin (lO p M ) and perfused 
with a free [Ca "^ ]^ indicated above the trace. Ionomycin (0 .02m M ) was then added to the 
perfusate together with a higher [Ca "^ ]^ as indicated above the trace. Panel B, section of 
trace from A  (shown by hatched box) converted to [Ca^^]. Panel 0 , the averaged Ca^^ 
w ave from the waves shown in B.
were used to estimate the average minimum [Ca^T during the Ca^^ waves
(267nM). Using the equation shown above, this predicts a Kd of 935nM.
The protocol described in Figure 4.4A was performed on intact
cardiomyocytes over a range of [Ca^^Ec from 0.1>1mM to enable different
Ca^^ wave frequencies to be obtained. On average, the Kd of Fluo-3 in
intact cardiomyocytes was found to be 898±64nM (n=6) in comparison to
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558±15nM (n=6) for Fluo-3 in free solution (Figure 4.5A).
4.3.5 Comparison of Ca^* wave characteristics in permeabiiised and 
intact cardiomyocytes.
Figure 4.4B shows the result of applying the higher Fluo-3 Kd to the 
fluorescence record shown in Figure 4.4A.
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Figure 4.5 Using the for Fluo-3AM to compare Ca^* waves within 
permeabilised and intact cardiomyocytes
Panel A, Comparison of the intracellular dissociation constants (K^) for Fluo-3 in 
permeabilised (558±15nM ), Fluo3-AM in intact (898±64nM ), and Fluo-5F in permeabilised  
cardiomyocytes (1035±16nM ). Panel B(i-iv), Mean intracellular (1C) [Ca^^] from 200- 
900nM  plotted against wave characteristics in order to com pare the wave, (i) m ean
154
The dissociation constant for Ca^  ^of Fluo-3
maximum [Ca^"] in permeabilised (filled squares) and intact (open squares) 
cardiomyocytes, (ii) mean extracellular (EC) [Ca^ "^ ] in permeabilised (filled diamonds) and 
intact (open diamonds) cardiomyocytes, (iii) mean minimum [Ca^"”] in permeabilised 
(closed triangles) and intact (open triangles) cardiomyocytes, (iv) frequency in 
permeabilised (filled circles) and intact (open circles) cardiomyocytes.
This example predicted a mean maximum [Ca^ "^ ] attained during a Ca^ "" 
wave of 2.24p.M, similar to values seen in permeabilised cells. A section of 
Ca^  ^ record of -20s can be used to calculate the mean [Ca^ ]^ic, in the case 
of Figure 4.4B this value was 0.65pM. The mean Ca^ "^  wave for this section 
(Figure 4.4B) is shown in Figure 4.4C. The amplitude and time-course of 
the Ca^* wave is similar to that measured in permeabilised cells (Figure 
4.2B). Figure 4.5B(i-iv) shows, in a similar format to Figure 4.3A, the 
relationship between Ca^  ^wave characteristics (mean, maximum, minimum 
[Ca^ J^ic and wave frequency) this time plotted against the calculated mean 
[Ca^ l^ic. The diagram indicates that the maximum [Ca^ ]^ic predicted by this 
technique is similar to the measured values from permeabilised cells. A 
further indication that Ca^  ^ waves in intact and permeabilised 
cardiomyocytes are comparable is the calculation of the mean extracellular 
[Ca^ ]^ that would be necessary in a permeabilised cell to produce Ca '^' 
waves of the range of frequencies observed in intact cardiomyocytes. As 
shown in Figure 4.5B (ii), the intact-cardiomyocyte data points lay on a 
relationship that is indistinguishable from the permeabilised cell data.
4.3.6 Stimulated transient characteristics.
Figure 4.6A shows a section of a line-scan record taken from an intact 
cardiomyocyte loaded with Fluo-3 by incubation with the -AM form. The 
cell was stimulated at 0.5Hz and transient increases in fluorescence can be
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seen at these time Intervals. At the point indicated the solution was 
changed to one containing ionomycin and a high [Ca^^] as in Figure 4.4A to 
enable the estimation of Fmax. The hatched box above the transients 
represents the section of trace shown in Figure 4.6B converted to [Ca^^ 
using the mean value of Kd estimated from previous experiments.
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Figure 4.6 Stimulated [Ca^*] transient characteristics using the Ky of Fluo-3AM 
In intact cardiomyocytes
Panel A, M ean 20 voxel fluorescence signal taken from a line-scan confocal im age within 
the intracellular compartment of an intact cardiomyocyte stimulated at 0 .5H z as shown 
below the trace. The period of stimulation is shown above the trace together with the 
subsequent perfusion of 0 .02m M  ionomycin and a high [Ca^T as indicated. Panel B,
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Conversion of the trace underneath the hatched box in panel A, converted to [Ca^^] with 
the stimulus marker provided below the trace. Panel C, the averaged Ca^^ transient from 
the region marked by the open box in panel B.
On average this predicts the maximum and minimum [Ca^T of the transient 
to be 1.19±0.2|iM n=11 and 158±30nM, n=11 respectively. As shown in 
Figure 4.6C, the peak [Ca^T of the average Ca^  ^transient is lower than the 
values observed during a Ca^  ^wave in both intact and permeabilised cells.
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4.4 DISCUSSION
The purpose of this study was to establish the intracellular Kd of the 
commonly used Ca^  ^ indicator Fluo-3 in cardiomyocytes and compare the 
Ca^  ^ wave characteristics in permeabilised and intact cells. This chapter 
shows that the permeabilised cardiomyocyte can be used as a simplified 
system allowing accurate indicator calibration and therefore measurement 
of cytosolic [Ca^ ]^ during Ca^  ^wave activity and stimulated Ca^  ^transients.
4.41 The Kd value for Fluo-3 in free solution
The Kd of 0.56pM for Fluo-3 in free solution is within 60nM of some 
previously published values [138; 163-165], within 160nM of others [109] 
[162] [123] and 220nM lower than one other report [166]. These 
dissociation constants (measured in free solution) are commonly applied to 
fluorescence measurements measured in intact cardiomyocytes to 
determine the [Ca^ "^ ]ic, e.g. [33; 169]
4.4.2 The Kd value for Fluo-3 in permeabilised cardiomyocytes
A simple set of measurements indicate that Fluo3 (and Fluo-5) 
fluorescence is higher within the cytosol compared to free solution, yet the 
affinity of Ca^  ^ for the dye is not significantly altered. These results are at 
odds with a previous study by Harkins et al (1993) that characterised the Kd 
of Fluo-3 in a salt solution in the presence of 55mg/ml aldolase to simulate 
intracellular conditions [163]. The presence of the soluble protein caused a 
shift in Kd from 0.51 jiM (salt solution only) to 1.09|iM (salt solution plus 
soluble protein). However, Baylor (2000) stressed that in intact cells, both 
structural, and soluble proteins are important in any shift in Kd and
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concluded that in vitro salt solution calibrations, even with added soluble 
protein, may be unreliable indicators of fluorophore behaviour within the 
intracellular environment [155]. The present study is the first to expand 
upon the work of Harkins et a! (1993) by characterising the intracellular Kd 
of Fluo-3 by using isolated permeabilised cardiomyocytes [163]. The 
permeabilised cell (with the exception of a proportion of the sarcolemma) 
has the advantage of retaining its structural and functional intracellular 
organelle membrane composition. It has been shown by earlier workers 
[170] that permeabilisation procedures using 50|xg/ml saponin for 30min 
caused the loss of soluble protein from xenopus laevis muscle fibres. 
Conceivably, a loss of soluble protein could explain the lack of change in Kd 
within the intracellular environment seen in this study. However, this is 
unlikely for the following reasons: (1) exposure to the permeabilising agent 
by Endo (1980) was x30 longer than in this study [170]. It would be 
anticipated that the extent of soluble protein loss by using an acute 
permeabilising technique will be less; (2) the compound p-escin is thought 
to be less disruptive to the sarcolemma then saponin [104] and may 
therefore limit loss of soluble protein; (3) measurements reported in this 
study suggest significant Fluo-3 binding/interaction to intracellular 
constituents and yet no apparent change in the Kd of Fluo-3.
4.4.3 The Kd value for Fluo-3 in intact cardiomyocytes
This study is the first to report a Kd for Fluo-3 using -AM loading within 
cardiomyocytes. The Kd for Fluo-3 in intact cardiomyocytes was found to 
be 1.61X higher than in permeabilised cardiomyocytes or free solution. One 
option to explain the difference between the Kd in AM loaded and
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permeabilised cells is the difference in intracellular environment. One 
aspect that may vary is the intracellular pH. The pH in the intracellular 
mock solutions is pH 7.0 but can be as high as 7.2 within the intact cell. 
The literature concerning fluo-3 suggests that changes in pH are 
proportional to the affinity of the indicator for Ca^ "^ . It has been shown by 
Lattanzio (1990) that an increase in pH from 7.0 to 7.4 would cause a 
decrease in Kd of 33nM [157]. This change in Kd is neither in the correct 
direction or sensitive enough to account for the differences in Fluo-3 
dissociation constant seen between permeabilised and intact 
cardiomyocytes using acetoxymethyl ester loading. Another possibility is 
that FIU0-3AM enters organelles and sub-compartments of the 
cardiomyocyte. The subsequent signal would be a mixture of cytosolic and 
organelle Ca^  ^ signals. In this study, as with others, short loading periods 
were used to minimise organelle-loading [171]. This was supported by the 
absence of discrete areas of high fluorescence in images of -AM loaded 
cells (results not shown). One final possibility could be due to incomplete 
cleavage of the acid by esterases within the cardiomyocyte [154]. If this 
does occur, then the presence of partially hydrolysed forms of Fluo-3 could 
alter the apparent affinity of the indicator.
4.4.4 The use of wave characteristics to assess Fluo-3 Kd
The basis of these calculations is the assumption that the minimum [Ca^^ 
that occurs between Ca^  ^ waves in permeabilised cardiac cells is within 
approximately 20% of that in Ca^  ^waves of comparable frequency in intact 
cardiomyocytes. This assumption is thought to be reasonable since the 
minimum [Ca^ "^ ] is determined by balance between the release via the
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ryanodine receptors and uptake via SERCA pump, both of which are 
retained after sarcolemma permeabilisation. The studies on permeabilised 
preparations indicated that over wide range of mean cellular [Ca^T (a factor 
of 3), the frequency of Ca^  ^ waves changed by a factor of 3 but the 
minimum [Ca^T between waves ranged from only 150 to 300nM. This 
frequency - [Ca^ ]^ relationship was used to provide an accurate estimate of 
minimum [Ca^H in intact cardiomyocytes at a set Ca^  ^wave frequency.
4.4.5 Characteristics of Ca^* waves within intact cells
As shown in Figure 4.5B, the characteristics of Ca^  ^ waves measured in 
intact and permeabilised cells are very similar. In this study no major 
differences in Ca^ "^  wave characteristics were evident between the two 
preparations. In particular, the calculated peak of the Ca^  ^ wave during 
spontaneous release in intact cells appears to be very similar to that 
observed in permeabilised cells. This may be an unexpected result since 
the absence of a sarcolemma and the consequent change in the associated 
Ca^  ^ extrusion processes may alter the peak Ca^  ^ values. But, as 
described by others [172; 173] the net efflux at the time of the peak of 
the wave is relatively small. The bulk of the efflux from the cell occurs 
during the longer declining phase of the Ca^  ^wave. Since this latter phase 
is dominated by SERCA-mediated Ca^  ^ uptake, changes in the rate of Ca^  ^
extrusion will have only small effects of the rate of decline.
4.4.6 Characteristics of electrically stimulated Ca^* transients
Application of the Kd values for intracellular Fluo-3 to signals derived from 
stimulated cells (0.5Hz) predicted a lower maximum [Ca^ ""] (~1200nM) and 
minimum [Ca^ ]^ (~'160nM) than observed in Ca^  ^waves. Ca^  ^waves at a
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frequency of -0.5 Hz have a maximum [Ca^T of ~2600nM and minimum of 
~325nM. The values for stimulated cardiomyocytes are similar to published 
values measured at room temperature using an indicator calibrated within 
the cell [174]. Obviously using the Kd from extracellular calibration curves 
would have predicted a diastolic and systolic [Ca^T of approximately half 
this value.
The relationship between frequency of Ca^  ^waves and extracellular [Ca^ ]^ 
also raises an interesting phenomenon in relation to Ca^  ^wave production 
in stimulated intact ventricular cardiomyocytes. This point is illustrated in 
Figure 4.7. Data from two intact cells are presented, the first showing 
spontaneous Ca^  ^ waves, (panel A(i)), and the second showing stimulated 
Ca^  ^ transients (panel B(i)). The mean intracellular [Ca^"] within the 
spontaneously active cells is 713nM, and the stimulated cell is 464nM. The 
frequency of events however is very similar (0.4 vs. 0.5 waves or 
transients.s'^ respectively). Using the data presented in Figure 4.4B the 
mean [Ca^ ]^ in both these cells would predict a spontaneous Ca^  ^ wave 
frequency of 0.4.s'^  in the spontaneously active cell (which it is), & 0.26.s  ^
in the stimulated cell (as denoted by *). However since the latter cell is 
being stimulated at a faster rate (0.5.s )^ the production of Ca^  ^ waves is 
prevented because the stimulated transient in-between the predicted 
spontaneous events empties the SR. This may illustrate a general rule, 
that mean cellular [Ca^ ]^ determines the frequency of spontaneous events. 
These will not occur as long as stimulated Ca^  ^ transient frequency is 
greater than Ca^  ^wave frequency.
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Figure 4.7 Prevention of Ca waves within stimulated cells
D ata from intact cells with spontaneous Ca^ "^  w aves (Pane) A(i)), and stimulated transients 
(Panel B(i)). The averaged Ca^^ wave or transient is shown in Panel A(ii) and Panel B(ii) 
respectively. Refer to text for discussion.
This study emphasises the need to establish the behaviour of the indicator 
within the cytosol of the cell under study, before attributing values to the 
[Ca^T from Fluo-3 fluorescence. Based on the measurements in this study, 
the Kd for Fluo-3 in free solution is appropriate for measurements on 
permeabilised cells and perhaps for Fluo-3 acid loaded into cardiomyocytes 
via a patch pipette. However, this Kd is not necessarily appropriate for 
cardiomyocytes loaded with Fluo-3 by incubation in the -A M  form.
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CHAPTER FIVE
The role of FK506-bindlng protein in ventricular cardiomyocytes
The role of FKBP12.6 in ventricular cardiomyocytes
5.1 INTRODUCTION
In order to understand how the heart works, cardiac physiologists have 
continually reduced its complexity into smaller, more elementary 
components. Unfortunately, while this approach has successfully revealed 
many answers it has often provided many more questions. This evolving 
complexity has prompted extensive research on a subject that is continually 
expanding. Cardiac research in a form that is familiar today began on the 
gross anatomical level with pioneers such as Andreas Vesalius (1514- 
1564) and William Harvey (1578-1657) making monumental discoveries. 
Further progress required a reduction in the scale of research to that made 
possible by microscopy (Marcello Malpighi 1628-1694). In the last sixty 
years the scale has been reduced even further - to the level of the 
molecule. The subject of molecular cardiology within the post genomic era 
focuses not only on how the normal heart works, but also on finding genetic 
targets for the treatment of heart failure. One such potential molecular 
target, associated with the cardiac ryanodine receptor (RyR2), is FK506- 
binding protein. With the recent discovery of its role in stabilising the co­
ordinated gating behaviour of RyR2 in human heart failure (in which RyR2 
had become 'unstable') it was hoped that the search for a cure was near 
completion. This chapter focuses on the role of FKBP in the heart and why 
it may not be the much-anticipated molecular panacea for heart failure.
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5.2 FK506 Binding Protein 12.0
FK506-binding protein (FKBP) is a prototypic member of the immunophilin 
family. It is a protein with peptidyl-prolyl isomerase (PPIase/rotamase) 
activity and is a receptor for the binding of the immunosuppressant drugs - 
FK506 {Prograf - tacrolimus) and rapamycin {sirolimus). Immunophilins 
are a highly conserved family of proteins, widely expressed and present in 
high levels within some tissue [175]. The following discussion focuses on 
the role of FKBP within ventricular cardiomyocytes. However, the wide 
interest in this immunophilin did not stem from its presence within the heart 
but rather its presence within T-lymphocytes [176]. As mentioned above, 
FK506 (a macrocyclic lactam-lactone) was found to bind to FKBP and the 
resulting complex was found to prevent T-cell proliferation. The clinical 
application of FK506 (or the related but structurally different drug 
cyclosporine) therefore helps to prevent immunological graft rejection of 
patients undergoing organ transplantation. The immunosuppressant action 
of the FKBP-FK506 complex is discussed further in section 6.1.1.
5.2.1 Discovery of the association between FKBP12.0 and RyRI
FK-binding proteins are present within various cell types [175] and named 
according to their molecular weight in kDa. Two such FK-binding proteins 
have been associated with mammalian cardiac and skeletal tissue. The 
first is FKBP12.0 - a ubiquitous protein and the second is FKBP12.6, which 
will be focussed on later. FKBP12.0 is associated with RyRI. Who this 
finding was initially attributed to is ambiguous. Marks et a! (1989) 
performed extensive proteolytic mapping and micro sequencing of a highly 
purified RyR1 from rabbit skeletal muscle [177]. Two of the peptides could
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not be placed within the sequence of the intact protein. These were 
denoted KC7 and KC5. Collins (1991) performed a homology search of 
these proteins using computer-assisted sequence analysis [178]. This 
search found that KC7 was almost identical to FKBP. Collins suggested in 
the same study that RyR1 had an in vivo interaction with FKBP and more 
importantly, that the protein may modulate Ca^ "^  release. Later, in 1992 the 
association of a 12KDa FKBP (FKBP12.0) and RyR1 was shown to exist by 
the Marks group [179]. This study was based on co-purification, co- 
immuno-precipitation, and sub-cellular localisation of both RyRI and 
FKBP12.0 to the SR terminal cisternae (TC) and not SR longitudinal 
tubules. The Marks group proposed that since they were the first to show 
the existence of the unknown protein KC7 back in 1989 they had provided 
the first initial indication that FKBP12.0 was tightly associated with the 
RYR1. It is often omitted that the Collins study had identified KC7 as FKBP
[178].
5.2.2 The role of the association between FKBP12.0 and RyRI
Timerman et al (1993) performed functional studies on skeletal RyRI 
present in TC vesicles [180]. There were three major findings within this 
study: (1) the stoichiometry of FKBP-RyRI was found to be four using [^ H] 
FK-816. Thus RyRI consists of four ryanodine receptor protomers and four 
molecules of FKBP. Its chemical formula is therefore often represented as 
(FKBP12.0)4/(RyR1 protomer)4. This was later confirmed by the use of 
another radioactive isotope [^ ®S] FKBP [181], (2) when the drug FK506 was 
applied to the preparation, it formed a complex with FKBP12.0 and was 
dissociated from the RyRI, (3) FKBP12.0 was found to stabilise the closed
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conformation of RyR1 in skeletal TC. The finding that FKBP12.0 modulated 
RyR1 activity in this way was fundamental and has important implications 
for excitation-contraction (EC) coupling. Various studies were subsequently 
published in an attempt to further investigate the role of FKBP 12.0 on 
RyRI. Single channel recordings of RyRI located within TC in the 
presence and absence of FKBP12.0 provided the basis for much of this 
work [182]. FKBP deficient RyRI (formed by the incubation of the TC with 
FK506) were shown to have: (i) enhanced channel activation due to an 
increased sensitivity to Ca^ ,^ (ii) enhanced sensitivity to caffeine, (iii) 
decreased sensitivity to Mg^  ^[181], (iv) greater mean open times in 70nM to 
1.2pM [Ca^ ]^. Importantly the rebinding of recombinant FKBP12.0 
reversed this enhanced channel activation. In a separate study FK506 was 
found to activate RyRI in TC vesicles between lOOnM and ImM [Ca^ ""] 
[183]. The increase in RyR1 mean open time was not due to the increase 
in openings to full conductance but mainly due to the appearance of long 
periods of sub-conductance states (28%-38% of full conductance), which 
were distinct from the sub-conductance state seen when ryanodine is 
applied (45%). Whereas both studies [182; 183] showed an increase in the 
open probability of RyRI only the later [183] showed sub-conductance 
states. If taken together the studies above all suggest that the role of 
FKBP12.0 is to keep RyRI in a state of control such that 'leak' of Ca^  ^
through RyRI is reduced.
5.2.3 Further studies on the role of FKBP on RyR
There are two studies in the literature that encompass the above findings 
and go on to define the two classic roles of FKBP12.0 on RyRI. The first
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role is that of stabilisation. Brillantes et al (1994) expressed recombinant 
RyRI in Spodoptera frugiperda (Sf9) cells [184]. These insect cells were 
chosen because they do not express FKBP12.0, FKBP12.6, RyR-mRNA 
and RyR-protein [175]. RyRI was fully functional as a Ca^  ^ release 
channel and had a molecular mass of 2.3x10® daltons. The purified 
recombinant RyRls were reconstituted into planar lipid membranes and 
their properties were found to be very similar to that of native SR RyRI 
channels. The channels typically exhibited sub-conductance states to 
distinct levels with full conductance only being reached very occasional. No 
RyRI channels were stable in the full conductance state. If FKBP 12.0 was 
co-expressed with RyRI in Sf9 cells or added to the purified expressed 
RyRI in the bi-layer, stable channels with openings to the full conductance 
were formed. RyRI channels associated with FKBP12.0 had a longer 
mean open time and decreased open probability after activation by caffeine 
(5mM) and a decreased sensitivity to caffeine. To verify the properties 
shown above, FK506 or rapamycin was applied to native channels that 
exhibited full conductance. Both of these drugs induced the reappearance 
of sub-conductance states. Since channels without FKBP12.0 are capable 
of occasionally opening to full conductance (albeit not in a stable state) it 
can be concluded that FKBP12.0 is not required for the achievement of full 
conductance. Therefore, FKBP12.0 reduces the open probability of RyR 
but stabilises the open state once it is open. It is thought that FKBP12.0 
allows the four sub-units of the RyRI channel to gate co-ordinately allowing 
the channel to function to full conductance and therefore eliminating the 
appearance of sub-conductance states [185]. This phenomenon has 
obvious implications in reducing non-activated Ca^  ^ release from the SR if
1 6 9
The role of FKBP12.6 in ventricular cardiomyocytes 
this is indeed the role of FKBP12.0 in the whole cell.
5.2.4 How does FKBP stabilise RyR?
A model has been produced showing how stabilisation of the RyR1 is 
possible [186]. The model is based on the binding site of RyRI for 
FKBP12.0. The binding site is composed of a tetra-peptide (Ser-Leu-Pro- 
leu). The Leucyl-Prolyl bond is constrained in a twisted amide 
conformation. Since FKBP is a cis-trans peptidyl-prolyl isomerase this 
bond is a high affinity substrate for the enzyme FKBP. However if the 
isomérisation reaction took place from cis to trans this would lower the 
affinity for FKBP to RyRI [187] and they would dissociate from each other. 
Since FKBP12.0 has been shown to be tightly associated with the RyRI
[179] this reaction is thought not to occur. However the twisted amide is a 
high-energy structure that is unstable. Therefore the tight binding of four 
FKBP 12.0 to the four RyRI protomer binding sites stabilises the channel 
[188; 189]. Why the isomerase reaction does not occur is unknown but 
could be due to the spatial constraints imposed by RyRI. FK506 and 
rapamycin dissociate FKBP12.0 from RyRI since they have a substructure 
that mimics the twisted amide conformation of the peptidyl-prolyl bond and 
have a high affinity for FKBP12.0.
5.2.5 Coupling of RyRs by FKBP
The second role of FKBP12.0 is its induction of couple gating. Although 
touched on in the previous paper [184] a study by Marx et al (1998) 
investigated this phenomenon more fully [185]. Coupled gating refers to 
the phenomenon whereby RyRls in planar bi-layers exhibit simultaneous 
openings and closings. The results taken from both recombinant Sf9 RyRI
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co-expressed with FKBP12.0 and native skeletal muscle RyR1 from SR 
vesicles were used to investigate coupling. Three scenarios were 
presented whereby channels exhibited:
(1 ) Stable openings to 4pA in planar lipid bi-layers with current amplitude 
histograms with two discrete peaks corresponding to closed channels 
(OpA) and openings to the full amplitude of single channels (4pA).
(2) Two channels opening and closing independently in the same bi-layer 
one to 4pA, the other opening independently of the first. Current 
amplitude histograms corresponded to closed channels (OpA), 
opening to full amplitude for one channel (4pA), or for two (8pA) (9 
out of 44 experiments).
(3) Openings to 8pA twice the normal current. Current amplitude 
histograms revealed two discrete peaks corresponding to closed 
channels (OpA) and openings to 8pA (10% experiments).
The distributions indicated that the 8pA currents did not result from
openings of two independent RyRI channels and that the gating of the two
channels was likely to be coupled. That this scenario occurred in 10% of
experiments is of some importance since ultra-structural studies show that
10% of purified RyRI homo-tetramers are physically connected to form
contacting pairs. Specific [®H] ryanodine binding detected fractions of the
preparation with sedimentation coefficients suggesting more than two RyRI
homo-tetramers can remain physically connected during purification. The
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physical association of RyRls was not affected by the removal of 
FKBP12.0 and is therefore not needed to keep RyRls conjoined. 
Openings to 12, 16 and 20 pA indicative off coupled gating between 3, 4 
and 5 channels respectively were also observed. The theory of coupled 
gating was further reinforced when rapamycin (2p,M) induced two coupled 
RyRI channels to uncouple. The potential for coupling to allow 
synchronous Ca^  ^ release by a number of RyR1 by activating only one 
RyRI has important implications for EC-coupling [190]. Skeletal 
dihydropyridine receptor (DHPR) voltage sensors activate only half the 
RyRI channels, which are thought to be due to a direct protein-to-protein 
interaction [191]. The remaining half must be activated by some other 
means. Coupling would be an energy efficient way to achieve this. The 
cardiomyocyte is even more reliant on an efficient mechanism since Ca^ "^  
induced Ca^  ^ release (CICR) is thought to rely on influx of Ca^  ^ from even 
less (DHPR) channels per RyR2 than skeletal muscle with no direct protein 
to protein interaction between the two.
5.2.6 Is there a role for the PPIase activity of FKBP?
Although FKBP12.0 is tightly bound to RyRI, it is a soluble receptor, which 
is in constant equilibrium with the myoplasmic pool of FKBP (~3p.M). This 
was emphasised using a novel technique involving an exchange reaction 
between soluble ®®S-labeled FKBP12.0 and the FKBP12.0-RyR1 complex 
[181]. This process is temperature and concentration dependent and 
therefore at 37°C and myoplasmic concentrations, the technique showed 
that there should be rapid exchange of myoplasmic FKBP 12.0 with that 
bound to RyR1 in skeletal muscle. Using this technique the need for prolyl
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isomerase activity of FKBP12 was investigated. Since PPIase activity is 
inhibited by both rapamycin and FK506 it is not unreasonable to suspect 
that it is involved in the process of RyR1 modulation by FKBP12.0. The 
exchange of the FKBP12.0-RyR1 complex with wild type or PPIase 
deficient FKBP mutants (W59H, F36Y, F99Y - 0.3%, 5%, 0.1% activity 
respectively) had the same effects on RyRI modulation as seen previously 
[180; 182]. Therefore this study [181] concludes that the PPIase activity of 
FKBP is not critical for modulating the channel behaviour of RyRI. 
However a review by Marks (1986) provides some unpublished data 
suggesting that a mutant form of FKBP12.0 (F36Y - which lacks most of the 
prolyl isomerase activity but still binds to RyRI) does not modulate channel 
gating [175], Approximately 15% of the myoplasmic pool of FKBP12.0 is 
thought to be associated with the SR in skeletal fibres [181]. The 
information obtained from the exchange technique [181] has important 
implications for the use of permeabilised cells to study the function of FKBP 
(see section 5.13) and will be discussed later.
If FKBP12.0 is associated with RyRI in skeletal muscle and has such 
important implications for Ca^ "" homeostasis then the most understandable 
tissue to investigate next had to be cardiac muscle.
5.3 FK506 Binding Protein 12.6
5.3.1 The discovery of the association between FKBP12.6 and RyR2
Although FKBP12.0 was found within myoplasm of canine heart tissue, a 
novel FKBP was found to have a specific tight association with RyR2 [192]. 
This protein called FKBP-C, was readily distinguished from human 
recombinant FKBP12.0 by its slower mobility in Sodium Dodecyl Sulfate -
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Polyacrylimide Gel Electrophoresis (SDS-PAGE). Its molecular weight was 
thought to be approximately (but not) 13kDa [192] and later confirmed to be 
12.6kDa [193]. The interaction between cardiac RyR2 and FKBP12.6 was 
found to be tissue specific rather than species specific (a point that will be 
discussed later). FKBP12.6 is not detected in canine skeletal muscle TC of 
SR or canine heart myoplasm [192]. A further study isolated and cloned 
human FKBP12.6 and showed that FKBP12.6 is pharmacologically almost 
indistinguishable from FKBP12.0 such that both isoforms when present as 
a complex with FK506 inhibit calcineurin and are equipotent inhibitors of 
calcineurin dependent signalling pathways in Jurkat cells [193]. FKBP12.0 
and FKBP12.6 show 85% amino acid sequence homology [194] and 
PPIase activity that is inhibited by either FK506 or rapamycin [193]. The 
stoichiometry of FKBP12.6 is approximately four as determined by [^ H] 
dihydro-FK506 [193] and exchange with soluble ^®S-labeled FKBP12.6
[195], hence the same macromolecular formula can be applied as for 
FKBP12.0 (RyR2)4/(FKBP 1 2 .6 )4.
5.3.2 Are all potential RyR sites fiiled with FKBP?
Although there is a tight association between FKBP and the RyR receptor, 
the protein is in constant equilibrium with the myoplasm and there are a 
proportion of sites that are unoccupied. The idea of FKBP equilibrium was 
addressed by the novel exchange technique using soluble ^^S-labeled 
FKBP12.6/FKBP12.0 mentioned above [193;195]. The proportion of 
unoccupied sites using this technique can be calculated. Whereas only 6% 
receptor unoccupancy was calculated for rabbit skeletal muscle TC [193] 
17% was calculated for FKBP12.6 binding sites in the dog cardiac TC. The
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reason why this proportion of sites remain unoccupied is unclear but if such 
sites could be physiologically regulated such that they are filled when 
enhanced coupled gating is required (e.g. in heart failure) then this provides 
a useful resource enabling an enhancement of EC-coupling.
5.3.3 Specificity of binding
Timerman et al (1996) defined the selectivity for FKBP12.0 and FKBP12.6 
for canine RyR by the use of exchange methodology together with co- 
immuno-precipitation and competitive binding studies [195]. The binding of 
FKBP to SR vesicles is specific to the RyR isoform such that RyR2 has 
specificity for FKBP12.6 but RyRI binds both FKBP12.0 and FKBP12.6. 
The mRNA of both isoforms is present in skeletal and cardiac muscle, the 
mRNA for FKBP12.0 being higher then FKBP12.6. The information 
provided in this study was important in regards to Western blot analysis that 
had previously only shown FKBP12.0 in the cytosol of tissues. As 
mentioned above, the cytosolic concentration of FKBP12.0 in skeletal 
muscle is thought to be SfxM [193]. It is thought to be the same within 
cardiac tissue [195]. The FKBP12.6 concentration in cardiac tissue is 
unknown since it is too small to be detected by current assay methods. 
This is the reason why RyR2 is isolated as a complex with FKBP12.6 and 
FKBP12.0 is only detectable within the cytosol.
5.3.4 Does FKBP12.6 affect RyR2?
The physiological function of FKBP12.6 on RyR2 is somewhat controversial 
and will be discussed in detail in the next section, suffice to say that the 
above study [193] showed no modulation of RyR2 by FKBP12.6. This was 
an unexpected finding since studies had showed such similarity (both
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physically and pharmacologically) between FKBP12.0 and FKBP12.6. 
Three well-established techniques were used: (a) single channel 
recordings, (b) ryanodine binding studies, and (c) Ca^  ^ uptake 
measurements. There is no doubt that the authors would have desperately 
tried to find some similarity between alterations in RyR2 channel 
modulation by FKBP12.6 as had been shown in skeletal muscle [195]. 
However, they did not, and their excellent biochemical findings were not 
supported by any fundamental physiological role for FKBP12.6 within 
myocardial tissue. This was supported by a direct comparison between the 
role of FKBP12.6 and FKBP12.0 on rabbit skeletal RyRI and canine 
cardiac RyR2 [196]. Again using bi-layer studies, ryanodine binding and 
SR uptake experiments Barg et al (1997) established that rabbit skeletal 
muscle responded to removal of FKBP from RyRI (using FK506) by 
enhanced channel activation whereas repletion with FKBP 12.0 or 
importantly FKBP12.6 resulted in channel quiescence similar to control
[196]. This was evidence that RyRI was physically and functionally 
modulated by FKBP12.0 and FKBP12.6 equivalently. No such affects with 
cardiac RyR2s were observed. However, much research that followed 
these two studies did find a very important role for FKBP12.6 within 
cardiomyocytes and this work will be discussed in the next section.
5.3.5 The role of FKBP12.6 in ventricular cardiomyocytes
As with FKBP12.0 the role of FKBP12.6 and its association with RyR2 was 
investigated initially using single channel experiments and ryanodine 
binding studies [197]. Kaftan et al (1996) showed that as with FKBP12.0, 
the addition of rapamycin to cardiac SR channels comprised of RyR2 and
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FKBP12.6 induced activation whereby there was an increase in the open 
probability and the appearance of sub-conductance states. These results 
were very similar to the application of FK506 to the FKBP12.0-RyR1 
complex [183]. There were two interesting points made in this study that 
shed light on the mechanistic behaviour of RyR2 gating. Firstly, the effect 
of rapamycin on the FKBP12.6-RyR2 complex was bi-phasic. Channel 
activation occurs for the first 2-10min and is maintained even after removal 
of rapamycin from the bath. After lOmin channels are activated with 
smaller current amplitudes (i.e. sub-conductance states). There are two 
possible hypotheses as to why there is a temporal effect separating 
channel activation and channel amplitude. The first suggests that there is a 
mechanical difference between channel activation and channel amplitude. 
That you can separate these individual processes comes from studies 
using natural products called bastadins on RyR (discussed in section 5.10). 
The more favourable hypothesis (that resembles more clearly the known 
structure and function of the FKBP12.6-RyR2 complex) involves the 
proposal that progression from increased channel activation to sub­
conductance states is a multi-step process. Since the stoichiometry of 
FKBP12.6 to RyR2 is four the gradual dissociation of each FKBP12.6 from 
the RyR2 homo-tetramer induces different states in RyR2 gating, i.e. the 
initial loss of one FKBP 12.6 enhances channel activation and the 
subsequent loss of the second, third, and fourth induces sub-conductance 
states, reduced channel conductance and restructuring of the channel 
finally leading to altered permeation [197]. One counterintuitive result in 
this study was the finding that dissociation of FKBP12.6 from RyR2 resulted 
in decreased ryanodine binding to RyR2. Since ryanodine binds to the
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open channel and the channel is more activated then in theory ryanodine 
binding should have increased. This could be explained possibly by the 
increase in sub-conductance states and the induction of conformational 
changes in RyR2 leading to a decreased affinity for ryanodine.
5.3.6 Does FKBP12.6 play a role In coupling of RyR2s?
Three years after showing FKBP 12.0 is needed for functional coupling 
between skeletal RyRI channels (although physical coupling does not) 
[185], the same phenomenon was found to occur between cardiac RyR2 
channels via FKBP12.6 [63]. All the observations made in the previous 
study [185] were valid for FKBP12.6 with three additional findings;
(1) The removal of FKBP12.6 from RyR2 with rapamycin first uncoupled 
channels and then each individual channel exhibited sub-conductance 
states. This is similar to the bi-phasic action of rapamycin discussed above
[197], and the multi-step removal of FKBP12.6 from RyR2.
(2) In some experiments the open state but not baseline/closed states of 
the coupled channels showed more signal noise than those of single 
channels. This was especially so during the uncoupling transition. It was 
suggested that this was consistent with the stabilisation theory of FKBP 12.6 
on RyR2.
(3) Two coupled RyR2 channels exhibit an increased open probability 
compared with a single channel. It was thought this might be due to the 
doubling up of Ca^ "" activating sites present, i.e. the two coupled RyR2s
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essentially function as one channel but retain two Ca^  ^ binding sites. The 
finding that coupled channels exhibited increased sensitivity to caffeine 
reinforced this theory.
Influx of Ca^  ^ from the exterior to the interior of skeletal myocytes and the 
subsequent release of Ca^  ^from intracellular stores is well co-ordinated via 
protein-to-protein interactions, which are voltage dependent. In cardiac 
muscle however there are no such protein-to-protein interactions and Ca^  ^
is thought to be the link between the influx of trigger Ca^  ^ and release of 
amplified SR Ca^  ^ (CICR). Since this is a positive feedback system and 
naturally unstable, more emphasis must be put on how this actually 
terminates than compared to skeletal muscle. Coupled gating is a possible 
way in which release of SR Ca^ "^  can be synchronously released and 
terminated when required to do so. Interestingly when barium or potassium 
is used as the charge carrier coupled gating is still observed and rules out 
the possibility of local CICR between isolated channels in lipid bi-layers. 
Although the role of FKBP12.6 seems to be very similar to FKBP12.0 
(stabilisation of the co-ordinated gating behaviour of RyR), this is not 
always a consistent finding. Further studies such as those presented below 
have tried to resolve this inconsistency.
5.4 On the scale of things
5.4.1 The progression from molecule to bedside
John Gribbin once summarised why he chose to become a writer about 
science rather than a scientific researcher [198]:
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The fate of specialists in any one area of science is to focus more narrowly on 
their special topic, learning more and more about less and less, until 
eventually they end up knowing everything about nothing.
I stated at the beginning of this chapter that cardiac physiologists have 
often reduced the complexities of the heart into smaller more elementary 
components. The description of FKBP12.0 and 12.6 in previous sections 
has been the epitome of that reduction all the way to the level of the 
molecule and specialists in this area have gradually learned more and more 
about less and less. Although they have not reached the stage whereby 
they know everything about nothing it is necessary to bring the scale of 
things back up to the level of the whole heart. Only when this is achieved 
will the full importance of the role of FKBP12.6 within the heart be known. 
A logical progression would involve proceeding from the above studies on 
single (or coupled) RyR2 channels in lipid bi-layers to the level of the RyR 
channel cluster located on the SR. The Ca^‘" spark is the functional 
consequence of Ca^ "^  release from the RyR2 cluster and its morphology 
and frequency is a function of its gating behaviour. The next possible scale 
of expansion would then involve the whole cell. This can of course be done 
in conjunction with the investigation of Ca^  ^ sparks but should also include 
an appreciation of the numerous other Ca^  ^ homeostatic mechanisms and 
biochemical pathways present within cardiomyocytes. The penultimate 
stage would involve whole heart studies, which would allow the function of 
FKBP12.6 to be investigated with the heart functioning as a syncitium 
together with its extracellular matrix. Perfusion of whole hearts with drugs 
such a FK506 with concurrent measurements of changes in Ca^  ^ and
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voltage would provide invaluable insights into the role of FKBP12.6. Lastly 
and perhaps most importantly it must be remembered that the heart does 
not stand in isolation and integrative physiology using whole body studies 
are vital in ascertaining whether or not any of the previous studies are bio- 
medically significant. This section will look at work attempting to investigate 
some of these logical progressive steps and evidence that FKBP12.6 is 
indeed clinically relevant.
5.4.2 A step in the right direction
Investigating RyFR2 within lipid bi-layers is very specific i.e. it can be made 
sure that RyR2 is the only channel within the preparation the functional 
effects of which can be examined. Returning RyR2 back into the whole cell 
where it should be, while only investigating the specific role of FKBP12.6 
requires new technical approaches. While there are drugs that can be 
easily applied to whole cells that effect FKBP12.6 bound to RyR2 the 
specificity of these drugs is poor. This point is exemplified in studies 
investigating the effect of FK506 on cellular Ca^  ^ regulation in intact 
ventricular cardiomyocytes during EC-coupling and rest [113; 114].
5.4.3 The role of FKBP12.6 on EC-coupling In intact cardiomyocytes
FK506 (5|iM) was found to increase the amplitude of steady state twitches 
and Ca^ "’ transients during EC-coupling in rat ventricular cardiomyocytes 
[114]. This occurred when SR Ca^  ^ content was either moderately 
enhanced (with FK506) or the same as control (which was without FK506). 
FK506 was not found to alter influx of Ca^‘" via the DHPR or uptake of Ca^  ^
into the SR via SERCA2a. The larger Ca^  ^transient was thought to be due 
to a higher fraction of SR Ca^  ^ release when FK506 was applied due to
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enhanced sensitivity of RyR2 for Ca^ .^ The authors suggested that these 
findings were consistent with a previous investigation showing FK506 
increased channel open probability by enhancing the sensitivity of skeletal 
RyR1 to caffeine [182]. However, these observations had been seen in rat 
cardiac tissue RyR2 [114] not skeletal muscle RyRI as in the previous 
study [182]. There is actually only one paper previous to this study [114] 
which had showed similar effects on cardiac RyR2s. This was observed by 
applying rapamycin not FK506 [197]. There is also a study previous to this 
showing no such effect on FK506 on RyR2 [195]. Using information 
obtained from studies on RyRI and extrapolating it to studies on RyR2 
should be done with the greatest care. There are three main reasons why 
this is so:
(1 ) It is quoted in reviews that RyR1 and RyR2 share 66% genetic structural 
homology [199], they perhaps more importantly do not share 34% of the 
genetic sequence. This could have major functional consequences.
(2) The various accessory proteins and biochemical pathways that 
physically attach to and modulate RyR2 could be very different in skeletal 
tissue; this could have a profound effect on gating behaviour.
(3) The difference behind Ca^  ^ release from the SR in skeletal and cardiac 
muscle is mediated by the two different mechanisms - voltage sensitive 
sensors and CICR respectively and indeed RyR2 cannot replace RyRI 
during skeletal EC-coupling in RyRI knock-out mice [200].
The suggestion that enhanced sensitivity of RyR2 to Ca^  ^ leading to larger 
Ca^  ^ transients when SR Ca^  ^content, L-type Ca^ "" influx, and SERCA are
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all unchanged seems at first counterintuitive. FK506 should act to uncouple 
the RyR2 channels in the clusters and presumably decrease the efficiency 
of EC-coupling leading to a possible reduction in transient size. This 
dichotomy will be the focus of much of the majority of the next section.
5.4.4 The effects of FK506 on ventricular cardiomyocytes
It is possible that FK506 is having indirect effects to enhance Ca^ release 
rather than effects directly on FKBP12.6. FK506 for instance cannot
discriminate between FKBP12.0 and FKBP12.6 and could be acting via 
FKBP12.0 to release more Ca^  ^during the transient. It could also be the 
result of FK506 acting on other biochemical pathways. Evidence for the 
later is presented within the same study [114]. In the majority of cells 
during FK506 application, there was an increase in steady state Ca^  ^ load 
and a slowed decline of [Ca^^j during caffeine induced contractures. 
These effects were shown to be due to a decreased ability to extrude Ca^  ^
from the cytosol via Na^ /^Ca^ "^  exchange. FK506 does not affect NaVCa^^ 
exchange or Na^K^-ATPase in rat ventricular sarcolemmal vesicles and 
enzyme activities in homogenates and microsomes respectively. Therefore 
the affect of FK506 was thought to be indirect within the rat ventricular 
cardiomyocyte. This is one important effect of FK506, which would not 
have been picked up in previous bi-layer experiments. Xiao et al (1997) 
also performed experiments on rat ventricular cardiomyocytes [113]. This 
study showed that FK506 (50|iM) rapidly and reversibly enhanced cell 
contraction, increased the [Ca^^j transient and the diastolic [Ca^^i level. 
The concentration of FK506 used in this study is 10 times larger than that 
used by McCall et al (1996). The reason McCall et al (1996) used only 5p,M
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was due to the production of FK506 toxicity and the production of Ca^ "^  
waves [114]. At higher concentrations of FK506 and higher [Ca^ ]^j there 
was an increased incidence of Ca^  ^waves. Xiao et al (1997) when using 
50)iM showed the production of Ca^  ^oscillations in their contractile studies. 
The propagation of Ca^  ^waves involves the spontaneous release of Ca^ "^  in 
a co-ordinated fashion from one RyR2 cluster to the next. The frequency of 
Ca^" waves should increase at higher [Ca^ ]^j and therefore higher SR Ca^  ^
loads, however that they occur at a greater frequency when RyR2 coupling 
has been reduced by FK506 seems again counterintuitive. A possible 
explanation to this phenomenon could be the inhibition of NaVCa^^ 
exchange by FK506, which could have led to Ca^  ^ overload within the SR, 
and hence an increase frequency of Ca^ "^  waves rather then a direct effect 
of FK506 on RyR2 to produce them. However, McCall et al (1996) showed 
that a positive ionotropic affect could be achieved even when SR Ca^  ^ load 
was the same as control. The indirect effects of FK506 alluded to above 
are controversial but are further backed up by the effect of FK506 on the 
action potential [201]. DuBell et al (2000) showed that FK506 can inhibit 
repolarising currents and have suggested that the prolonged action 
potential duration results in an increased Ga^  ^ transient in rat 
cardiomyocytes [202]. The effects of FK506 whether they are direct or 
indirect on RyR2-FKBP12.6 seem to vary from one study to the next and 
from one species to another. It has recently been shown that FK506 does 
not have any effects on NaVCa^'' exchange in mouse or rabbit [203]. Su et 
al (2003) showed that transients in mouse were increased with no change 
in SR content, L-type Ga^  ^ current, or NaVGa^^ exchange [203]. However 
rabbit transients were decreased when exposed to FK506 (lOjiM). The
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finding in rabbit is similar to a report by Prestle et al [204]. No substantial 
changes in action potential duration were noted and the suggested 
explanations were with reference to the species differences in intracellular 
[Na"^ ]. Since [Na^ is higher in rat and mouse (12-15mM) this would reduce 
the potential for Ca^  ^ extrusion from the cell via Na^ C^a^  ^exchange and an 
increased leak of Ca^ "^  from SR induced by FK506 will not cause Ca^  ^
depletion. The diastolic [Ca^ ""] levels would subsequently rise and 
SERCA2a would pump Ca^  ^back up into the SR. FK506 will then increase 
the sensitivity of RyR2 and this phenomenon will dominate resulting in an 
increased Ca^'’ transient. Since in rabbit [Na"^ ] is much lower (4-5mM) [205] 
Ca^ "^  leaks from the SR and is extruded from the cardiomyocytes via 
NaVCa^^, decreasing SR Ca^  ^ content and the amplitude of the Ca^  ^
transient. Although this hypothesis fits well with their observations it does 
not incorporate the role of coupling. Specifically, it does not address the 
issue of why an increased transient can occur despite a decrease in 
RyR2 coupling due to FK506 application.
5.4.5 The effects of FK506 at rest in ventricular cardiomyocytes
Two of the above studies [114] [113] went on to look at the effects of FK506 
at rest. The first study [114] showed an accelerated loss of SR Ca^ "^  and 
increased resting Ca^  ^ spark frequency. This could have been due to an 
increased sensitivity of RyR2 to activating Ca^ "^ . The size of the Ca^  ^spark 
however was not altered. The authors explanation as to why Ca^  ^ spark 
morphology did not change in this study was that the increase in SR Ca^  ^
load seen when FK506 was applied was very small or that the effects on 
SR Ca^  ^ load are separate from the effects on SR Ca^  ^ release. This later
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explanation is unlikely since it has been shown that increases in SR load 
should increase the size of the spark along with the frequency [66; 121]. 
One possible problem with this study on Ca^ "^  sparks [114] is the lack of 
automated computer algorithm to detect Ca^  ^ sparks; eye detection has 
been shown to distort the distributions of spark characteristics [115]. 
Treatment of cardiomyocytes with FK506 has also been shown to increase 
the duration of Ca^  ^ sparks but with no change in frequency [113]. This is 
consistent with the idea that uncoupling RyR2 channels by the addition of 
FK506 results in a defect in RyR2 closure (spark termination). From the 
above study [114] the resting SR Ca^ "^  content would be expected to 
gradually decrease albeit at a faster rate than control. However, no such 
change was evident at rest or in results obtained assessing the caffeine 
releasable SR Ca^  ^ content [113]. The time period over which FK506 was 
applied to rat cardiomyocytes was 10min (5)iM). However it has been 
shown that an exposure of rapamycin for times greater than 32min [63] are 
needed to effectively uncouple RylR2. Perhaps exposure times were not 
sufficient in both the above studies [113; 114] to achieve this. Therefore 
drawing conclusions from the studies performed using FK506 to elucidate 
the function of FKBP12.6 within intact ventricular cardiomyocytes [113;114] 
is problematic since while there is a possibility that FK506 may directly alter 
Ca^  ^ release it is hard to distinguish this effect from the non-specific effects 
of FK506 on Ca^  ^homeostasis.
5.5 The need for novel techniques
It can be seen from the above two studies, studying the role of RyR2- 
FK506 within the whole cell is relatively complex when compared to the
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specificity bi-layers offer. However, one technique has been used 
successfully to specifically study the role of the RyR2-FKBP12.6 complex 
within cardiomyocytes. The technique involves using adenovirus mediated 
gene transfer to over-express FKBP12.6 within cardiomyocytes. Using 
these transfected cardiomyocytes, experimental techniques such as 
electrophysiology, Ca '^' uptake measurements, Ca^  ^ spark measurements, 
and cell shortening can all be performed relative to a control population of 
cardiomyocytes transfected with a control virus (either Ad-GFP or Ad- 
LacZ). The advantage being that the RyR2 complex remains within the SR 
and within the cardiomyocyte and the only parameter changed is the over 
expression of FKBP12.6. Prestle et al (2001) performed studies showing 
that rabbit adult cardiomyocytes over-expressing FKBP12.6 exhibited an 
increase in fractional shortening (21%) relative to control cardiomyocytes 
[204]. Cells were then permeabilised and subject to Ca^ "^  uptake 
measurements. Cells over-expressing FKBP 12.6 showed a significantly 
increased SR Ca^  ^ uptake rate without the addition of ruthenium red (5|iM) 
and similar uptake rate with ruthenium red (5|liM) compared to control. 
These results together with the finding of an increased caffeine induced 
contracture when FKBP12.6 was over expressed suggests that FKBP12.6 
functions to increase the closed probability of the RyR2 and by doing so 
reduce resting Ca^  ^ leak (by 53%) and increase SR Ca^ "" content.
5.5.1 The use of permeabilised cells to study the role of FKBP12.6
The permeabilised cell provides a unique way of manipulating the 
intracellular environment while maintaining structural and functional 
integrity. Since FKBP12.6 is a soluble protein present within the myoplasm,
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permeablllsation may be thought to be problematic when performing these 
experiments due to possible protein loss. In our hands [88] this is not 
thought to occur for the following reasons:
(1) FKBP is tightly bound to RyR and the 'off rate of the exchange reaction 
of soluble FKBP12.0 from RyR1 is thought to be negligible [181].
(2) Despite vigorous homogenisation and biochemical purification steps the 
binding sites of RyRI and RyR2 in isolated and washed TC are still filled 
with FKBP12.0 and FKBP12.6 by 94% and 83% respectively.
(3) The time period over which these experiments are performed is within 3- 
4 min (Ca^ "^  spark measurements only over a 60s period). Soluble protein 
loss has only been measured when experiments are performed for 30min 
[170].
(4) Functional effects are considerably different between cells over­
expressing FKBP12.6 and control cardiomyocytes (see section 5.15.3). 
Over expression of FKBP12.6 results in an increased SR Ca^ "^  content but 
reduced spark size suggesting a functional effect of decreased RyR2 
mediated Ca^ "^  leak (see section 5.15.3). Normally increased SR Ca^ "” 
content would result in an increased spark size and frequency.
(5) Substantial intracellular binding of fluorescent indicators occurs when 
cells are permeabilised denoted by a higher intracellular fluorescence. The 
fluorophore is presumably bound to proteins retained by the permeabilised 
cell [88] (see section 3.2.4).
(6) The permeabilisation agent used (p-escin) is less disruptive to the 
sarcolemma then other permeabilisation agents such as saponin [104].
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5.6 The biomedical significance of FKBP12.6
5.6.1 Are these studies relevant to the whole heart?
A clue as to the biomedical importance of FKBP 12.6 came from a study 
involving five paediatric patients receiving prophylactic treatment of FK506 
(tacrolimus) for organ transplantation [206]. These patients developed 
either congestive heart failure (CHF) or hypertrophic obstructive 
cardiomyopathy, which resolved after changing to cyclosporin treatment or 
lower doses of FK506. The effects of FK506 in most of these patients 
seemed to be partially reversible. This is an important observation and has 
similarities to the described mode of action of FK506 and its interaction with 
the FKBP12.6-RyR2 complex in that FKBP12.6 can rebind to depleted 
RyR2. This is also important since high concentrations of FK506 can lead 
to Ca '^' overload and the production of Ca^ "^  waves which diminish when the 
dose is lowered [114]. This was the first report of a cardiac toxicity effect in 
humans. Marx et al (2000) investigated cardiac dysfunction on a molecular 
scale [207]. The macromolecular complex of RyR2 incorporates not only 
four 565,000 dalton homo-tetramers but also muscle A kinase anchoring 
protein (mAKAP), protein phosphatase 2A (PP2A), protein phosphatase 
(PP1), protein kinase A (PKA), PKA regulatory subunit (Rll), and 
FKBP12.6. The stoichiometry of PKA phosphorylation is 3.8 moles of 
phosphate per mole of channel (RyR2). PKA phosphorylation of RyR2 is 
significantly elevated in failing hearts from humans and dogs with pacing- 
induced heart failure compared to non-failing hearts by approximately four­
fold. This is not due to increased levels of PKA protein associated with 
RyR2 and in this study was adjusted for any change in number of RyR2
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due to heart failure. Marx et al (2000) investigated PKA dependent 
phosphorylation of RyR2 in human patients using left ventricular assisting 
devices (LVAD) [207]. The devices allow for the improvement of 
heamodynamic and contractile properties of diseased hearts until cardiac 
transplantation donors become available. When an LVAD is placed within 
the heart a core of tissue is removed. This pre-LVAD sample is therefore 
representative of end stage heart failure tissue and post-LVAD sample 
comes from hearts with improved function. PKA phosphorylation of RyR2 
was significantly increased in heart failure tissue samples compared to 
samples from non-failing hearts and returned to normal levels following 
LVAD treatment. It is known that circulating catecholamines levels are 
raised in heart failure. Many patients with end stage heart failure are 
treated with p-adrenergic agonists prior to cardiac transplantation, however 
some are not. PKA phosphorylation of RyR2 is significantly elevated in the 
hearts from patients treated with p-adrenergic agonists prior to cardiac 
transplantation. Therefore exogenous p-adrenergic administration can 
increase levels of RyR2 PKA dependant phosphorylation. Hyper­
phosphorylation could be explained by the significant decrease in PP2A 
and PP1 associated with RyR2. PP1 associated with the RyR2 returned 
back to normal level post-LVAD (PP2A did not). The PKA phosphorylation 
of RyR2 was found to inhibit FKBP12.6 binding to RyR2 and therefore 
provides a possible mechanism for the physiological and patho­
physiological regulation of FKBP12.6 dissociation from RyR2. It must be 
noted that protein kinase C (PKC) did not induce the dissociation of 
FKBP 12.6 from RyR2. Dissociation of FKBP 12.6 from the RyR2 due to 
PKA phosphorylation increased the open probability and induced the
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appearance of sub-conductance states in single channel recordings. One 
additional finding in 15% of heart failure RyR2 channels was a long lasting 
sub-conductance state. This level of RyR2 channel activity was never 
observed in normal hearts, which were almost always completely inactive 
(50nM [Ca^^). If high circulating levels of p-adrenergic agonists are 
present in heart failure patients then the level of PKA phosphorylation will 
be high and FKBP 12.6 will dissociate from RyR2. If p-adrenergic agonists 
are then given to these patients the response seems blunted. This could 
be because no further PKA phosphorylation can take place. It was shown 
in this study that pre-LVAD patients had a blunted response to 
isoproterenol compared to normal hearts and post-LVAD restored the p- 
adrenergic agonist response (measurements using contractile 
experiments). The localisation of the RyR2 macromolecular complex and 
p-adrenergic system to the T-tubule is advantageous for it allows local 
regulation for the RyR2 at the site of EC coupling. Overall it is seen from 
this study that inappropriate SR Ca^  ^ release via RyR2 in heart failure 
patients due to higher levels of PKA phosphorylation compared to normal 
hearts could lead to significant decreases in SR Ca^ "^  content (not shown) 
and hence contractile dysfunction.
5.6.2 Should the transient be increased or decreased on removal 
of FKBP12.6?
This chapter has tried to emphasise the need to progress in a logical 
fashion from whole heart to the scale of the molecule or vice versa. While 
the above study [207] is pivotal in the degree of knowledge gained on the 
role of FKBP12.6 in heart failure, it has jumped from bedside patient to the
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molecular level without the intervening steps. This was done for obvious 
reasons. Human tissue is always in very short supply and in this case was 
an extremely precious commodity since it came from patients using LVAD’s 
prior to cardiac transplantation. The tissue would also have been difficult to 
work with in terms of obtaining intact cardiomyocytes from which to do 
intact cell measurements from. As pointed out in an editorial by Terraciano 
(2000) the results from this study would indicate that higher levels of PKA 
phosphorylation of RyR2 are present in heart failure, which would lead to 
an increased leak from RyR2 and presumably a decrease in SR Ca^  ^
content [208]. This ultimately would lead to a decreased Ca^ "^  transient. 
However also noted, was that in theory alterations in RyR2 gating should 
not have a steady state effect on SR Ca^  ^ release in the whole cell and 
hence no steady state change in the peak of the Ca^  ^ transient. This 
phenomenon was described using rat cardiomyocytes and is termed auto­
regulation [209]. However auto-regulation only holds true if: (1) there is no 
significant non-RyR2 mediated leak from the SR during diastole and (2) that 
other important proteins involved in Ca^  ^ homeostasis are working 
normally, i.e. NaVCa^ "^  exchange, L-Type Ca^ "" influx, SERCA2a and 
phospholamban.
The activities of other Ca^ "^  regulatory proteins were not measured in this 
study [207]. Therefore the question still remains: will dissociation of 
FKBP12.6 from RyR2 in heart failure patients cause a decrease in SR Ca^  ^
content. The theory of auto-regulation suggests this will not occur since 
Ca^ "^  regulatory proteins will compensate for decreases in SR Ca^ "^  content. 
Possible evidence for this was seen in a previous study [114] whereby the
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application of FK506 increased the open probability of RyR2, increased the 
resting leak of SR Ca^  ^but indirectly inhibited NaVCa "^  ^exchange mediated 
efflux of Ca^ "^ . This resulted in a maintained or moderately increased SR 
Ca^  ^ content. The literature concerning whether or not SR Ca^ "" content is 
altered in heart failure is extremely varied with different models of heart 
failure producing various differences in regulatory protein functional 
expression and related changes in SR Ca^  ^content. It is beyond the scope 
of this thesis to discuss all the heart failure studies. However from the 
above, it must be borne in mind that the cardiomyocyte does not just 
consist of RyR2. Although molecular and biochemical studies shed 
important light on the function of specific proteins, it is their interaction with 
the other Ca^ "^  homeostatic mechanisms which are perhaps more important 
and which require whole cell studies.
A series of recent papers has tried to provide a more comprehensive 
picture of a particular model of heart disease and RyR2 gating 
abnormalities leading to changes in SR Ca^* content. The first study 
introduced a model of tachycardia-induced heart failure induced by pacing 
Beagle dogs for 21 days using an externally programmable miniature 
pacemaker [208;210]. The heamodynamic characteristics of the heart 
failure model were progressive left ventricular dilation, contractile 
dysfunction, and relaxation disturbances. Using SR vesicles the 
characteristics of polylysine induced SR Ca^  ^release at two concentrations 
was investigated together with Ca^  ^uptake experiments in both normal and 
heart failure SR vesicles. The time course of rapid Ca^  ^ release induced by 
polylysine was decreased in heart failure SR vesicles. The Ca^  ^ uptake 
rates were also significantly decreased compared with normal SR vesicles
193
The role of FKBP12.6 in ventricular cardiomyocytes
but the releasable fraction of sequestered Ca^  ^ upon addition of polylysine 
was significantly larger in failing SR vesicles than in normal vesicles. 
Ryanodine binding studies were also performed. The number of binding 
sites in failing hearts was significantly lower than normal hearts but there 
was no difference in Ky for [^ H] RyR binding between the two groups. The 
polylysine concentration dependency in terms of the initial rate of Ca^* 
release and RyR2 binding shifted towards the lower concentration of 
polylysine in failing SR vesicles. These results suggest that RyR2 has an 
increased sensitivity in the heart failure model. From the descriptions 
presented in this chapter it seems likely the FKBP12.6 has some role to 
play in these observations. Indeed in their second paper the stoichiometry 
of FKBP12.6 to RyR2 was markedly decreased from 3.6 to 1.6 in normal 
and heart failure SR vesicles respectively [211]. The physiological 
consequence of this ratio change was investigated by the application of 
FK506 to the vesicles. There was a dose dependent Ca^ "^  leak in normal 
SR but in heart failure vesicles a significant Ca^  ^ leak was observed even in 
the absence of FK506. Increased doses of this drug produced no further 
increase in leak. An interesting method to monitor conformational changes 
in RyR2 concurrent with measurements of Ca^  ^ leak was also presented in 
this study. The technique involved the use of methyl-courmarin-acetamido 
(MCA). This is a fluorescent probe, which was bound to RyR2. The probe 
was excited at a wavelength of 360nM and the subsequent emission signal 
collected at 440nm. The fluorescence produced was an indication of the 
protein conformational change of RyR2 and nicely followed the 
observations made on leak analysis. This confirmed that RyR2 
conformational changes are responsible for the increased Ca^  ^ leak seen in
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normal SR vesicles when FK506 is applied in a dose dependant fashion. 
The third study produced by the same group used the same tachycardie 
model to study polylysine-induced enhancement of ryanodine binding 
during FK506 application [212]. This binding was reduced after increasing 
concentrations of FK506 in normal SR vesicles but no significant change 
was seen in failing SR vesicles. The inhibition by FK506 of polylysine- 
induced ryanodine binding was not thought to be a direct effect of FK506 
since the binding sites for ryanodine and FK506 are different. However a 
conformational change in the RyR2 was thought to have occurred when 
FK506 dissociated FKBP12.6 from RyR2 ultimately resulting in a decrease 
in ryanodine binding. [^H] dihydro-FK506 binding in SR vesicles was also 
lower in failing vesicles than in normal vesicles. The rate of Ca^  ^ release 
was decreased after application of FK506 in normal SR vesicles but 
unchanged in failing SR vesicles. The total amount of Ca^  ^ released in 
normal vesicles was enhanced by FK506 suggesting that the releasable 
fraction of sequestered Ca^  ^ for the total amount of Ca^  ^ uptake is 
increased similar to failing SR vesicles. The application of this drug to 
failure vesicles however showed no such increase in Ca^  ^ release, the 
FKBP12.6 presumably removed already. Importantly it was also shown 
that FK506 does not have an effect on the activity of the Ca^'^-ATPase of 
the SR.
One last study by this group continued the work of Marx et al (2000) on the 
use of p-adrenergic drugs in heart failure [207]. While it seems sensible to 
apply p-adrenergic agonists to a weakly contracting heart it seems 
counterintuitive to give p-adrenergic blockers to heart failure patients yet
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they have proven to be one of the most important treatments for heart 
failure. It is thought that the beneficial effects to patients include increased 
relaxation, restoration of p-receptor population, decreased sympathetic 
nervous activity, and reduced heart rate [213]. However the molecular 
mechanisms underlying the reason why p-blockers are beneficial in heart 
failure is unclear. Doi et al (2001) investigated this [214]. Using the same 
tachycardie model of heart failure (but this time 4 weeks of pacing) the 
authors tried to assess whether or not a chronic low dose of propranolol (a 
p-blocker) could reverse the effects of PKA dependent hyper­
phosphorylation of RyR2. Using SR vesicles and techniques used in their 
previous papers the findings suggested that dogs given propranolol did not 
develop heart failure and showed no signs of left ventricular remodelling. 
There was no spontaneous leak of Ca^  ^ via RyR2 and FK506 increased 
leak unlike SR vesicles from dogs not given propranolol. MCA 
fluorescence confirmed the conformational changes in RyR2. Untreated 
vesicles showed PKA hyper-phosphorylation, which was reversed by 
propranolol treatment. The chronic pacing decreased the amount of RyR- 
associated with FKBP12.6, but the decrease was prevented by propranolol 
treatment. pH] dihydro-FK506 binding was significantly larger in 
propranolol treated than that obtained for the propranolol-untreated 
vesicles, although it was still less than the normal vesicles. (The 
stoichiometry: of normal SR vesicles (3.62±0.62), propranolol untreated 
(1.14±0.16), propranolol treated (2.38±0.46)). SR Ca^  ^ uptake and the 
amount of SR Ca^  ^ ATPase were decreased in heart failure SR vesicles 
and were no different with or without propranolol. These results suggest 
that RyR2 mediated Ca^  ^ leak when FKBP12.6 is dissociated from RyR2 is
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inhibited by propranolol and prevents LV remodelling improving cardiac 
function in the tachycardie heart failure model. The mechanism behind 
these observations involved reversal of the PKA dependant 
phosphorylation of RyR2 and the re-association of FKBP12.6 to RyR2. A 
very interesting feature not reported in this study is that the full complement 
of FKBP 12.6 was not restored to normal levels yet the heart failure was 
improved significantly. Does this mean that the full stoichiometry of 
FKBP12.6 to RyR2 of 4 is not needed? Perhaps only possibly 2-3 
(2.38±0.46) are required to achieve full co-ordination of RyR2? This must 
be taken into account when dissociating FKBP12.6 off of RyR2 and looking 
at the functional effects of the ryanodine receptor, simply dissociating some 
of the FKBP 12.6 may not be enough and may explain why there is a 
variation in range of effects of FK506. Either way a questions that still 
remains is: what is the function of the other possible 50% of sites if they are 
not all involved in stabilising RyR2?
5.6.3 Concerns
There are possible concerns over the molecular studies described above: 
even though they have progressed from the lipid bi-layer experiments 
discussed earlier to the use of SR vesicles, this preparation is a long way 
from whole cell studies incorporating the effects of other regulatory proteins 
determining SR [Ca^H- There is also doubt as to whether the tachycardie 
model represents a true form of heart failure since the process is reversible 
three weeks after the termination of pacing. Furthermore, no hypertrophic 
compensatory phase was apparent in this model.
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5.6.4 Future work is needed
Many models of animal heart failure exist and have been fully characterised 
using electrophysiological studies and data regarding Ca^  ^ regulatory 
protein expression. Unfortunately, to date, no one has studied the 
molecular role of FKBP12.6 on RyR2 in whole intact cells from one of these 
well-characterised failure models. The challenge to establish a coherent 
understanding of the role of RyR2 in Ca^  ^ homeostasis within intact 
cardiomyocytes with the incorporation of all other regulatory proteins 
associated with RyR2 and the sarcolemma, will ultimately be more 
beneficial in comparison to trying to establish the role of FKBP 12.6 on 
RyR2 in isolated systems such as lipid bi-layers or SR vesicles.
5.6.5 The importance of FKBP12.6 stoichiometry within 
cardiomyocytes
It becomes apparent when reading this chapter that the literature on SR 
Ca^  ^ release due to dissociation of FKBP12.6 from RyR2 presents a 
dichotomy. On one hand, dissociation increases CICR gain and 
contractility (as in the application of FK506) or alternatively dissociation 
induces so much SR Ca^  ^ leak that CICR gain and contractility decreases 
(as seen in heart failure). It is hard to reconcile a mechanism whereby 
these two scenarios can co-exist. The former case requires a sufficient SR 
Ca^ "^  content to allow a larger Ca^ "” transient to be triggered for any given L- 
type Ca^ "^  influx. The latter case suggests that the SR Ca^  ^ content is 
reduced to such an extent by RyR2 mediated Ca^  ^ leak that any Ca^ "” 
transient produced will be decreased to a level such that it is not sufficient 
to produce an efficient contractile response. In both cases it should be
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noted that coupling between RyR2 is considered decreased due to the 
dissociation of FKBP12.6 from RyR2. One way to reconcile these two 
situations is to consider the phosphorylated status of RyR2. Hyper­
phosphorylation resulting from increased levels of p-adrenergic stimulation 
in heart failure results in dissociation of FKBP12.6 from RyR2 and a 
subsequent increase in Ca^  ^ leak from the SR. However this same 
sympathetically driven phosphorylation must also occur during a fight or 
flight response. An increase in CICR would be desirable during this 
sympathetic drive as oppose to a decrease in SR Ca^  ^ content. It is 
apparent that the exposure time to p-adrenergic agonists differs in the two 
cases: in heart failure p-adrenergic agonists are present chronically 
however during the ‘fight or flight' réponse the exposure is acute. The 
temporal effects are related to altered FKBP12.6 stoichiometry and thus 
provide a possible mechanism whereby increases and decreases in CICR 
gain can be achieved by a similar mechanism [215].
'In normal hearts, as each of the PKA sites Is transiently phosphorylated there is a 
progressive physiological increase in RyR2 channel activity and increase EC coupling gain 
resulting in increased contractility. However, in failing hearts where on average three or 
four of the PKA sites are chronically depleted of FKBP12.6 they become destabilised or 
'leaky*. Under these conditions uncoupling of RyR2s would occur due to PKA 
phosphorylation of RyR2 and depletion of FKBP12.6 from the macromolecular complex.'
This would mean that when the stoichiometry of FKBP12.6 is one or two 
(such as in heart failure) there would be a decrease in CICR gain due to 
decreased coupled gating. Evidence for this comes from the 
measurements of Ca^ "^  sparks within cardiomyocytes from failing hearts,
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which show a prolonged decay and an increased width [215]. The 
decrease in RyR2 coupling would result in a decreased SR Ca^  ^ content 
and a shift in the Ca^  ^ activation curve to the left. Unusually in this study 
the Ca^  ^ sparks were smaller in amplitude when RyR2 was hyper- 
phosphorylated. This was thought to be due to a decreased SR Ca^ "^  
content. However it seems more logical that de-coupling would have 
produced an increase in spark amplitude along with other the morphological 
characteristics and further aid the increase in SR Ca^ "” leak and subsequent 
decrease in SR Ca^  ^ content similar to the report that will be discussed in 
depth later [216]. It becomes clear from these previous studies that without 
a handle of SR Ca^  ^ content spark characteristics are hard to interpret 
since so much of the size of the Ca^  ^ spark is reliant on SR Ca^ "^  content. 
More work therefore needs to be carried out with measurements of Ca^  ^
flux through RyR2 and the resultant change in SR Ca^  ^content.
5.7 The balance between phosphorylation and phosphatase activity
The importance of the in vivo balance between phosphorylation and 
phosphatase activity on RyR2 has been emphasised by Reiken et al (2003) 
and provides a stark warning for those authors studying the effects of 
FKBP12.6 on RyR2 using isolated cardiomyocytes [215]. If RyR2 were 
hyper-phosphorylated (such as in heart failure) one would expect the 
function of the macromolecular complex to be altered. Furthermore, 
additional phosphorylation by p-adrenergic agonists would result in a 
blunted response. However, Gomez et al (1997) found that RyR2 function 
was unaltered in animals with heart failure [217]. To investigate this 
disparity [215] cardiomyocytes were isolated by Langendorff perfusion and
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isoproterenol added to the perfusate. No significant change in RyR2 
phosphorylation status was observed as reported by Gomez et al [217]. If 
however sodium fluoride (NaF) a weak phosphatase inhibitor, was added to 
the perfusate along with the isoproterenol a significant increase in PKA 
mediated phosphorylation was observed. This data suggests that when 
experiments are performed on isolated cardiomyocytes the balance 
between the phosphatase effects and PKA mediated phosphorylation of the 
RyR2 must always be considered. It seems that phosphatase mediated by 
PP1 and PP2a located on RyR2 has a dominant effect during Langendorff 
perfusion without phosphatase inhibitors to the extent that the true hyper- 
phosphorylated status of RyR2 is lost. Phospholamban was 
phosphorylated by isoproterenol with or without NaF. This could be 
because no such phosphatase or kinase is attached to this protein. In heart 
failure a chronic hyper-adrenergic state predominates along with a 
decrease in phosphatase attached to RyR2. PKA hyper-phosphorylation 
therefore ensues and FKBP12.6 is subsequently dissociated from RyR2. 
This might not be seen in acutely dissociated cardiomyocytes when 
perfused with isoproterenol since phosphatase dominates the situation. 
Flash freezing of the heart as soon as it removed from the body needs to 
be performed if the in vivo phosphorylation status of RyR2 is to be 
captured. When hearts are flash frozen after isoproterenol infusion a 
significant PKA mediated phosphorylation of RyR2 occurs and FKBP12.6 is 
dissociated [217].
5.7.1 The testing of other heart failure models
With this in mind multiple animal heart failure models were investigated
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[215]. The salt sensitive Dahl rats, which developed hypertension and 
subsequent hypertrophic cardiomyopathy, showed evidence of hyper­
phosphorylation of RyR2 in the presence of NaF but not in absence or 
control. PLB was also phosphorylated. This is an example of severe 
cardiac hypertrophy where RyR2 and PLB were hyper-phosphorylated 
which differs from heart failure in which RyR2 is PKA phosphorylated and 
PLB is not. Furthermore unlike heart failure where phosphatase is 
decreased hypertrophic cardiomyopathy showed no such decrease. This is 
therefore similar to acute p-adrenergic stimulation. Performing the same 
study in a six-month post-myocardial infarction (PMI) rat model showed 
PKA hyper-phosphorylation of RyR2 and hypo-phosphorylation of PLB. 
There was a concurrent decrease in phosphatase levels. This is similar to 
that of heart failure [207]. Again with another model concerning the 
cardiac-specific over-expression of human matrix metalloproteinase type 1 
(MMP-1), which shows progressive cardiac dysfunction the same 
experiments carried out at six, twelve, and twenty-four months of age 
showed progressive PKA hyper-phosphorylation of RyR2. Mice with 
cardiac specific over expression of p2-adrenergic receptor showed 
significant PKA hyper-phosphorylation of RyR2 [215]. All of these models 
were associated with increased dissociation of FKBP12.6 to RyR2. This 
study provides good evidence for the link between PKA hyper­
phosphorylation, dissociation of FKB12.6, increased spark size, and heart 
failure. The cardiac tissue has obviously been handled with extreme care 
and expertise to provide solid evidence. However, the complexity of the 
PKA phosphorylation status of RyR2 and its functional consequences are 
not so straightforward.
202
The role of FKBP12.6 in ventricular cardiomyocytes
5.7.2 Controversy in interpretation of results due to PKA 
phosphorylation of RyR2
Li et a! (2002) showed that PKA phosphorylation of RyR2 did not affect 
Ca^  ^ sparks in mouse ventricular cardiomyocytes [109]. Spark frequency 
was used as a measure of SR Ga^ "" leak in permeabilised cardiomyocytes 
from control cells (wild type), PLB knock out cardiomyocytes which had no 
inhibition of SERCA2a dependent Ca^  ^ uptake, and PLB double mutant 
which lacked a regulatory phosphorylation site and therefore SERCA2a 
continually inhibited SR Ca^ "^  uptake. When cAMP was added to wild type 
cardiomyocytes a significant increase in Ca^  ^ spark frequency occurred. 
No such increase was evident in PLB knock out or double mutant 
cardiomyocytes. The study also assessed SR Ca^ "^  content, which together 
with the data above suggested that PKA dependent RyR phosphorylation 
did not affect resting SR Ca^  ^ leak in these myocytes and that the 
increased Ca^  ^ spark frequency and size is dependent on PLB 
phosphorylation and consequent increases in SR Ca^  ^content. This study 
had therefore tried to separate the affects of PKA phosphorylation on RyR2 
and SERCA2a mediated Ca^  ^uptake and analyse the consequent SR Ca^ "^  
content. This study is in direct contention with the studies by the Marks, 
A.R. group. There are some worrying aspects to this skinned cell study 
[109]. The most obvious was the major disparity in Ca^  ^ spark frequency 
between intact and permeabilised cells. This was by no means a small 
difference. At 50nM in permeabilised cells the control cell had a frequency 
of approximately 350 sparks.pl'\s'^ but the spark frequency in intact cells 
was approximately 40 sparks.pl \s'1. Even more problematic with these 
measurements is that that the resting [Ca^ ]^ in intact cells (~150nM) is
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thought to be two or three times higher than that used in the permeabilised 
cells (50nM). This would result in a higher SR Ca^  ^ content in the intact 
cells and increased Ca^  ^ spark frequency yet this was by no means seen, 
in fact the reverse was observed and no indication of SR Ca^ "^  content in 
intact cells was given. In rabbit cardiomyocytes Ca^ "" spark measurements 
in p-escin permeabilised cells are difficult to evaluate in comparison to 
intact rabbit cardiomyocytes since cellular [Na^ favours extrusion of Ca^ "^  
from the cell and depletion of SR Ca^ "^  content. However the frequency of 
Ca^  ^ sparks in cultured cardiomyocytes compared to freshly dissociated 
cells (see section 5.15.3) is very similar and is comparable to the frequency 
in permeabilised and more importantly intact rat cardiomyocytes [64]. The 
controversy above could therefore represent a problem with the 
permeabilisation technique used. Even though the permeabilisation agent 
used in this study [109] (Streptolysin-0) produces more consistently sized 
pores (30nm) these are still twice the size of those produced by saponin 
and p-escin (8-15nm). The permeabilisation technique was shown to take 
10-25min depending on the cell density. This combined with the 
experiment that lasted for a further 16min is problematic. Endo (1980) 
showed considerable loss of soluble protein from muscle cell cytoplasm in 
30min [170]. That this study took place over a possible 41min is of concern 
and in the worst possible scenario resulted in the loss of FKBP12.6 from 
the permeabilised preparation. This would have resulted in no further 
phosphorylation of the mutant cells in this study. Experiments in this thesis 
take place over an acute time of 3-4min including permeabilisation times 
(~"0.5min). That FKBP remains bound to SR vesicles despite vigorous 
homogenisation and biochemical purification steps suggest that
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dissociation of the FKBP by permeabilisation is an unreasonable 
consequence. However this defence might only be plausible if the 
experiment is performed acutely. Another consideration with this study is 
the use of extremely low [Ca^ ]^ of 10 and 50nM. This was achieved by the 
use of lOmM EGTA. In rabbit cardiomyocytes lOmM EGTA does not allow 
visualisation of Ca^  ^ sparks let alone caffeine release which was shown to 
occur in the mouse in this study. Why this disparity exists is unknown. 
Reiken et al (2003) would suggest that this [Ca^ ]^ is too low to activate 
RyR2 [215]. This may have been used to ensure that the addition of cAMP 
did not cause enhanced SR uptake and Ca^  ^ waves. The use of the 
mutants in this study presents extremity cases of PLB regulation, which 
may mask the effects of PKA phosphorylation on RyR2, mediated Ca^  ^
release. The idea that PKA can affect the phosphorylation status of the 
RyR2 and alter release from the SR is far from certain. Ca^  ^
calmodulin kinase II (CaMKII), which also phosphorylates the cardiac RyR2 
at Ser-2809, does not seem to produce similar bi-layer results as PKA [218- 
220]. PKA phosphorylation modulation of RyR2 is also complex when there 
are dynamic changes in myoplasmic [Ca^^. This phenomenon can alter 
the open probability of RyR2 [58]. Clearly further work is needed on this 
important topic.
5.8 The use of transgenic whole animal models
Shou et a! (1998) published a different technique, which probably hoped to 
achieve a more integrated approach [221]. The approach was to create 
transgenic mice deficient in FKBP12.0 using embryonic stem cell 
technology. Unfortunately the mammalian need for FKBP12.0 (from birth)
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has never been highlighted so vividly. The majority of mice were said to 
have died between embryonic day 14.5 and birth (8 out of 557 mice 
survived). Caesarean section was used to examine some embryos within 
this period of time. Pathology revealed severe cardiac abnormalities 
including dilated cardiomyopathy, ventricular septal defects, enlarged 
hearts, oedema, anatomical defects suggestive of non-compaction of the 
left ventricle, hypertrophic trabeculae and deep inter-trabecular recesses. 
Other systemic abnormalities including severe haemorrhage and necrosis 
of the liver (liver centrolobular necrosis), exencephaly and neural tube 
closure defects. Of the 1% that survived (8 animals) only 1 mouse lived 
past a few weeks (14 months) the others dying of a cardiac wasting 
syndrome. This fortunate' mouse showed clinical signs and anatomic 
defects consistent with human cardiomyopathy and heart failure. Even 
though FKBP 12.0 is associated with skeletal muscle RyRI not one single 
skeletal muscle abnormality was seen at the gross anatomical level or via 
electron microscopy. However on the molecular level when RyRI was 
incorporated into lipid bi-layers from FKBP12.0 deficient mice abnormalities 
were present. FKBP12.0 deficient mice showed RyRI channel 
abnormalities associated with removal of FKBP12.0 from RyRI, i.e. an 
increased open probability and appearance of sub-conductance states. 
When RyR2 was incorporated into lipid bi-layers and similar experiments 
carried out the same observations were noted as for FKBP12.0 i.e. an 
increased open probability and appearance of sub-conductance states. 
These results challenge the idea of functional selectivity of FKBP12.0 to 
RyRI modulation and FKBP12.6 to RyR2 modulation suggested by various 
studies described above. FKBP 12.0 deficient mice had abnormal gating of
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both RyR1 and RyR2 yet no skeletal abnormalities were present. The 
FKBP12.6 present within the tissues of the FKBP12.0 deficient mice could 
not restore the normal channel properties to RyR1. This raises the 
question of whether or not in vivo FKBP12.0 is needed for EC-coupling. 
Although this study raises important questions on the role of FKBP12.0 at 
the systemic level its benefit as an important model for the testing of 
pharmacological agents and other therapies that may retard or reverse 
human heart failure as stated at the end of the study is somewhat 
controversial. Certainly a survival rate of 0.2% does not fit in with the 
attempt to reduce, refine, and replace animal experimental procedures. 
Another important aspect to transgenic models such as this one is the 
possibility of changes not usually present in adult mice representing 
adaptive changes to compensate for the lack of FKBP12.0. Therefore the 
slim chance of any surviving animal is somewhat obscured by the 
possibility of an abnormal physiology corresponding to an adaptive model. 
This is where the relatively acute procedure of over- expressing a protein in 
adult cardiomyocytes provides a more beneficial model in which adaptive 
changes are extremely limited due to the short time in which to occur. One 
way this could be incorporated into a transgenic model would be to produce 
conditional knockouts. This would ensure that embryonic or neonatal 
adaptive changes will be prevented and changes in expression for the 
selected protein will only be seen in the adult model if and when so desired. 
Since a transgenic model had been produced without FKBP12.0 it seems 
prudent to produce a mouse without FKBP12.6 [216]. However whereas 
the FKBP12.0 mouse lacked FKBP12.0 exons 3 and 4 encoding for the 
functional domains involved in FK506 and rapamycin binding, cis-trans
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prolyl isomerase activity and TGF-B type 1 receptor binding, the FKBP 12.6 
mouse [216] lacked exon 3 on the FKBP12.6 gene encoding for the binding 
sites for RyR2, FK506 and calcineurin. The survival rate in this model 
compared to the FKBP12.0 transgenic mouse is somewhat unknown since 
there is no indication of the total number of transgenic mice produced. 
Whole cell experiments were performed on 5-6 mice, which survived to 4-6 
months of age. There is also no indication whether other developmental 
abnormalities were produced other then the hypertensive induced cardiac 
hypertrophy seen in male mice. This could be due to the specific binding of 
FKBP12.6 to RyR2 in the heart and hence no other systemic abnormalities 
detected or a lack of reporting. This is in stark contrast to the widespread 
systemic problems associated with the FKBP12.0 transgenic and probably 
represents the ubiquitous nature of the protein. By using whole cell 
experiments performed on voltage clamped cardiomyocytes loaded with 
Fura-2, Xin et al (2002) showed that both male and female mice had 
unaltered L-type Ca^  ^channel alterations but both had an increase in CICR 
gain, i.e. an equivalent Ica produced a much larger increase in the peak 
[Ca^ "^ ]i transient. When voltage clamped at 10mV the CICR gain was 83% 
and 67% in male and female mice respectively (but not significantly 
different). Shortening measurements followed this trend. Using LSCM 
sparking events were detected in voltage clamped cells using lOOpM Fluo- 
4. This is the first study to associate an increase in spark amplitude with 
RyR2 deplete of FKBP12.6 and in this study was observed in FKBP12.6 
null male and female mice in comparison to wild type, this situation being 
analogous to the application of FK506 which previously had only been 
shown to increase frequency [114] and duration [113]. An increase in width
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and duration of Ca^  ^sparks was also observed in FKBP12.6 null mice seen 
in comparison to wild type mice although duration was not expressed in the 
conventional way at the half maximal level. Instead spark duration was 
expressed with a prolonged rise time taken from the point of rise to peak of 
the spark, and an increased decay time constant, which was an exponential 
fit of the rapid phase of F/Fo decay. It was suggested in this study that the 
increase in spark size and therefore longer opening times augments SR 
Ca^ "" release and directly gives rise to the increase in CICR gain. This 
comment would be at odds with the theory of stoichiometry as proposed 
above by Reiken et al (2003) since the RyR2 is supposedly fully depleted of 
FKBP12.6 [215]. This latter study would suggest that longer openings 
times and a larger leak of SR Ca^  ^ into the myoplasm would decrease SR 
Ca^  ^content and ultimately reduce the CICR gain. A mechanism therefore 
must be maintaining SR Ca^ "^  content or enhancing it to allow for the 
increase in gain. A mechanism to maintain SR Ca^ "^  content would be 
critical since FKBP12.6 mice will also have a lack of co-ordination between 
RyR2 channels (this being needed for efficient EC-coupling). Another 
possibility is that FKBP12.0 is compensating for the lack of FKBP12.6 in 
some way. No experiments were performed to assess SR Ca^ "" content or 
the regulation of other Ca^ "" regulating proteins. Despite the increase in 
CICR gain and similar spark characteristics in both male and female 
FKBP12.6 null mice only male mice suffered from hypertension and 
hypertrophic cardiomyopathy. If tamoxifen (a oestrogen receptor 
antagonist) was given to the female mice they also developed cardiac 
hypertrophy. This suggests that the stimulation to allow a hypertrophic 
response was prevented by oestrogen, and therefore is protective against
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cardiac hypertrophy. The stimulation for cardiac hypertrophy is thought to 
be an increase in cellular [Ca^ ]^. Oestrogen receptor signalling determines 
how the heart adapts to increased levels of [Ca^ ]^. There could have been 
other stimuli responsible for the inducement of cardiac hypertrophy such as 
changes in calcineurin activity, which is known to affect NFAT, and 
subsequent gene expression (since this binding site has been deleted). 
Since hypertrophy is related to hypertension, increases in peripheral 
resistance could have been a triggering factor [216].
5.9 Novel modulators of RyR involving FKBP
Many studies have used FK506 to reveal the association between 
FKBP12.6 and RyR2. However FK506 is an exogenous modulator of RyR2 
function. Endogenous substances in vivo must regulate the association 
between the two. Phosphorylation has proved to be used as an in vivo 
modulator of RyR2-FKBP12.6 function. The sheer complexity and 
abundance of biochemical pathways existing within cardiomyocytes 
suggest that there may be other in vivo modulators of FKBP-RyR function. 
The next section summarises some novel products that modulate RyR2 via 
their interaction with FKBP.
5.10 Bastadins
The first group of products are obtained from the sponge lanthella basta 
located in the Great Barrier Reef. The products are macrocyclic natural 
products derived from bromotyrosine. They have been called bastadins, 
two of which have been studied in depth. Bastadin 5 has been shown to 
modulate the skeletal and more weakly the cardiac RyR via FKBP [222]. 
Using ryanodine binding and RyRI, bastadin 5 was shown to increase the
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specific [^ H] ryanodine binding in a dose-dependent manner. The 
mechanism by which this was achieved, involved stabilising high affinity 
binding sites for pH] ryanodine while minimising binding sites with a lower 
affinity. It does not alter the apparent affinity of the Ca^  ^ activator site for 
Ca^ "^  unlike caffeine. The compound also attenuates the inhibition of the 
binding of pH] ryanodine by mM concentrations of Mg^ "^  and Ca^ "". Bastadin 
5 does not interact with known RyR1 channel modulators and has a greater 
potency and intrinsic activity toward enhancing pH] ryanodine occupancy 
compared to caffeine. Another lanthella basta product competes with 
Bastadin 5 and is called Bastadin 19. Bastadin 19 inhibits the activity of 
Bastadin 5 while behaving like a partial agonist. The potency of Bastadin 
5 was three times greater than Bastadin 7 another Bastadin from the same 
sponge. Using SR vesicle experiments the author showed that Bastadin 5 
(i) decreases the net rate of SR accumulation in a dose dependent 
manner, (ii) markedly enhances CICR, (iii) but is unable to release Ca^ "" 
when added to loaded SR vesicles at low (<100nM) extra-vesicular Ca^ ,^ 
unlike a mixture of Bastadins from the same sponge. Using lipid bi-layer 
experiments it was established that Bastadin 5 slowed the gating transitions 
of RyRI increasing the open and closed time constants without effecting 
channel unitary conductance for Cs"^ . Importantly FK506 suppresses the 
dose dependent activation of pH] ryanodine binding sites by Bastadin 5 to a 
level seen with FK506 alone. Further more Ca^  ^efflux induced by addition 
of Bastadin 5 mixture added to loaded SR vesicles was completely inhibited 
by pM FK506. The results suggest some sort of interaction between 
bastadin and FKBP. SR pre-treated with bastadin 5 does not induce 
release of the FKBP to the supernatant unlike FK506. These results are
211
The role of FKBP12.6 in ventricular cardiomyocytes
consistent with the hypothesis that bastadins modulate RyR1 function by 
interaction with FKB12.0 and that dissociation of the immunophilin by 
FK506 removes the bastadin effectsr site. The above results were
performed skeletal muscle RyR1. The effects were also observed in 
cerebellar microsomes enriched in RyR1 but the effects were less 
efficacious. Bastadin 5 was also less effective than caffeine towards the 
cardiac isoform RyR2. The isoform selectivity would suggest that
FKBP12.0 is the target of bastadin 5 not FKBP12.6. What the bastadins 
are binding to in cardiac SR vesicles to affect RyR2 function remains 
unknown. It could be FKBP12.0 bound to RyR2 albeit to a much lower 
extent. Bastadin 5 markedly slows channel gating without changing the 
steady state channel open probability and stabilises the high affinity full 
conductance state of the RyR without causing a physical dissociation of 
FKBP12.0. This product could be mimicking an in vivo process within 
muscle cells. Another bastadin of importance in relation to FKBP is 
bastadin 10 [223]. This structure also interacts with FKBP12.0 and without 
physical dissociation alters the gating of RyRI. However the modulation of 
gating of RyRI is different to that of bastadin 5. This natural product 
stabilises the open conformation of the channel and sensitises the channel 
to activation by Ca^ "^  to such an extent that it essentially eliminates
regulation of the channel in the physiological range of Ca^ "^ . Bastadin 5 in
comparison stabilises both open and closed channel states but has no 
effect on the Ca^ "^  sensitivity of the channel to activation by Ca^ "^ . Both 
products however alleviate the inhibition Whereas changes in RyRI
gating caused by bastadin 5 were thought to be due to a decrease in 
negative co-operativity, Bastadin 10 is thought to decrease the free energy
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associated with the open conformation of the channel. Again bastadins rely 
on binding to FKBP12.0 since RyR modulation by bastadin 10 was 
selectively eliminated by pre-treatment of channels with FK506 or 
rapamycin and was reconstituted by human recombinant FKBP 12.0. The 
effects of bastadin 10 were importantly noted as being reversible and 
prevented run down of RyRI channels in lipid bi-layers allowing them to 
open for periods of 20-30min.
The isolation of these products raises important issues regarding the 
possibility that there are indeed endogenous molecules within the cell that 
have the potential to activate the mechanisms illustrated above. The 
structure of the different bastadins also emphasises the point that subtle 
changes of structure can have major effects on modification of RyRI gating 
behaviour.
5.11 Ivermectin and Midecamycin
It has been suggested that FK506 can have a direct effect on RyR [224]. 
This was observed when exposing FK506 to RyR channels with the 
subsequent production of sub-conductance levels, which were unrelated to 
the release of FKBP. It has also been shown that rapamycin can directly 
activate RyRI without the need for FKBP12.0 [225;226]. Since rapamycin 
has a macrocyclic lactone structure, studies have looked at compounds 
with a similar structure to see if the same channel altering effects exist. 
Ahern et al (1999) investigated two such drugs [227]. The first was 
ivermectin, which is in wide spread use in veterinary medicine as an 
anthelmintic. The drug is derived from Streptomyces avermitilis and is a
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member of the avermectin class of macrocyclic lactones. The second drug 
looked at in the study was midecamycin, which is an antibiotic. Using bi­
layer studies of single RyR1 from native TC vesicles, Ahern et al (1999) 
established that ivermectin reversibly activates RyRI without affecting 
single channel conductance. The open probability, mean open time and 
frequency of openings all increased. (In comparison Bastadin 5 does 
increase channel open time but not the open probability and structurally 
lacks a lactone group). These observations were also apparent in FKBP12 
stripped channels, which had originally showed long openings to a 
submaximal, level with brief openings to higher conductance. The sub­
conductance states were converted to maximum conductance levels 
reversibly. The ability of ivermectin to convert sub-conductance to full 
conductance is in comparison to FK506 and rapamycin which increase 
channel opening to sub-conductance states. Midecamycin showed similar 
effects to ivermectin on RyRI isolated channels however a higher 
concentration was required then that of ivermectin. The results also 
observed that that removal of FKBP12.0 was not needed for the action of 
the two drugs. It was confirmed by western blotting that neither compound 
could dissociate FKBP12.0 from RyR. In comparison with bastadin studies 
presented above it was noted (unpublished result) that ivermectin did not 
act synergistically with rapamycin in promoting removal of FKBP12.0 from 
RyRI unlike bastadin 5 and FK506. Using Ca^ "^  uptake studies it was 
established that ivermectin caused a concentration dependent decrease in 
rate of Ca^ "^  uptake in both the absence and presence of ruthenium red 
suggesting an increase leak from RyRI and reduced rate of uptake by 
SERCA2a. Interestingly it was found that ethanol alone reduced SERCA2a
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mediated Ca^ "^  uptake and DSMO increased SERCA2a mediated Ca '^’ 
uptake, however ivermectin in either of these vehicles substantially reduced 
Ca^  ^ uptake. Midecamycin had minimal effects on SR Ca^  ^ uptake. Using 
thapsigargin to negate the affects of SERCA2a and assess RyR1 mediated 
Ca^  ^ release ivermectin was shown to enhance Ca '^’ release via RyR1. 
Midecamycin however had no affect. Ivermectin added after 5mM MgCb 
(used to ensure enough retention of Ca^  ^ within SR vesicles) increased 
Ca^ "^  release overcoming the block of RyR1 by 0.9mM free Mg'". 
Furthermore caffeine-activated Ca^ "' release was greater with ivermectin 
than in control. The sensitivity of RyR1 to caffeine was enhanced. No such 
effect was seen with Midecamycin. Using skinned rat extensor digitorum 
longus fibres ivermectin was shown to reduce Ca^  ^ loading and increases 
caffeine-induced contraction. Midecamycin had no such effect. Again the 
emphasis here is on subtle structural changes that have the ability to alter 
channel gating. It is proposed in this study that rapamycin, ivermectin and 
midecamycin all bind to RyR1 at the same site.
Hyperthermia is an interesting toxicity of ivermectin that has been reported 
in a dog [228]. This is reminiscent of a similar process that occurs in 
humans and pigs called malignant hyperthermia (MH). The syndrome is 
characterised by muscle rigidity, hyperthermia, dyspnoea, arrhythmias, and 
death. It is thought to be the result of a single Arg to Cys mutation on 
RyR1. An autosomal recessive gene determines susceptibility. The 
metabolic consequences are due to a reduced sensitivity to inactivation by 
Mg  ^and Ca^  ^ and have the following sequence of events: (1 ) leak of Ca^  ^
into the myoplasm from the SR, (2) muscle contraction and hyper­
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metabolism due to uncontrolled and sustained increase in myoplasmic 
Ca^ "^ , (3) ATP depletion, (4) increased aerobic and anaerobic metabolism 
resulting in excessive carbon dioxide and lactic acid production, (5) thermo­
genesis and peripheral vasoconstriction, (myoplasmic enzymes and 
electrolytes are released from the cell and more Ca^ "” enters the myoplasm, 
(6) rhabdomyolysis, (7) contraction proceeding independently of 
myoplasmic Ca^  ^ levels. (8), death due to an increased potassium 
concentration, arrhythmias, and sudden cardiac death. The triggering 
event can be volatile anaesthetics, depolarizing muscle relaxants, 
exertional/environmental stress hence the alternative name of porcine 
stress syndrome (PSS). It is possible that the above macrocyclic lactones 
discussed in this section at in a similar way on RyR1 with an end result 
similar to that seen in this syndrome.
Overall, as predicted by Kaftan et al (1996) it is highly probable that 
associations between FKBP and other trans-membrane signalling 
molecules will be discovered [197].
5.12 Unresolved issues
5.12.1 What Is the function of FKBP12.0 in cardiomyocytes
Although this question is not experimentally investigated within this thesis, a 
brief summary of current work on this subject is presented below.
Cardiac RyR2 is associated with FKBP in human, rabbits, rats, mice, dogs, 
chickens, frogs and fish [229]. As discussed earlier, dog heart only binds 
FKBP12.6 other species bind both FKBP12.6 and FKBP12.0. The 
stoichiometry of FKBP to RyR2 is thought to be four for both FKBP12.0 and
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12.6 (except the dog). FKBP12.0 has a seven fold weaker affinity for RyR2 
in the above selection of species whereas in the dog it is more likely to be 
500 fold and hence binding is virtually negligible. This relatively large 
myoplasmic pool of FKBP12.0, which is thought to be 3|xM, suggests a 
function within cardiomyocytes. This of course could be completely 
unrelated to EC-coupling. Immunophilins may have multiple sub-cellular 
locations in addition to the cytosol and it could be these locations that are 
regulated by the cytoplasmic pool by FKBP12.0. FKBP12.0 could be 
affecting many different binding sites for instance transforming growth 
factor has been reported to be associated with FKBP and may have an 
important role [230].
One investigation involving FKBP12.0 knock out mice [221] may provide an 
important clue as to a possible role for FKBP12.0 in the heart. Even though 
FKBP 12.0 was knocked out, it was cardiac changes that were most 
apparent and not changes in skeletal muscle morphology. Therefore is 
FKBP12.0 required for cardiac development?
A study has however found that RyR2 channels obtained from FKBP12.6 
knockout mice have shown no abnormalities when incorporated into SR 
vesicles [231]. This result is similar to reports using canine cardiac SR 
where removal and restoration of FKBP12.6 did not modulate RyR2 
channel activity [195]. Since FKBP12.0 is present in the mice and can bind 
to RyR2, it could be that FKBP12.0 substitutes for the lack of FKBP12.6. 
However this hypothesis would be harder to reconcile in the dog where the 
affinity for FKBP12.0 for RyR2 is negligible.
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Two studies presented in this thesis aim to investigate previously 
unresolved issues associated with FKBP function.
5.12.2 What is the role of FKBP12.6 in EC-coupling?
The controversy involving the role of FKBP 12.6 in CICR has been reviewed 
above. The study presented here (see section 5.13) utilises the technique 
of FKBP12.6 over-expression in cultured cardiomyocytes in order to study 
the role FKBP12.6 plays in the formation of the Ca^  ^ transients, Ca^  ^
sparks, and waves. The study suggests that FKBP12.6 has a major effect 
on the size and frequency of Ca^  ^ sparks which is in line with the 
implication that FKBP 12.6 is essential for coupling of RyR2 channels within 
a cluster and therefore termination Ca^  ^ sparks. Enhanced coupled gating 
is also suggested as a possible mechanism allowing for the enhanced 
synchronous Ca^ "^  release seen in cells over-expressing FKBP12.6. This 
finding was independent of SR Ca^  ^ content. This study shows that over­
expression of FKBP12.6 reduces SR Ca^  ^ leak by reducing the size of Ca^  ^
sparks and results in an increased SR Ca^  ^ load. Thus over-expression of 
FKBP12.6 could be a therapeutic option for the treatment of heart failure in 
cases where the SR Ca^ "^  content has diminished due to enhanced RyR2 
mediated leak. This function is usually the role of positive inotropic agents 
such as digoxin. However, as with such drugs, toxicity can occur. The SR 
can become overfilled with Ca^" and Ca^  ^waves occur. The production of 
Ca^ "^  waves, which are potentially arrhythmic, could be a fatal disadvantage 
to this novel therapeutic approach.
5.12.3 Is calcineurin activity required for modulation of RyR by FKBP
This question is discussed in chapter 6.
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5.13 Over-expression of FK506-binding protein FKBP12.6 increases 
the synchronicity of SR Ca^* release in adult rabbit cardiomyocytes.
5.13.1 METHODS
5.13.2 Single ventricular cardiomyocyte isolation from the rabbit heart
Single cell isolation from the rabbit was performed as in section 2.1.
5.13.3 FK binding protein 12.6 over-expression within rabbit 
cardiomyocytes
Recombinant adenoviruses were generated by standard procedures using 
full-length cDNA of the human FKBP12.6 gene [204]. Adenoviral infection 
with a multiplicity of infection (MCI) of 100 was performed to produce two 
populations of adenovirus transfected cardiomyocytes (i) over-expressing 
FKBP12.6 (Ad -FKBP12.6) and (ii) expressing (3-galactosidase as control 
(Ad-LacZ). Infected cardiomyocytes were washed and subsequently 
cultured in supplemented Ml 99 medium (Sigma) for 48hrs. Verification of 
transgene expression and virus transfection efficiency has been detailed 
elsewhere [204]. Previous measurements suggest that the level of 
FKBP12.6 over-expression was approximately 6 times normal values.
5.13.4 Measurement of intracellular Ca^* within intact cardiomyocytes
Aileen Rankin of the University of Glasgow performed these experiments.
Cells were incubated with IpM Fura2-AM for 10 min at 37®C, after which
Fura-2AM was removed and the cells incubated for a further 15 min.
Cardiomyocytes were allowed to settle on a coverslip, placed on a custom-
made microscope stage and super-fused with a modified Krebs-Buffer with
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the following composition (mM); 140 NaCI, 4 KCI, 1 MgCb, 5 HEPES, 11.1 
Glucose, 0.3 NaH2PO4.2H20, and 1.8 CaCb at 37°C. Cells were 
stimulated at 1Hz with 2ms duration voltage pulses delivered through 
parallel platinum wires (stimulation voltage was set to 1.5 times the 
threshold). The Fura-2 fluorescence was measured at 180Hz using a 
spinning wheel spectrophotometer (Cairn Research Ltd UK). After 60-90s 
stimulation at 1Hz, SR Ca^ "^  load was estimated by rapidly switching the 
super-fusing solution to one containing 20mM caffeine for 8s. After a 15s 
wash to remove caffeine, electrical stimulation was restarted. This protocol 
was repeated several times on an individual cell. Fura-2 fluorescence 
measurements were converted to [Ca^T using a calibration protocol 
previously outlined [168].
5.13.5 Simultaneous field stimulation of intact cardiomyocytes with 
confocal imaging
Intact cardiomyocytes were perfused with a modified Krebs solution (20- 
21 °C) and field stimulated at 0.5Hz. The exact timing of electrical 
stimulation was marked in the confocal image by activating a light-emitting 
diode mounted above the cell bath for 2ms (i.e. the duration of one line- 
scan) 8ms before electrical stimulation.
5.13.6 Ca^* spark and wave measurements in permeabilised 
cardiomyocytes
Intact cardiomyocytes were allowed to settle onto the cover-slip at the base 
of a small bath and subsequently superfused with a mock intracellular 
solution with the following composition (mM): 100 KCI, 5 Na2ATP, 10 
Na2Creatine Phosphate, 5.5 MgCl2, 25 HEPES, 0.05 K2EGTA, 0.01 Fluo-3
220
Over-expression of FKBP12.6 in ventricular cardiomyocytes
free acid (Molecular Probes), pH 7.0 (20-21 °C). The [Ca^T in the solution 
was varied by the addition of known amounts of 1M CaCb stock solution 
(BDH). Perfusion was terminated and p-escin O.Img.mM (Sigma) added to 
the cell suspension. When cardiomyocytes were permeabilised 
(ascertained by confocal imaging, 0.5-1 min) the p-escin was immediately 
removed by re-perfusion of the bath. Confocal line-scan images were then 
recorded using a BioRad Radiance 2000 confocal system [88]. The [Ca^ "^ ] 
in the solution used to generate Ca^  ^sparks was measured by ensuring the 
line-scan covered a significant region of extracellular space as well as the 
entire cell length. Under these conditions the fluorescence signal recorded 
from the line-scan contains signals from both intracellular and extracellular 
compartments. To enable this trace to be converted to [Ca^ ""] a series of 
calibration solutions were used at the end of each period of spark 
measurement. The cardiomyocyte was superfused sequentially with the 
following solutions: (i) a solution containing nominally ~400nM Ca^ "^ ; (ii) a 
solution containing <1nM Ca^ "^ ; (iii) a solution containing 33pM Ca^ "^  (all 
calibration solutions contained lOmM total [EGTA]). Since in the steady 
state, extracellular [Ca^ ]^ will equal intracellular [Ca^T in the permeabilised 
cell, the [Ca^T in the experimental solution can be calculated (using an 
apparent affinity constant of Fluo-3 for Ca^" of 558nM [88]. In all 
experiments included in the analysis, the [Ca^T in the test solution was 
145-165nM. Ca^  ^sparks were quantified using an automatic detection and 
measurement algorithm adapted from a previously published method [115]. 
All Ca '^' spark measurements were made within 2min of cell 
permeabilisation; this time was standardised to minimise loss of soluble 
proteins. Previous work on isolated SR vesicles indicates that FKBP loss
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after vigorous homogenization procedures is minimal [195].
5.13.7 Statistics
Data was expressed as means±SEM. Comparisons were performed by 
using the paired students' f-test, and differences were considered 
significant when P <0.05.
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5.14 RESULTS
5.14.1 Measurement of Ca^* transients in intact ventricular 
cardiomyocytes using Fura-2
Figure 5.1 A shows changes in intracellular [Ca^ ""] measured in field 
stimulated (1Hz) cardiomyocytes (36-37°C) after transfection with (i) the 
control virus Ad-LacZ or (ii) Ad-FKBP12.6. Peak systolic [Ca^ "^ ] was higher 
in cardiomyocytes over-expressing Ad-FKBP12.6 compared to the control 
(Ad-LacZ). After 60s of continuous stimulation, SR Ca^ "^  load was 
assessed by rapid application of 20mM caffeine for 8 seconds. As shown 
in Figure 5.1 A the caffeine-induced Ca^  ^ transient was larger in 
cardiomyocytes over-expressing Ad-FKBP12.6 compared to the control 
virus Ad-LacZ. The averaged data (Figure 5.1 B) confirms that both the 
amplitude of the Ca^^-transient and caffeine-induced release are 
significantly higher in FKBP12.6 over-expressing cardiomyocytes. Diastolic 
[Ca^ "^ ] was not significantly different between the two groups (Ad- 
FKBP12.6: 220±55nM, n=25 vs. Ad-LacZ: 250±61nM, n=25). Mean Ca^  ^
transient amplitude and associated caffeine-induced Ca^  ^ release 
amplitude for each cell from both experimental groups, are plotted in Figure
5.1 B to illustrate the approximately linear correlation between these two 
parameters in the both experimental groups. The least-squares best fit to 
the control group (Ad-LacZ) is shown to indicate the relative position of the 
Ad-FKBP12.6 data. Consequently, cardiomyocytes with comparable 
amplitudes of caffeine-induced Ca^  ^ release, if anything, may generate 
larger Ca^  ^ transients when transfected with Ad-FKBP12.6. Since caffeine- 
induced Ca^  ^ release is an indication of SR Ca^ "^  content, this result implies
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more effective coupling of SR release In the Ad-FKBP12.6 group.
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Figure 5.1 Ca^ transients and caffeine-induced Ca^* release
A, Intracellular [Ca^^] signals recorded 48hrs after transfection with (i) A d-LacZ (ii) Ad- 
FKB P12.6 B, A  plot of caffeine-transient amplitude vs. Ca^^ transient amplitude for 
individual cardiomyocytes from both Ad-LacZ (closed circles) and A d-FK B P12.6 (open 
circles) groups. M ean values (±SD ) for both groups are shown by grey diamond symbols. 
C, Tim e course of recovery of Ca^^ transient after a rest period, Ca^^ transients normalised 
to amplitude achieved in steady state values are expressed as m ean±SEM , n=20 in each
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group, (open circles, Ad-FKBP12.6; closed circles, Ad-LacZ).
After a 15s wash to remove caffeine, electrical stimulation was restarted 
and the time-course of the restoration of the Ca^ "^  transient noted. As 
shown in Figure 5.1 C, a more rapid recovery of systolic [Ca^ ""] was 
observed in FKBP12.6 transfected cells compared to Ad-LacZ cells. The 
average time to reach 50% of the steady-state Ca^  ^ transient amplitude 
was 5.6±0.7s in Ad-LacZ compared with 3.14±0.5s with Ad-FKBP12.6 
(P<0.05, n=15 cells in each group).
5.14.2 Line-scan imaging of Ca^* transients in cardiomyocytes
Intact cardiomyocytes were loaded with Fluo-3 and subsequently field 
stimulated at 0.5Hz (20-21 °C). Fluo-3 fluorescence was monitored with 
line-scan confocal imaging; the scan line was arranged parallel to the long 
axis of the cardiomyocyte. Figure 5.2A shows the average cellular 
fluorescence and the corresponding line-scan image from cardiomyocytes 
transfected with the control virus Ad-LacZ (Figure 5.2A(i)), and Ad- 
FKBP12.6 (Figure 5.2A(ii)). The average of 6 sequential Ca^  ^ transients 
from each cardiomyocyte was used to assess the kinetics of the transient. 
As shown in Figure 5.2B, the mean peak (F/Fo) of the averaged transient 
was significantly greater in the Ad-FKBP12.6 group by -125%. The rate of 
rise (AF/Fq.s'^ ) of the Ca^  ^ transient at a standard Ca^  ^ (F/Fo=1.4, -300nM) 
is greater by -190% in the cardiomyocytes over-expressing FKBP12.6 than 
control cells (Figure 5.2C). In contrast, there is no significant difference in 
the rate of decline of [Ca^ ]^ in the two groups.
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Figure 5.2 Imaging of transients
A, Confocal line-scan images of Ca^*-transients recorded from (i) Ad-LacZ infected and (ii) 
A d-FK BP12.6 infected cardiomyocytes stimulated at 0 .5H z at 20-21 °C. B, Mean (±SEM )
Ca^* transient peak (F /F q values) in the two experimental groups (n=9 cells in each group). 
C, Mean rate of rise and rate of decline of the Ca^"-transient at a set [Ca^*] (F /F q=1 .4).
5.14.3 Quantitative assessment of the degree of synchrony of Ca^* 
release during stimulated Ca^* transients using confocal line-scan 
imaging.
On examining the confocal images in Figure 5.2A, the cardiomyocytes 
over-expressing FKBP12.6 appeared to have a more uniform release
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pattern compared to Ad-LacZ transfected cardiomyocytes. Some sites 
along the length of the Ad-LacZ cardiomyocyte did not respond to 
stimulation, others sites responded after a delay. This observation was 
quantified in the following manner: (1) the central intracellular area was 
divided into 12 x 20 voxel bands as illustrated in Figure 5.3A(ii); (2) the 
average fluorescence within each 20 voxel band was plotted as 12 
individual Ca^  ^ transients (an example of 3 transients are shown in Figure 
5.3B); (3) the time from stimulation to 50% of the peak of each transient 
(Timeso) was calculated for each of the 12 bands (see Figure 5.3B); (iv) this 
measurement was performed on 6 serial steady-state Ca^^-transients from 
each cardiomyocyte. The range of Timeso values measured in a number of 
cardiomyocytes from the two experimental groups was displayed as 
histograms (Figure 5.3C) for: (i) Ad-LacZ cells; (ii) Ad-FKBP12.6; (iii) and 
freshly dissociated cardiomyocytes (FD), i.e. cells used within 3-4 hrs of 
animal sacrifice. Only the values for Timeso less then 0.5s are shown, 
values greater than 0.5s are considered ‘missed-fires’ and quantified 
separately. The distribution of Timeso values for the cells infected with 
FKBP12.6 had a much narrower profile than the control Ad-LacZ cells. As 
indicated in Figure 5.3D, the corresponding number of miss-fires was lower 
in FKBP12.6 infected cells (2.73%) than Ad-LacZ cells (7.5%). In 
comparison, cardiomyocytes that were freshly dissociated (FD), showed the 
lowest values of mean Timeso, range of Timeso and percentage of miss-fires 
(1.43%) of all 3 groups (Figure 5.3D).
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Figure 5.3 Measurement of Ca *^ transient synchrony
A(i) mean cellular fluorescence from a confocal line-scan image of a Q,a^* transient 
recorded from a cultured cardiomyocyte after transfection with A d-FK BP12.6. A(ii) 
confocal line-scan image was split into 12x20 voxel sections as indicated in the pseudo­
colour image. The mean fluorescence signal in each 20-voxel section was used to 
measure the time from stimulus to 50%  of the transient amplitude (Timeso). An exam ple of 
3 selected regions indicated by blue, red and black circles in Panel A(ii) is shown as 3 
separate transients (blue red and black lines correspond to sections shown in Fig 5.3A(ii)). 
C, Distribution histograms of Timeso values measured from Ad-LacZ group (n=9 cells), Ad- 
FKBP12.6 group (n=9 cells) and freshly dissociated cells (n=4 cells). D, % of sites not
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generating a Ca^  ^transient (Timeso > 0.5 s) in the three experimental groups.
Figure 5.4A summarises this data in terms of: (I) mean Timeso and (ii) mean 
range (of Timeso) values. FKBP12.6 over-expression significantly reduced 
both the mean (by 40%) and range of values (by 62%) towards the values 
measured in freshly dissociated (FD) cardiomyocytes (mean Timeso of the 
FD group is 61 % lower than Ad-LacZ, the range of Timeso values is 84% 
lower than the Ad-LacZ group). Subsets of the data were constructed on 
the basis of Ca^^-transient amplitude; the 4 largest Ca^" transients in the 
Ad-LacZ group were compared with the 4 smallest Ca^ "” transients in the 
Ad-FKBP12.6. The mean Ca^ "^  transient peak in these two sub-groups was 
not significantly different (F/Fo=1.95±0.06 vs. 1.93±0.06, Ad-LacZ vs. Ad- 
FKBP12.6), yet as shown in Figure 5.4B, the mean Timeso and range of 
Timeso values were still significantly lower in the Ad-FKBP12.6 group (mean 
Timeso is 31% lower than Ad-LacZ, the range of Timeso values is 73% lower 
than the Ad-LacZ group). This data suggests that in addition to increased 
Ca^ "^  transient amplitude, FKBP12.6 over-expression causes a more rapid 
and synchronous increase of intracellular Ca^ "".
5.14.4 Measurements in permeabilised cardiomyocytes
The above results suggest that FKBP12.6 modulates Ca^  ^ release from 
cardiac SR. The release of Ca^  ^from the SR is via clusters of RyR2 units. 
The activity of individual RyR2 clusters generates localised Ca '^' release 
events termed Ca^  ^ sparks. The frequency, amplitude and time course of 
Ca^ "^  sparks determines the spontaneous Ca^  ^leak from the SR.
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Figure 5.4 Mean and range of Timeso values
A, M ean Timeso and m ean range of Timeso values for A d-Lacz (n=9 cells), Ad-FK BP12.6  
(n=9 cells) and freshly dissociated cardiomyocytes (FD, n=4 cells). B(i) Mean Timeso and 
(ii) mean range of Timeso values for a sub-set of the Ad-LacZ and FKBP12.6 groups with 
similar Ca^^-transient amplitudes.
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Figure 5.5 Ca '^' sparks and caffeine induced Ca^* release in permeabilised
cardiomyocytes
A(i) Sequential fluorescence confocal line-scan images (512x30000 pixels) from a single 
permeabilised cardiomyocyte exposed to experimental and calibration solutions. The  
cardiomyocytes brighter central region is due to a higher Fluo-3 fluorescence within the 
cell: dimmer flanking signals are from the Fluo-3 in the perfusing solutions. The calculated 
[Ca^""] in the perfusion solution is shown above the images, experimental solutions 
contained a total [EGTA] of 50|iM  and lOpM Fluo-3. [Ca^^] marked by * indicates solutions 
containing a total [EGTA] of lO m M . The arrow indicates addition of lO m M  caffeine. As
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indicated in A(i), two regions (20 voxels wide) of a series of line-scans were averaged and 
displayed as fluorescence signals (A(ii)) from the extracellular (EC - black line) and 
intracellular (10 -  grey line). A(iii), [Ca^ "^ ] calculated from the mean fluorescence signal of 
a 20-voxel region from the intracellular (10, grey trace, Fig. A(ii)) and extracellular 
compartments (EO, black trace, Fig. A(ii)). The [Oa^ "^ ] was calculated on the basis of the 
fluorescence signals in 417nM, <1nM Oa^* and SOpM (buffered with 10mM total EGTA). 
B. pseudo-colour line-scan epi-fluorescence image of Oa^  ^ sparks within single 
permeabilised cardiomyocytes perfused with the experimental solution containing 155nM 
Oa^  ^ (i) Ad-LacZ infected cell and (ii) Ad-FKBP12.6 infected cell.
An investigation of the direct effects of FKBP12.6 over-expression on 
sparks in intact rabbit cardiomyocytes is complicated by the rapid 
sarcolemmal extrusion of intracellular Ca^ "^  and loss of SR Ca^  ^ during 
quiescent periods required for Ca^  ^ spark recording. For this reason, 
sarcolemmal fluxes were functionally by-passed by the permeabilisation of 
the sarcolemma with B-escin. Under these circumstances, single 
cardiomyocytes can be superfused with a standardised [Ca^ "^ ] and pH in the 
presence of ATP and CrP. Ca^ '" spark activity was monitored by the 
inclusion of 10pM Fluo-3 in the perfusing solution. Figure 5.5A(i) shows the 
protocol used to measure Ca^  ^ sparks and assess SR Ca^  ^ content in 
permeabilised cells.
The cardiomyocyte was perfused with nominally 150nM [Ca^ ]^ (O.OSmM 
EGTA) for at least 1min prior to confocal measurements to ensure a steady 
state SR Ca^* content. Ca^  ^ sparks were recorded for one minute and SR 
load was assessed by the rapid application of 10mM caffeine. To enable a 
more precise measurement of the [Ca^ "^ ] in the cytosol of the permeabilised 
cell, a series of calibration solutions were used, these consisted of: a 
reference [Ca^ ]^ solution (~400nM free [Ca^T, 10mM EGTA)); a low [Ca^T
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solution (<1nM [Ca^ "^ ], 10mM EGTA) to enable a recording of minimal 
fluorescence (Fmin); a high [Ca^T solution (33|iM [Ca^^, 10mM CaEGTA) to 
enable the recording of the maximum fluorescence (Fmax). Although the 
reference [Ca^ "^ ] solution of ~400nM did not cause any noticeable change in 
cell shortening, the Fmax solution caused the cell to develop a gradual 
irreversible hyper-contracture. The recordings of fluorescence from the 
external solution (Figure 5.5A (ii)) allowed the calculation of the [Ca^ ]^ in the 
reference solution (417nM). Subsequently, the intracellular fluorescence 
measured in the reference solution and in the low Ca^ "^  solution (<1nmol/L 
Ca^ )^ allowed the conversion of intracellular fluorescence in the 
experimental solutions to a [Ca^H signal (Figure 5.5A (iii)). This established 
the [Ca^ "^ ] in the weakly buffered experimental solution (in Figure 5.5 this 
was 155nM). In these experiments, the integral of caffeine-induced Ca^ "^  
release was used to assess the SR Ca^ "^  content.
5.14.5 sparks and caffeine-induced Ca^* release in permeabilised 
cardiomyocytes overexpressing FKBP12.6
To quantify Ca^ "^  spark activity (Figure 5.5B (i) and (ii)) the first 15s of each 
line-scan image was analysed using an automated spark detection program 
adapted from a previously published method for use in permeabilised 
cardiomyocytes [115].
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Figure 5.6 Mean Ca * spark characteristics
Mean ±S EM  values for: (i) peak F/Fo: (ii) spark width (full width half maximal) (iii) spark 
frequency; (iv) spark duration (full duration half maximal). 5 8  Distribution histograms for 
spark amplitude (i & ii), width (iii & iv) and duration (v & vi) measured in LacZ and 
FKB P12.6 transfected cardiomyocytes at 145-165nM  [Ca^^. Distributions based on: 1631 
sparks detected in 18 Ad-LacZ transfected cardiomyocytes and 587 sparks detected in 9 
A d-FK BP12.6 transfected cardiomyocytes.
The results collated from a number of cardiomyocytes are shown in Figure
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5.6. It can be seen from this summary that the peak, width, duration and 
frequency of the Ca^  ^ sparks are all significantly less in cardiomyocytes 
over-expressing FKBP 12.6 (n=9 cells) compared to Ad-LacZ (n=18 cells); 
Ca^  ^ spark peak F/Fo (1.80±0.03 vs. 1.96±0.02), width (3.15±0.07pm vs. 
3.33±0.07pm); duration (26.09±1.5ms vs. 29.21 ±1.0ms) and frequency 
(0.04±0.007events.pm'\s  ^ vs. 0.06±0.004events.pm"\s"^). The spark peak, 
duration and width distribution histograms show no difference in the shape 
of the distribution between the two experimental groups (Figure 5.6B), 
indicating that a sub-population of Ca^  ^ sparking events could not be 
detected.
5.14.6 Effects of higher [Ca^*] on permeabilised cardiomyocytes 
overexpressing FKBP12.6
Perfusing with a weakly buffered solution containing ~400nM Ca^  ^ has 
previously been shown to cause spontaneous Ca^  ^ release and propagated 
Ca^ "^  waves in freshly dissociated permeabilised cardiomyocytes [88]. 
Figure 5.7A and 5.7B shows mean signals from a 20-voxel intracellular (1C) 
and extracellular (EC) region of a permeabilised cardiomyocyte infected 
with Ad-LacZ. This protocol did not induce Ca^  ^ waves; instead, Ca^  ^
release consists of high frequency, smaller amplitude events that did not 
propagate significant distances (see Figure 5.7B(iii)).
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Figure 5.7 Ca * wave characteristics
A Protocol used to measure Ca^* wave characteristics, signal based on a 20-voxel 
intracellular signal Ca^* signal (10, grey trace) and extracellular Ca^* signal (EC, black 
trace). The solution changes are indicated above the record, addition of caffeine at points 
indicated. B(i) & (ii), examples of Ca^* waves recorded in 20 voxel regions of
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permeabilised cardiomyocytes perfused with solutions containing -400nM  [Ca^*]. B(iii) & 
B(iv) line-scan images of Ca^^ release events recorded in permeabilised cardiomyocytes 
from Ad-LacZ and Ad-FKBP12.6 groups. C, distribution histograms of the width of Ca^ "^  
release events >500nM [Ca^^] recorded from Ad-LacZ (n = 4 cells) and Ad-FKBP12.6 
groups (n = 6 cells). D, Mean integrals of the caffeine induced Ca^^ release in 
permeabilised cardiomyocytes equilibrated in 150nM and 400nM [Ca^ ""].
However, as illustrated in Figure 5.7B(ii) & (iv), the same protocol in Ad- 
FKBP12.6 transfected cardiomyocytes causes the development of coherent 
Ca^ "" waves that frequently propagate along the entire length of the 
cardiomyocyte. To quantify the distances propagated by Ca^  ^ release 
events, the line-scan images were thresholded to display Ca^ "^  release 
events over 500nM, and the width of release events were measured in 
each cell. This was performed using IDL as follows:
(1) The experimental image file (A) (400nM [Ca^ ]^, O.OSmM EGTA) 
containing the Ca^ "^  events is obtained, measured and median filtered 
(512x30000 pixels).
(2) The experimental calibration file (B) (400nM [Ca^ ]^ lOmM EGTA) is 
obtained measured and median filtered (9x9 box) (512 x 30000 pixels).
(3) A third image file is created (C) by taking the first 30000 pixel strip in 
image (B) (of which there are 512) and averaging the fluorescence from 
these 30000 pixels. The mean fluorescence is then outputted as one 
averaged number for that pixel strip. This is then repeated for each of the 
remaining 512 pixel strips.
(4) Image (A) is divided by image (C) to give image (D). This gives a 
fluorescence signal which is divided by the signal in the 400nM calibrating 
solution.
(5) Image (D) is multiplied by a scaling factor of 50.
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(6) Assuming a Kd of 558nM a ‘cut-off fluorescence value, which 
represents 500nM, is calculated. This is used to threshold events >500nM.
(7) 32 pixel regions (10pm) are then averaged across each of the 30000 x 
512 rows. If the mean value of this 32 pixel region is greater than the ‘cut­
off then this is given a value of 1 in a new binary image (E). If the mean 
value of this 32 pixel region is < than the ‘cut-off the value is given a value 
of 0. The data from this analysis is presented therefore as rows of 32 pixel 
regions that are either black (0) or white (1) in a binary image (E).
(8) Individual 32 pixel white bands are termed single events of 10pm. If 
however if a single event touches another event either side of it or below it 
than this is counted as a single event, the width of which is denoted by how 
many individual 10pm bands are beside each other within one event.
The distribution histogram of the duration of release events is shown in 
Figure 5.7C. It is clear from this graph that there were very few release 
events that propagated further than 40pm in Ad-LacZ transfected 
cardiomyocytes, while a significant number of events propagated up to 
100pm in the Ad-FKBP transfection group. Correspondingly fewer events 
of duration <10pm occurred in the FKBP12.6 over-expressing 
cardiomyocytes compared to the control group (results not shown). Finally, 
the average of the integral of the Ca^ '" signal induced by lOmM caffeine is 
shown in Figure 5.7D for the two bathing [Ca^T used in this study, i.e. 
~150nM and ~400nM. Under both conditions (150nM and 400nM) the 
caffeine-induced Ca^  ^ release was 3-4 fold larger in the Ad-FKBP 12.6 
group.
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5.15 DISCUSSION
This study examines the effects of over-expression of FKBP12.6 in 
cardiomyocytes cultured for 48 hours. Data from Fura-2 loaded 
cardiomyocytes indicated that FKBP12.6 over-expression increased the 
amplitude of the Ca^ "^  transient and SR Ca^ "^  content.
The term E-C coupling ‘efficiency’ is used within this study instead of the 
term gain’ since the latter term requires an assesment of L-type Ca^" 
current, SR Ca^  ^ release and SR Ca^ "^  content within the same cell. These 
types of electrophysiological experiments have not been performed here, 
however SR Ca^ "^  release and Ca^ "^  content have been assessed within this 
study while L-type Ca^  ^ current has been found to be simlilar between Ad- 
LacZ and Ad-FKBP 12.6 cell types (results not shown) and so the looser 
term ‘efficiency’ compared to ‘gain’ is used below. Previous reports have 
indicated increased E-C coupling efficiency on removal of FKBP12.6 [114]. 
On the basis of these previous studies, over-expression of FKBP12.6 (as 
within this present study) should decrease E-C coupling efficiency. 
However the results in Figure 5.1 show that E-C coupling efficiency was, if 
anything increased. This discrepancy may reflect the complex relationship 
between different levels of FKBP 12.6 occupancy and E-C coupling 
efficiency as indicated by a recent study [215]. This suggests that removal 
of a limited amount of FKBP12.6 will increase RyR2 activity and enhance 
E-C coupling gain. More complete removal of FKBP12.6 from the RyR2 
cluster will cause uncoupling of RyR2 units within a cluster, and the 
development of sub-conductance states in individual RyR2 units. These
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changes will have two consequences: (i) reduced effectiveness of L-type 
Ca^  ^ channel to initiate SR Ca^ "' release and (ii) increased ‘leak’ of Ca^ "" 
from the SR during diastole leading to a reduction in SR Ca^  ^ content 
consistent with previously published data [63;215]. The results of the 
present study suggest that cultured cardiomyocytes from the rabbit have a 
low FKBP12.6/RyR2 interaction since FKBP12.6 over-expression increased 
E-C coupling efficiency and decreased diastolic Ca^ "^  leak. In support of 
this, SR Ca^ "” leak from rabbit cardiomyocytes cultured for 48hrs did not 
respond to FK506 sequestering agents, but sensitivity to rapamycin was 
restored by FKBP 12.6 over-expression [204]. A more rapid recovery of 
Ca^ "^  transients after SR depletion by caffeine in FKBP12.6 over-expressing 
cardiomyocytes (Figure 5.1C) is consistent with reduced RyR2 mediated 
Ca^  ^ leak during diastole as suggested by earlier studies [204;211;232]. In 
summary, these results suggest that the enhanced Ca '^' transient after 
FKBP12.6 over-expression is a consequence two effects: (i) decreased SR 
Ca^ "^  leak from the SR allowing a higher SR content to be achieved during 
diastole and (ii) an additionally enhanced efficiency of the SR Ca^  ^ release 
mechanism, possibly as a result of increased coupled gating of RyR2 by 
FKBP12.6. This hypothesis may appear to be difficult to reconcile with a 
recent study in FKBP12.6 knockout mice [216]. In this case, absence of 
FKBP12.6 was associated with larger Ca^ "” transients in mice 
cardiomyocytes. Previous work has shown that mouse RyR2 has 
significant affinity for FKBP12.0 [229]. Therefore, as suggested in the latter 
study, FKBP12.0 may substitute for FKBP12.6 with in mice heart cells, thus 
reducing the apparent effects due to the absence FKBP 12.6.
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5.15.1 Effects of FKBP12.6 over-expression on synchronicity of E-C 
coupling.
As shown in Figure 5.2, marked asynchrony of Ca^  ^ release was evident in 
cardiomyocytes transfected with the control virus Ad-LacZ. Similar 
asynchrony was observed in cardiomyocytes cultured for the same period 
of time (48hrs) without virus infection (results not shown). In 
cardiomyocytes over-expressing FKBP12.6, larger Ca^ "^  transients were 
accompanied by more synchronous Ca^ "^  release. The higher degree of 
synchrony is consistent with the more rapid rate of rise of the Ca^  ^transient 
(Figure 5.2B). The similar rate of Ca^ "^  transient decay suggests that SR 
Ca^ "^  ATPase and NaVCa^^ exchanger activity are not dramatically different 
in the two experimental groups. This supports the direct measurements of 
SERCA2a activity measured previously [204]. Recent experiments 
measuring L-type Ca^ "^  channel amplitude found no effect of Ad-FKBP12.6 
over-expression (Stewart Miller, University of Glasgow - results not 
published). These results show that E-C coupling efficiency is increased by 
FKBP12.6 over-expression. However, in determining the mechanism it is 
difficult to distinguish between two options: (i) an increased synchrony as a 
result of a higher SR Ca^ "^  content or (ii) a direct effect on the coupling L- 
type Ga^ "^  channel activity and SR Ca^ "^  release. Evidence for the latter 
comes from comparing Ca^ "^  transients of similar amplitudes in the different 
groups. In this sub-set, the Ad-FKBP12.6 group still retained lower mean 
Timeso and range of Timeso values. This latter result indicates that 
enhanced SR Ca^ "^  content alone cannot account for the increased 
synchrony of release and supports the hypothesis that E-C coupling 
efficiency is enhanced after FKBP12.6 over-expression.
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5.15.2 Effects of FKBP12.6 over-expression of sparks in
permeabilised cardiomyocytes.
Measurement of Ca^ "^  spark activity in the steady state is problematic in 
intact rabbit cardiomyocytes because intracellular [Ca^T and SR Ca^  ^
content rapidly decreases on cessation of stimulation due to net 
sarcolemmal efflux. Furthermore, Ca^ "” spark parameters are very sensitive 
to intracellular [Ca^^ [64; 121], therefore interpretation of results is difficult 
without knowledge and/or control of the intracellular [Ca^H in cells from 
different experimental groups. For these reasons, Ca^  ^ spark activity was 
monitored in permeabilised cardiomyocytes at a precisely measured 
bathing [Ca^ ]^. Previous work has established that Ca^  ^ spark 
characteristics (amplitude, time course and frequency) in permeabilised 
cells are indistinguishable from those observed in intact cells [64] and 
regulated by known modulators of RyR2 activity (Ca-calmodulin and cyclic- 
ADPribose) [64] but with the added advantage that cytoplasmic conditions 
can be standardised. As shown in Figure 5.3, Ca^  ^ sparks occurred less 
frequently and were smaller in amplitude, width and duration in FKBP12.6 
over-expressing cardiomyocytes. These results are generally consistent 
with previous measurements of Ca^ "^  sparks on removal of FKBP12.6, since 
increases in Ca^  ^spark frequency [114] amplitude [216], width and duration 
[113:216] were noted. These reports plus others on isolated RyR2 
channels suggest that association of FKBP12.6 with RyR2 would shorten 
the averaged duration of a Ca^  ^spark by decreasing the channel open-time 
[113] and enhancing the degree of coupled gating [63]. Mathematical 
modeling of the RyR2 cluster indicates that coupled gating is important in 
terminating Ca^  ^ release [48]. This work predicts that Ca '^' spark duration
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would decrease on increasing the degree of coupling between RyR2 units 
in a cluster. Furthermore, the effect of FKBP12.6 on spark frequency is 
anticipated from studies on isolated RyR2 channels where FKBP12.6 
decreased the open probability [63]. The overall effects of FKBP 12.6 over­
expression on Ca^ "^  spark activity is consistent with the reduction of diastolic 
SR Ca^ "" leak indicated by the more rapid restoration of the steady state 
Ca^  ^ transient amplitude after a rest (Figure 5.1 B). The direct effects of 
FKBP12.6 over-expression on RyR2 activity described above could not 
have been easily observed in intact rabbit cardiomyocytes since the SR 
Ca^  ^ content rapidly decreases on cessation of stimulation. Therefore the 
data on Ca^  ^ sparks from permeabilised cardiomyocytes should be 
regarded as verification that FKBP12.6 over-expression affects RyR2 
activity analogous to studies of Ca^  ^ leak from the SR [204;212], or isolated 
RyR2 activity in a bi-layer [207].
Previous work has suggested that occupancy of RyR2 with FKBP 12.6 is 
close to maximal (4FKBP12.6:1RyR2 tetramer) under basal conditions 
[207]. Thus, over-expression of FKBP12.6 would not be expected to boost 
FKBP12.6:RyR2 stoichiometry significantly. However, two lines of 
evidence suggest that FKBP 12.6 binding to RyR2 is considerably lower 
than normal in 2-day culture cardiomyocytes: (i) previous work indicates 
that rapamycin has no effect on RyR2-mediated Ca^  ^ leak in 2 day cultured 
cardiomyocytes, but rapamycin sensitivity is regained after FKBP12.6 over­
expression [204]; (ii) Ca^  ^ spark characteristics after 2 days in culture are 
significantly different from those observed in freshly dissociated 
cardiomyocytes. Ca^  ^ sparks measured in freshly dissociated
243
Over-expression of FKBP12.6 in ventricular cardiomyocytes
cardiomyocytes (n=20 cells) were smaller in amplitude (F/Fo=1.72±0.02), 
narrower in width (2.90±0.03 p.m), shorter in duration (24.1 ±0.97 ms) 
compared to LacZ transfected cardiomyocytes. Therefore a possible 
explanation of the results is that 2-day cultured cardiomyocytes have a 
lower than normal FKBP12.6:RyR2 stoichiometry which dramatically 
increases diastolic Ca^  ^ leak. Over-expression of FKBP12.6 in these cells 
returns the FKBP12.6:RyR2 stoichiometry towards normal, reducing 
diastolic SR Ca^  ^ leak, increasing SR Ca^ "^  content and thereby increasing 
Ca^  ^ transient amplitude. The increased FKBP12.6 stoichiometry also 
increased the degree of coupled gating between RyR2 units in a cluster 
thereby increasing the efficiency of E-C coupling independent of SR Ca^  ^
content.
5.15.3 Effects of FKBP12.6 over-expression on spontaneous SR 
release.
Previous work has shown that increasing cytosolic [Ca^T above 200nM in 
permeabilised cardiomyocytes initiates spontaneous SR Ca^  ^ release and 
propagated Ca^  ^ waves similar to that observed in Ca^^-overloaded intact 
cardiomyocytes [64;88]. However, as shown in Figure 5.7, spontaneous 
Ca^  ^ release in permeabilised cardiomyocytes after 2 days of quiescent 
culture consisted of small amplitude events that propagated only limited 
distances within the cytosol. In contrast, when cardiomyocytes over­
expressing FKBP 12.6 were perfused with identical solutions, coherent Ca^  ^
waves that propagated along the majority of the length of the 
cardiomyocyte occurred in a similar fashion to those observed in freshly 
dissociated cells. Measurements of caffeine-induced Ca^ "^  release
2 4 4
Over-expression of FKBP12.6 in ventricular cardiomyocytes
suggested that SR Ca^ "^  content was ~4 times higher than the Ad-LacZ 
transfected cardiomyocytes when perfused with 400nM Ca^ "^ . The frequent 
low-amplitude Ca^  ^ release events observed in Ad-LacZ transfected 
cardiomyocytes would suggest a large diastolic Ca^  ^ leak and explain the 
reduced ability of the SR to retain Ca^ "". FKBP 12.6 over-expression not 
only reduced the number of release events, allowing the SR Ca^  ^content to 
increase to a higher steady state, but also permitted the generation of large 
amplitude propagating Ca^ "^  waves. The conditions necessary to generate 
Ca^ "" waves in cardiomyocytes has been studied extensively and suggests 
that low amplitude Ca^  ^ release will not generate a sufficiently large 
cytosolic Ca^ "^  signal at the adjacent release site to allow propagation 
[121;138;233]. This appears to be the case in the 2-day cultured 
cardiomyocytes, while the higher SR Ca^ "^  content in FKBP 12.6 over­
expressing cells supports sufficiently large SR Ca '^' release to allow 
propagation.
5.15.4 SUMMARY
This is the first report to suggest that alterations in RyR2 activity associated 
with FKBP12.6 binding to RyR2 is necessary for the generation of 
propagating Ca^  ^waves in cardiac muscle. This form of SR Ca^  ^ release is 
thought to be beneficial to the cell under conditions of Ca^  ^ overload since 
the transient increases of intracellular [Ca^"] are an efficient method of 
stimulating Ca^ "" efflux from the cardiomyocyte while preventing the 
development of a sustained contraction [69;88;234]. However, 
spontaneous Ca^ "^  waves also generate potentially arrhythmic depolarising 
currents and are thought to be a common cause of triggered arrhythmias.
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Recent work on myocardium from failing human hearts and animal models 
of heart failure has shown a reduction in FKBP12.6 binding to RyR2 [207]. 
This change in stoichiometry (as a result of PKA mediated hyper­
phosphorylation of RyR2) causes increased diastolic SR Ca^  ^ leak [211] 
and therefore would reduce twitch amplitude. The results presented in this 
study support the idea that returning FKBP12.6:RyR2 stoichiometry to 
normal will restore Ca^ "^  transient amplitude and may be a possible 
therapeutic approach in heart failure [235]. However, the data also 
indicates the possible detrimental consequences of this approach. If the 
mean cytosolic Ca^  ^ is above a crucial level as a result of other pathological 
changes, increasing FKBP 12.6:RyR2 stoichiometry may increase SR Ca^ "^  
content and alter RyR2 function in such a way as to increase the amplitude 
of spontaneous Ca^ "^  release from the SR and consequent arrhythmic 
depolarising currents.
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CHAPTER SIX
Over-expression of an FKBP12.6 mutant lacking a calcineurin binding 
site in rabbit ventricular cardiomyocytes
Over-expression of an FKBP12.6 mutant
6.1 INTRODUCTION
6.1.1 The many roles of calcineurin
Calcineurin is a serine/threonine phosphatase, which is present within the 
cytoplasm of many cell types [236]. It has a wide range of cellular 
functions. These include migration of neutrophils [237], hippocampal long 
term depression [238], gene regulation and cell differentiation [239]. 
Calcineurin also mediates the effects of insulin like growth factor [240], 
cardiac hypertrophy [241] and T-cell immuno-suppression [176]. This latter 
mechanism is of particular relevance here since a link to the FK506 Binding 
Protein (FKBP) has been well documented. An intracellular rise in [Ca^T 
upon stimulation of the T-cell receptor by antigen causes the phosphatase 
calcineurin to de-phosphorylate the cytoplasmic form of the transcription 
factor Nuclear Factor of Activated T-cells (NFAT). This causes the NFAT to 
translocate into the nucleus and initiate transcription of interleukin 2 (IL-2) 
and T-cell proliferation. However, exogenous application of the drug 
FK506, binds to FKBP. This complex binds to and inhibits calcineurin. 
Subsequent T-cell activation is prevented which results in immuno­
suppression [175].
6.1.2 The molecular structure of immunophilin ligands
The molecular structures of the common immunophilin ligands are 
presented in Figure 6.1. FK506, rapamycin and cyclosporin are all
immunosuppressive drugs, which bind to immunophilins (see Chapter 5 for 
discussion). FKBPs bind FK506 and rapamycin, while cyclophilins bind 
cyclosporin A. It can be seen from Figure 6.1 that while FK506 and
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rapamycln share common structural characteristics, the structure of 
cyclosporin is markedly different. Cyclophilins and FKBP have rotamase 
activity and their corresponding exogenous ligands inhibit that enzymatic 
activity. The fourth structure in Figure 6.1 is 506BD. This drug is an 
unnatural ligand that shares similar structural characteristics to FK506 and 
rapamycin. However while 506BD inhibits the rotamase activity of 
FKBP12.0 it does so without preventing T-cell proliferation, suggesting that 
this enzymatic activity is not involved in immuno-suppression [175;242].
Mb, Me. .Me
Me, Me MeN‘Mbh
Me O Me
cyclosporin A (CsA)
Me' Me
.Me
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Me<
OH
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Me rapamycin
Figure 6.1 Molecular structure of exogenous Immunophllln ligands
Refer to text for discussion. (Figure taken from Schreiber, S.L. (1992) Immunology Today 
1 3 ,1 3 6 -1 4 2 ).
6.1.3 Complexes formed between FKBP, its ligands and calcineurin.
The molecular structure of the complex formed between FKBP, FK506 and 
calcineurin has been studied in detail [243]. It is thought that the FKBP12.0
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molecule physically blocks the phosphatase active site of calcineurin to 
potential substrates (e.g. NFAT). Rapamycin is an immunosuppressive 
drug with similar actions to FK506 (see section 5.2.5). However, if 
rapamycin complexes with FKBP12.0 and attempts to bind to calcineurin, 
the larger effective domain of rapamycin (relative to FK506) penetrates into 
the calcineurin complex. FKBP12.0-Rapamycin cannot therefore inhibit the 
phosphatase activity of calcineurin.
calcineurin B
calcineurin A
FK506
FKBP12
phosphatase active site
Figure 6.2 The effect of the FKBP-FK506 complex on calcineurin
FKB P12.0 is seen here to block the phosphatase active site when a complex is formed 
with FK506. Calcineurin is a heterodimeric protein consisting of a catalytic subunit - 
calcineurin A, and a Ca^^ binding subunit -  calcineurin B. (Figure taken from Marks, A.R. 
(1996) Physiological Reviews  76, 631-649).
6.1.4 Is calcineurin important in RyR2 activity?
One method that has been used to investigate the function of FKBP on 
RyR2 involves the application of the drug FK506. This dissociates FKBP 
from RyR and results in an increase in open probability [180]. It is also 
known that phosphorylation of RyR2 can result in an increase in open 
probability [207]. This presents a dilemma, is the increased open 
probability induced by the FKBP-FK506 complex due to the removal of
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FKBP from the RyR or the inhibition of calcineurin phosphatase activity 
within the cell and subsequent phosphorylation of RyR? To try to resolve 
this issue, authors have applied rapamycin to RyR2 [197]. Rapamycin 
dissociates FKBP from RyR2 and forms an FKBP-rapamycin complex. The 
result is also an increase in open probability of RyR2. However, in this 
case the increased open probability cannot be due to inhibition of cellular 
calcineurin phosphatase activity and subsequent phosphorylation of RyR2 
since the FKBP-rapamycin complex cannot block the phosphatase active 
site on calcineurin. Rapamycin therefore can be used to investigate RyR2 
open probability when FKBP has been removed without the possible side 
effects of cellular calcineurin inhibition. Therefore it is generally concluded 
the calcineurin plays no part in the modulation of RyR gating, and the 
observed change in RyR open probability can be explained simply by 
dissociation of FKBP from RyR2 [175].
6.1.5 The range of molecular species resulting from the use of drugs
Various drugs have been applied to the RyR2 complex in order to verify the 
role of FKBP and calcineurin on RyR2 function. Three such scenarios 
established by the use of drugs were presented above. The first scenario 
involves the application of FK506. This results in the dissociation of FKBP 
from RyR2 and inhibition of cellular calcineurin by the FKBP-FK506 
complex within the cytosol. The status of calcineurin is assumed in this 
scenario to be unbound to the RyR2 macro-molecular complex and 
inhibited, i.e. not working. This status of calcineurin (unbound and not 
working) can also be achieved in a second scenario by the application of 
CsA and rapamycin since the latter drug dissociates FKBP from RyR2 and
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cyclosporin A potently inhibits calcineurin [244] (Table 6.1). Both of these 
situations result in an increased open probability of RyR2.
MolecUar Species Calcineurin Status Achieved by which drugs Effect on RyR2
Scenario 1 + 2 UNBOUND 
NOT WORKING
FK506 or 
CsA + Rapamycin
Increased Activity
Scenario 3 UNBOUND
WORKING
Rapamycin Increased Activity
Scenario 4 BOUND
WORKING
- Decreased Activity
Scenario 5 BOUND
NOT WORKING
CsA Increased Activity
Scenario 6 UNBOUND
WORKING
FKBP12.6 MUTANT Decreased Activity
Table 6.1 The use of various drugs to produce different molecular species to 
investigate the role of calcineurin on RyR2
Refer to text for discussion.
The third scenario of unbound and working is achieved by the application 
of rapamycin alone since rapamycin only dissociates FKBP from RyR2 but 
cannot inhibit cellular calcineurin. This also results in an increased open 
probability (Table 6.1). As suggested above, this has been used by 
authors to suggest that calcineurin inhibition plays no role in RyR2 open 
probability and it is therefore the unbinding of FKBP that is responsible for 
the increase in RyR2 activity since when FKBP is bound to RyR2 there is a 
decrease in the open probability (scenario 4) [175].
6.1.6 What if calcineurin does not just exist within the cytosol but 
forms part of the RyR2 macromolecular complex?
The above conclusion is based on the principle that calcineurin does not 
form part of the macromolecular complex of RyR2 (i.e. is unbound as in 
scenario 1-3). But what if calcineurin is bound to the RyR2 
macromolecular complex and working? This fourth scenario would result in
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a decrease in the RyR2 open probability. This begs that questions of 
whether it is now the association of FKBP to RyR2 or the calcineurin 
phosphatase activity and subsequent decrease in phosphorylation status of 
RyR2, which leads to the decrease in the open probability?
6.1.7 Is calcineurin ever bound to the RyR2 macromolecular complex?
Whether or not calcineurin is bound to the RyR2 macromolecular complex 
is a controversial issue. A study performed on human solubilised cardiac 
protein [207] suggests that calcineurin is not part of the RyR2 complex and 
results associated with the change in open probability of RyR2 are solely 
due to FKBP. However recent evidence suggests that this may not be the 
case in all species. Bandyopadhyay et al (2000) has demonstrated that 
calcineurin is associated with RyR2 via FKBP 12.6, which acts as an anchor 
[245]. These results were demonstrated in solubilised rat cardiac SR 
proteins. The association between RyR2 and calcineurin is Ca^  ^
dependent such that high concentrations of [Ca^ ]^ (lOOpM) lead to co- 
immuno-precipitation whereas low [Ca^ "^ ] (20mM EGTA) lead to an absence 
of calcineurin on RyR2. RyR2 is not the only Ca^ "^  channel that is 
associated with calcineurin. Cameron et el (1995) has demonstrated that 
calcineurin is anchored to IP3R via FKBP [246].
6.1.8 So if calcineurin is indirectly bound to the RyR2 macromolecular 
complex does it play a role in RyR2 open probability?
Suggestions that calcineurin has a role in the heart originate from studies 
involving the treatment of rats with cyclosporine. This results in alterations 
to the contractile properties of rat hearts [247;248]. Cyclosporin (CsA) 
binds to the intracellular CsA binding protein cyclophilin (CyPA) and the
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resulting complex inhibits phosphatase activity of calcineurin. It can 
therefore be used as an immunosuppressive agent, in the rat heart, CsA 
results in reduced peak systolic pressure, increased sensitivity to external 
Ca^ "^  and reduced maximal stress development [247]. The chronic 
application of CsA results in varying Ca^ "^  handling consequences some of 
which are hard to reconcile with a single function of CsA [249]. Ryanodine- 
binding studies indicate a reduced maximal RyR binding suggesting a 
reduced RyR density. This could explain the reduction of contractile 
properties. The affinity for ryanodine binding to RyR is also decreased in 
CsA treated rats (increased Kd). That these changes occurred at different 
times during the treatment period of three weeks indicated that the 
molecular mechanisms causing the changes in the ryanodine binding 
studies are different. If CsA inhibits calcineurin (and phosphatase activity) 
then an increase in RyR2 activity would be expected. This is consistent 
with the increased caffeine sensitivity and decreased ruthenium red 
sensitivity observed [249]. However, Ca^  ^ sensitivity in this same study 
was unaltered. This latter finding is hard to reconcile with the above 
observations [250]. Calcineurin was also up-regulated during the chronic 
treatment with cyclosporin which may explain the observations on 
ryanodine binding alterations but is again hard to reconcile with those 
regarding the caffeine and ruthenium red sensitivity of RyR2.
6.1.9 Can conclusions be made on the functional role of calcineurin 
on RyR2 from the above study on the chronic appiication of 
cyclosporin?
The above study is extremely hard to draw any definitive conclusions from.
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since multiple physiological effects occurred during simultaneous changes 
in protein expression. However, another study involving 2-day-old neonatal 
rat hearts also demonstrated a role for calcineurin on RyR2 [245]. The 
authors demonstrated in non-beating neonatal cells that application of 
various calcineurin inhibitors 20pM deltamethrin, 10pM CsA, and lOpM 
FK506 all lead to Ca^  ^oscillations. 10)iM rapamycin does not result in Ca^  ^
oscillations as frequently (presumably because rapamycin cannot inhibit 
calcineurin) but 20pm for 30min resulted in oscillations (presumably 
because at this concentration and time exposure to rapamycin the drug 
results in dissociation of FKBP from RyR2 and hence calcineurin is no 
longer able to be anchored to RyR2). Importantly, further addition of CsA 
or deltamethrin to these pre-incubated cells results in no further action. 
Therefore this fifth scenario presented in this study suggests therefore that 
only the calcineurin when bound and working inhibits Ca^ "^  release in the 
neonatal cells but not when unbound or not working (Table 6.1).
6.1.10 Evidence for a role of calcineurin on RyR2 in skeletal muscle
Perhaps the most detailed study associating the function of calcineurin with 
RyR is data produced in a mouse skeletal muscle cell line (C2C12) [244]. 
As with the previous results [245] (with RyR2), a Ca^  ^dependent interaction 
between RyRI, FKBP12.0 and calcineurin can be demonstrated in these 
cells. Pre-treatment with CsA caused an increased activity of RyR2 as 
assessed by the response to caffeine. Two mutant calcineurin isoforms 
were also used to investigate the functional role of calcineurin on RyRI. A 
constitutively active form of calcineurin (ACnA), results in a decrease in 
RyRI activity, which can be partially reversed by CsA. While ACnA(H1-
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101Q)), an inactive form of calcineurin, results in an increase in RyR1 
activity. Using Cain, an endogenous calcineurin inhibitor, confirms this 
action.
6.1.11 The function of calcineurin on RyR2 within adult ventricular 
cardiomyocytes
The above studies would predict that when calcineurin is bound to RyR2 via 
FKBP12.6 it has an inhibitory effect on RyR2. However there is now a 
dichotomy. Is this decrease in RyR2 activity due to FKBP that is bound to 
the RyR2 macro-molecular complex or calcineurin, which is also bound, 
and possibly exerting its phosphatase activity on RyR2? (Figure 6.3). Since 
as discussed previously cyclosporin is a good method of inhibiting 
calcineurin, the above studies suggest the bound calcineurin can account 
for the decrease in RyR2 activity. However this is hard to reconcile with 
the data presented in the previous chapters on the role of FKBP12.6 on 
RyR2 in decreasing the open probability of RyR2. One conclusive scenario 
could help solve this inconsistency within the literature. The final scenario 
as presented in table 6.1 is to allow binding of FKBP12.6 to RyR2 but 
without FKBP anchoring calcineurin (Figure 6.3). This chapter describes 
preliminary results obtained from cultured adult ventricular cardiomyocytes 
over-expressing an FKBP12.6 mutant, which cannot bind to calcineurin. If 
FKBP 12.6 is the predominant coordinator of RyR2 open probability then 
this virus should have the same effect as over-expressing FKBP12.6 alone.
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UNBOUND 
NOT WORKING
CsA + Rapamycin 
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FK506
•  •  •
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BOUND 
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UNBOUND
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BOUND / ^ +  
WORKING
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Rapamycin
UNBOUND
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FKBP12.6 Mutant
Figure 6.3 Various methods to elucidate the function of FKBP12.6 on RyR2
Refer to text for discussion. X  defines that calcineurin is not working. NB. Rapamycin  
does not inhibit calcineurin and cannot form a complex consisting of FK B P12.6-FK 506- 
rapamycin unlike FK506, which can.
However if calcineurin is important in regulating RyR2, the channel/RyR2 
cluster should demonstrate increased activity compared to over-expressing 
FKBP12.6 alone.
6.1.12 Construction of the FKBP12.6 mutant virus
Although the experimental work on Ca^  ^ sparks was performed personally,
the following is a brief account of work performed by Tim Siedler (University
of Goettingen) who performed site directed mutagenesis of the calcineurin
binding site on the FKBP12.6 DMA sequence. This alteration prevents
FKBP12.6 from binding to calcineurin. The mutated sequence was then
incorporated into an adenovirus vector and used to transfect rabbit
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ventricular cardiomyocytes as in section 2.2.3. While the mutant virus 
produced - FKBP12.6°®®^ V90K (Ad-FKBP12.6 mutant) does not to bind to 
calcineurin, its FK-506 affinity and rotamase activity are preserved (results 
performed by Tim Seidler but not shown). The following is a summary of 
the methods used to generate the mutant virus. They are included only for 
reference purposes since the detail of the experiments are outwith the 
scope of this thesis. With the knowledge that the composite FKBP12.0- 
FK506 surface can contact calcineurin, mutation of amino acids 
G89PA/90K in FKBP 12.0 has been demonstrated to increase the K\ for 
calcineurin to greater than SOOOnM, while leaving the FK506 affinity similar 
to wild type levels (FK506 Ki=0.6nM) [251]. This mutation was introduced 
into FKBP12.6 at the analogous position (G89P V90K) by site directed 
mutagenesis. Site directed mutagenesis was performed using the human 
FKBP12.6 mRNA in the vector pACCMV.pLpA. The vector was mutated 
using the methods of Vandeyar et al (1988) using the following primers 
(included for reference only) [252];
For: 5' ccacgggccacccccctaagatccctcccaatgcc 3'
Rev; 5' ggcattgggagggatcttaggggggtggcccgtgg 3'
{Where: a -  adenine, c -  cytosine, g -  guanine, and t -  thymine)
After Dpnl digestion, positive clones were confirmed by automatic 
sequencing and the DMA amplified for co-transfection with pJM17 for virus 
production as described previously in section 2.2 [96]. Details of the 
sequence alignment for FKBP12.0, FKBP12.6 and FKBP12.6 mutant are 
presented in appendix 6 .1 .
258
Over-expression of an FKBP12.6 mutant
6.2 METHODS
Single ventricular cardiomyocyte isolation from the rabbit heart v^ as 
performed as described in section 2.1.1. Recombinant adenoviruses were 
generated by standard procedures using full-length cDNA of the human 
FKBP12.6 gene [204]. Adenoviral infection with a multiplicity of infection 
(MG!) of 100 was performed to produce three populations of adenovirus 
transfected cardiomyocytes (i) over-expressing FKBP12.6 (Ad -FKBP12.6), 
(ii) expressing p-galactosidase as control (Ad-LacZ) and over-expressing 
an FKBP 12.6 Mutant which over-expresses FKBP12.6 protein which is 
unable to bind to calcineurin. Infected cardiomyocytes were washed and 
subsequently cultured in supplemented Ml 99 medium (Sigma) for 48hrs.
6.2.1 spark measurements In permeabilised cardiomyocytes
Ca^  ^ spark measurements were then performed on these cells after 
permeabilisation and perfusion with a free [Ca^ "'] of 145-165nM. The [Ca^T 
was calibrated using the same confocal protocol and automated spark 
detection programs as discussed section 5.14.4.
6.2.2 Statistics
Data was expressed as means±SEM. Comparisons were performed by 
using the paired students’ t-test, and differences were considered 
significant when P<0.05.
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6.3 RESULTS
Figure 6.4 A(i-iii) shows confocal line-scan images recorded from 
permeabilised rabbit cardiomyocytes after transfection with (i) Ad-LacZ, (ii) 
Ad-FKBP12.6, (iii) Ad-FKBP12.6 Mutant respectively on the same day and 
conditions. Ca^ "^  sparks were evident as transient increases in 
fluorescence. Ca^ "^  sparks recorded in FKBP12.6 and FKBP12.6 Mutant 
transfected cardiomyocytes were smaller and less frequent than the Ad- 
LacZ control. The data taken from a number of cells is summarised in 
Figure 6.4 B(i-iv). The average Ca^  ^ spark peak, frequency, width and 
duration (Figure 6.4B i-iv) were all significantly reduced in cells over­
expressing the Ad-FKBP12.6 mutant compared to Ad-LacZ (peak F/Fo, 
1.72±0.03 vs. 1.85±0.06, P<0.05; frequency, 0.045±0.004pm'^s‘  ^ vs. 
0.067±0.005pm'^s \  P<0.05; width, 3.03±0.08pm vs. 3.30±0.05pm, P<0.05; 
duration, 24.62±0.9ms vs. 27.30±0.8ms vs, P<0.05; Ad-FKBP12.6 Mutant 
(n=12 cells) vs. Ad-LacZ (n=11 cells)). Ca^  ^ spark characteristics from Ad- 
FKBP12.6 over-expressing cells are also presented: (peak F/Fo, 1.73±0.03; 
frequency, 0.048±0.006pm s^ \  width, 3.00±0.06pm, duration, 25.4±0.6ms; 
Ad-FKBP12.6 n=10 cells). These were similar to spark characteristics 
within cells over-expressing Ad-FKBP12.6 Mutant.
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Figure 6.4 Effects of the FKBP12.6 mutant on Ca^* sparks
A, Confocal images of Ca^^ sparks within ventricular cardiomyocytes transfected with: (i) 
Ad-LacZ (n=11), (ii) A d-FK BP12.6 (n=10) and (iii) Ad-FKBP Mutant (n=12). Summary of 
mean Ca^* spark data is presented in Panel B, Ca^* spark (i) peak, (ii) width, (iii) duration
and (iv) frequency.
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6.4 DISCUSSION
Confocal imaging of Ca^  ^ sparks within adult rabbit ventricular 
cardiomyocytes over-expressing a FKBP12.6 Mutant unable to bind to 
calcineurin reveals Ca^  ^ sparks, which are similar to Ca^  ^ sparks from cells 
over-expressing unaltered FKBP12.6. This suggests that a reduction in 
Ca^ "^  spark size and frequency can be attributed to the over-expression of 
FKBP12.6 and not the phosphatase action of calcineurin on RyR2. This 
data verifies conclusions reached by Marks et al (1996) that suggest that 
bound calcineurin does not play a direct role in the reduction of RyR2 
activity [175]. In fact the same group fails to find any biochemical evidence 
for the association between calcineurin and the RyR2 macromolecular 
complex in adult human cardiomyocytes [207]. This is in contrast to 
Bandyopadhyay et al (2000) who show a Ca^  ^ dependent association 
between the two proteins in neonatal rat cardiomyocytes [245]. It has been 
suggested that this inconsistency may be due to the low levels of [Ca^T 
used to study this association by Marks et al (2003) in this latter study 
[245].
6.4.1 Dynamic changes in [Ca^ j^
It is understandable that the changes in [Ca^ ]^ within the ventricular
cardiomyocyte are dynamic and do not remain at a resting [Ca^T as used in
this study. However the [Ca^T needed for calcineurin to bind to RyR2 has
only been investigated at lOOp-M [245]. While [Ca^T within the
sarcolemmal cleft is unknown, it is possible that a [Ca^ ]^ of lOOjiM may be
reached however it would not be maintained for any length of time and
certainly would not be the mean intracellular [Ca^T which only rises to
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approximately 1|xM during a transient. Therefore further investigation is 
required to identify whether calcineurin can bind to RyR2 at more 
physiological dynamic ranges of [Ca^^.
6.4.2 Evidence on the effect of calcineurin on RyR2
While the effects of calcineurin on RyR2 in adult rabbit ventricular 
cardiomyocytes do not seem apparent, this is in marked contrast to the 
data presented in neonatal rat ventricular cells [245] and skeletal muscle 
cell lines [244]. It cannot be assumed that these cell types will have the 
same levels of protein expression and Ca^  ^ dynamics [253]. 
Bandyopadhyay ef al (2000) demonstrated that a certain proportion of 
neonatal rat heart cells were spontaneously oscillating. This suggests that 
these cells are on the verge or have achieved SR Ca^  ^ overload. It could 
be that calcineurin within the cytosol or bound to RyR2 plays a predominant 
role in RyR2 inhibition over FKBP in these cell types. To date no study has 
demonstrated a direct role of calcineurin on RyR2 in adult ventricular 
cardiomyocytes. This study was the first to do so and has found no such 
mechanism.
6.4.3 Specificity of agents use to investigate the action of calcineurin
The use of calcineurin inhibitors to investigate the role of calcineurin on 
RyR2 has been the main focus of evidence for its possible role. However 
these drugs do not have 100% specificity for calcineurin. They are known 
to affect other Ca^  ^ regulatory pathways within cardiomyocytes such as the 
Na^K* pump [254]. These may in theory lead indirectly to a rise in SR Ca^* 
content, which would increase RyR2 activity independent of calcineurin 
inhibition. The method of adenoviral over-expression used in this study
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provides a novel way to investigate the possible role of calcineurin on RyR2 
without the need for drug application.
6.4.4 Further work
This study is by no means a completed piece of work and further 
investigation is required. Firstly an assessment of SR Ca^  ^ content would 
be helpful to establish if the reduced diastolic SR Ca^  ^ leak leads to an 
increase in SR Ca^ "^  content as seen when Ad-FKBP12.6 is over­
expressed. Secondly although calcineurin may not play a direct role in 
RyR2 Ca^  ^ release it may have a function on other Ca^  ^ regulatory 
processes that can only be assessed within the intact ventricular 
cardiomyocytes. Hence valuable investigation could be obtained by 
electrophysiological measurements on intact cells, especially regarding SR 
Ca^  ^ load and Ca^  ^ transients. It would also be important to clarify the 
levels of over-expression encountered within FKBP12.6 and FKBP12.6 
mutant cells. Finally since the binding of calcineurin to FKBP12.6 may be 
Ca^  ^ dependent it will be important to establish the degree of binding in the 
physiological [Ca^ "^ ] found within ventricular cardiomyocytes. This could be 
extended to compare the effects of Ad-FKPB12.0/FKBP12.6 mutant virus 
on Ca^  ^transients and waves.
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Conclusions
The general aim was to study the role of FKBP12.6 in regulating 
sarcoplasmic reticulum (SR) Ca^  ^release in permeabilised cardiomyocytes.
In itial work concerned the characteristics o f spontaneous Ca^* release from  
perm eabilised cells, in particular, the aim was to discover the relationship between  
intraceiiuiar [Ca^*] and the ability o f the SR to generate Ca^* waves.
It was necessary to establish a permeabilisation technique that allowed 
spontaneous SR Ca^  ^ release in rabbit ventricular cardiomyocytes to be 
studied. This was achieved by acute exposure to the compound p-escin. 
Subsequent perfusion with solutions containing O.OSmM EGTA, 10pm Fluo- 
3 and set [Ca^H allowed confocal visualisation of Ca^  ^sparks and waves. It 
was deemed necessary to be able to accurately calibrate these events. 
The permeabilised cell provided the ideal preparation in which to achieve 
this. This is very difficult to achieve within intact cells since an assumption 
of the resting [Ca^T is required. In permeabilised cells this parameter can 
be accurately assessed by subsequent perfusion of calibration solutions 
containing lOmM EGTA and therefore a known buffered [Ca^H. By varying 
the external and therefore the internal [Ca^T within these permeabilised 
cardiomyocytes, Ca^ "^  waves were produced when [Ca^ "^ ]ic was above 
200nM. Increasing to lOOOnM [Ca^Hic resulted in an increase in the 
frequency, peak, and minimum of the Ca^  ^ wave. At these [Ca^T mean 
extracellular [Ca^T and intracellular [Ca^T were equal. However when 
cardiomyocytes were exposed to [Ca '^’] above 2pM a significant gradient 
between extracellular and intracellular [Ca^ "^ ] existed. This was found to be 
due to mitochondria, which took up Ca^  ^during the peak of the Ca^  ^wave.
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This was essential at these high [Ca^ ""] to prevent irreversible cell 
contracture and subsequent cell death.
The second aim was to com pare the Ca^* wave behaviour in perm eabiiised  
cardiomyocytes and Ca^* wave behaviour within the intact ceiis
Since Ca^ "^  wave characteristics had been extensively calibrated within the 
permeabilised cell it was necessary to establish if these events were 
different from Ca^  ^waves within intact ventricular cardiomyocytes. No such 
difference was encountered, concluding that sarcolemmal Ca^ "" extrusions 
mechanisms were not prominent in removing Ca^  ^ during the peak of the 
Ca^ "^  wave.
...and  to use the wave characteristics in in tact ceiis to caiibrate the com m only used  
fluorescent Ca^* indicator -  Fluo-3IAM.
The ability to equilibrate extracellular Ca^  ^ concentration very rapidly with 
the intracellular [Ca^T in the permeabilised cell allowed accurate calibration 
of the affinity for Ca^ "^  by Fluo-3 both in the external solution and within the 
cell. The Ca^ "^  indicator dye Fluo-5F was also calibrated in the same 
fashion and was found to be of lower affinity than Fluo-3 and subsequently 
enabled more accurate assessment of the peak of the Ca^  ^ wave. The 
Ca^  ^ wave characteristics within the permeabilised cell were then used to 
calibrate the affinity of Fluo-3AM within intact cells. This was found to be of 
a lower affinity than Fluo-3 within the extracellular solution or within the 
permeabilised cardiomyocyte. This factor emphasised the need to 
accurately calibrate the fluorescent dye of choice within the intact cell and
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not assume an affinity, which is assessed outside the cell to be the same as 
within the cell.
The main aim o f this thesis was to study the effects o f adenoviral m ediated over­
expression o f FKBP12.6 on Ca^* sparks and Ca^* waves within adult rabbit 
ventricular cardiomyocytes.
Adenoviral over-expression of FKBP12.6 within rabbit cardiomyocytes was 
achieved successfully. Peak-systolic intracellular [Ca^ "^ ] (measured with 
Fura-2 in intact cells) was higher in the Ad-FKBP12.6 group compared to 
control, as was the rate of rise of the transient. Using confocal microscopy 
the transients were visualised to release Ca^  ^ more synchronously. This 
was quantitatively shown to be the case. Furthermore, this was achieved if 
anything, by an equivalent SR [Ca^T between cells over-expressing 
FKBP12.6 and control group. Restoration of the Ca^ "^  transient to steady 
state amplitude after emptying the SR of Ca^  ^ was faster in cells over­
expressing FKBP12.6 than control suggesting that diastolic leak of Ca^  ^
from the SR was reduced by FKBP12.6. This was further confirmed by 
Ca^  ^ spark measurements within permeabilised cells, which were reduced 
in size and led to an enhanced SR [Ca^ "^ ]. Finally Ca^  ^ waves were 
examined at 400nM [Ca^ ]^ within permeabilised cells over-expressing 
FKBP12.6. Control cultured cells were only able to produce Ga^  ^ events 
which propagated approximately 40pm across the width of the cell. 
However, cells over-expressing FKBP12.6 were able to produce coherent 
global Ca^ "^  waves. The SR Ca^ "^  content was markedly higher at 400nM 
within these latter cells compared to control. Overall over-expression of
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FKBP12.6 within rabbit ventricular cardiomyocytes led to both a reduced 
diastolic leak of Ca^ "^  from the SR and enhanced SR Ca^ "^  release, which 
was independent of SR Ca^  ^content. This could be due to an enhanced E- 
C coupling efficiency. These characteristics may have obvious benefits 
within particular cases of heart failure where diastolic leak of Ca^ "^  has been 
increased to such an extent that SR Ca^  ^ content declines. However as 
with other positive ionotropic agents the possible consequences of the 
production of Ca^ "^  waves when intracellular [Ca^ "^ ] is increased may be 
counterproductive.
The final aim was to s tudy Ca^* sparks within cardiomyocytes over-expressing a 
m utant form o f FKBP12.6, which lacked the ability to b ind to calcineurin.
Recent studies suggest that it is possible that calcineurin (a phosphatase) 
when (and if) bound to RyR2 is responsible for the decrease in open 
probability originally shown to be due to FKBP12.6. The construction of an 
adenovirus, which over-expresses FKBP12.6 which lacks a calcineurin 
binding site results in Ca^  ^ sparks that are indistinguishable from Ca^  ^
sparks when simply over-expressing FKBP12.6 alone. The mutant virus 
reduced the size of the Ca^  ^ spark relative to a control group. Therefore in 
adult rabbit cardiomyocytes it seems that calcineurin plays no direct role 
when (and if) bound to RyR2 in reducing the channels open probability
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FINAL CONCLUSION
It can be seen therefore that the permeabilised cell together with confocal 
microscopy, represents an excellent model in which to study and accurately 
calibrate Ca^ "^  release events from the SR of ventricular cardiomyocytes. 
Furthermore accurate calibration of fluorescent indicators within the cellular 
environment can also be achieved. The ability to measure and manipulate 
Ca^  ^ dynamics such as Ca^ "^  sparks and waves within such a preparation 
can lead to furthering our knowledge of E-C coupling.
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Appendix
Appendix 2.1
Automated spark detection algorithm originally composed by Cheng et al 
(1999) and adapted for the permeabilised cell by Godfrey Smith to enable 
the extracellular regions to be cropped from the image [115].
Pro proc_spark1, ima,tscan,zoom,psize,human,cri,run,outflle,left,right,time_up,tlme_down 
:proc_spark picks out and quantifies sparks 
procedure parameters;
;ima=image file 
;tscan = ms per line 
;zoom = zoom set
: psize = pixel size (um) when zoom=1
: human = user interface 1 =active, other=inactive
;cri = criteria for spark region folds of SD above mean
;run = number of times procedure has been called in this program (optional)
;outfile = output filename (optional)
: setup LUT
device, decomposed=0 
;Set up for 16 bit display 
ired=220 
loadct,0
;Load up grey scale 
tvlct,r,g,b,/get 
;Get r g & b values 
r(ired)=255
;set red vales 
g(ired)=0 
b(ired)=0 
r(ired-1 )=255 
g(ired-1 )=255 
b(ired-1 )=255
tvlct,r,g,b
;Put values back into LUT
: measure up image file 
a=size(ima) 
nx=a(1 ) 
ny=a(2)
(Iterative computation of variance or SD by Cheng (NIH)
; modified by Smith (Glasgow)
ima=float(median(ima,7))
(minimal median filter to remove data points at extremes (used to be 5)
imm=ima ;**imm is used later for spark
detection**
(Window,0,xs=nx,ys=ny,title='lmage after median filter',xpos=512,ypos=0 
(tv, ima
(0.8-um and 10-ms spatiotemproal smoothing filter
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ss=(0.8/psize)
;ss = no. of pixels in 0.8um 
st=(10./tscan)
;st = no of pixels in 10ms
ct=0
;ct = time counter
imb=fltarr(nx,ny)
;set up image array 
for ia=-fix(ss/2),fix(ss/2) do begin 
(for groups of +/- 2um 
imb=imb+shift(ima,ia,0)
(Shift image +/- 2um 
ct=ct+1 
endfor
for ib=-fix(st/2),fix(st/2) do begin 
(for groups of + /-1 0ms 
imb=imb+ shift(ima,0,ib)
(Shift image + /- lOum  
ct=ct+1 
endfor 
ima=imb/ct 
imb=ima
ibmx=bytarr(nx,ny) 
imbx=rebin(ima,nx,1 ) 
imbx=rebin(imbx,nx,ny) 
ima=ima/imbx
(initial normalization-divide image by mean at each x 
sd=stdev(ima,mean)
(inital estimate SD within the cell edges 
print,'1st cell area mean= ',mean, ' & SD= ',sd
(mask for potential spark regions >m+1 5SD  
mask=bytarr(nx,ny)
(set up image mask array 
mask(where(ima gt 1 +1.5*sd))=1 
(set everything above 2.5xSD in ima to 1 in
(the corresponding area of mask image 
mask=median(mask,5)
(median filter to blur the edges 
ima=imb*(1-mask)
(excise potential spark regions and put in ima
(calculate baseline spatial profile with potential spark regions excised 
(** this is also used later for spark detection 
base=smooth(rebin(ima,nx,1 )/rebin(1 .-float(mask),nx,1 ),3,edge=1 ) 
imb=imb/rebin(base,nx,ny)
(normalize image imb with corrected baseline
(tem=imb(pl:pr,*)*(1.-mask(pl:pr,*))
(final calculation of background SD 
tem=imb*(1 .-mask)
sd=stdev(tem(where(tem gt 0.)),mean) 
print,'new cell area mean= ',mean, ' & SD= ',sd
(Spark detection bit;
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;make a binary image of cri*SD i.e. spark sites 
imx=(imb-(1.0+cri*sd)>0.0)*100000.<1.0 
imi=fix(imx) 
im=median(imi,5)
;take care the edge effect of the smoothing
im(0:ss/2,*)=0
im{nx-ss/2-1:*,*)=0
im(*,0:st/2)=0
im(*,ny-st/2-1:*)=0
;NB image im is a cri*sd mask
;make a 2*SD image for automated regional counting 
imx=(imb-(1.0+2.0*sd)>0)*100000.<1.0 
imi=fix(imx) 
ime=median(imi,5)
;take care the edge effect of the smoothing
ime(0:ss/2,*)=0
ime(nx-ss/2-1 :*,*)=0
ime(*,0:st/2)=0
ime(*,ny-st/2-1:*)=0
imf=ime
;NB images ime and imf is a 2*sd mask
;**Use the median filtered image imm (with sparks) and baseline image (spark areas 
removed)
;NB, the rebin of imb will ensure that the areas of sparks will have a baseline 
imb=imm/rebin(base,nx,ny)
;imb= new image (normalised with minimal filtering on sparks)
(Display two copies of this image
window,2,xs=nx,ys=ny,title-Normalised image (Win2)',xpos=512,ypos=0
window,0,xs=nx,ys=ny,title-Normalised image+2SD sparks(WinO)',xpos=1024,ypos=0
wset,0
tv,(imb-.5>0)*150<255
(display the normalized image with contrast enhanced 
wset,2
tv,(imb-.5>0)*150<255
(window,3,xs=nx/2,ys=ny/2,title-3.8*SD image(Win3)',xpos=512,ypos=520 
(Window, 1 ,xs=nx/2,ys=ny/2,title-2.0*SD image(Win1 )',xpos=770,ypos=520 
(wset,3
(imNew=congrid(im,nx/2,ny/2)
(tvscl,imNew
(cri*SD image
(wset,1
(imeNew=congrid(ime,nx/2,ny/2)
(tvscl,imeNew
(2-SD image
skc=0
(initalize spark counter 
s=fltarr(20,500)
(array to hold (up to 500) spark parameters (20 values)
jump1: ime=imf
While (total(im) ne 0) do begin 
a=min(where(im eq 1))
(im is the cri*sd mask
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Tline=a/nx 
Xcord=a mod nx
;get coordinates of spark, TIine and Xcord
(Define search area 
nnl=fix(min([left/psize, Xcord]))
(calculate length(nnl) 
nnr=fix(min([right/psize, nx-Xcord-1 ]))
(calculate right hand coord (nnr) 
mmb=fix(min([time_up/tscan, TIine]))
(calculate breadth (mmb) 
mme=fix(min([time_down/tscan, ny-Tline-1 ]))
(calculate end coord (mme) 
ym=bytarr(nnl+nnr+1 ,mmb+mme+1 )
(array to hold growing points 
ym(nnl,mmb)=1
(initial seeding for growth
sk=ym
(array to hold the spark as seen in the 2SD image
( extra window to observe spark detection 
(window,4,title='Debug',xs=nnl+nnr+1,ys=mmb+mme+1
for iii=0,500 do begin 
(Surface growth generation count 
yt=sk
(potential new surface points 
(dilation of ym by 3*3 filter 
(Odd integers=True' 
yn=(ime(Xcord-nnl:Xcord+nnr,Tline-mmb(Tline+mme)) and 
fix(smooth(float(ym),3,edge=1)*100.<1)
(no further growth, stop and calculate the parameters 
if total(yn) eq 0 then goto, jump2
(Update sk 
sk=sk>yn
(excise the points that already included in the cluster 
(ime = 2*SD mask im=3.8*SD mask
ime(Xcord-nnl:Xcord+nnr,Tline-mmb:Tline+mme)=ime(Xcord-nnl(Xcord+nnr,Tline-
mmb(Tline+mme)-fix(sk)>0
im(Xcord-nnl(Xcord+nnr,Tline-mmb(Tline+mme)=im(Xcord-nnl(Xcord+nnr,Tline-
mmb:Tline+mme)-fix(sk)>0
(true new surface point 
ym=yn-fix(yt)>0
(wset,4
(tvscl,sk
(file=dialog_message('OK?') 
if iii eq 500 then print,'WARNING: SPARK SEARCH AREA MAY BE TOO SMALL' 
endfor
jump2;skc=skc+1
(spark measurement 
pixels=total(sk)
(total pixels
(time position
a=rebin(float(sk),1 ,mmb+mme+1 )
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a=where(a ne 0) 
tpos=Tline-mmb+min(a)
;at,bt: initiation and end time
durmax=max(a)-min(a)+1
;max duration
at=max(a)
bt=min(a)
;x coordinate
a=rebin(float(sk),nnl+nnr+1,1 ) 
a=where(a ne 0)
xpos=Xcord-nnl+(max(a)+min(a))/2.
;ax,bx: left and right edges
ax=max(a)
bx=min(a)
; max width
breadthm=max(a)-min(a)+1
averdur=pixels/breadthm 
(average duration 
averwid=pixels/durmax 
(average width
w=imb{Xcord-nnl(Xcord+nnr,Tline-mmb(Tline+mme)*sk
peak=max(w)
(peak pixel 
p=where(w eq peak)
p=p(0)
xxx=p mod (nnl+nnr+1) 
ttt=p/(nnl+nnr+1)
averp=total(imb((Xcord-nnl+xxx-1 )((Xcord+xxx-nnl+1 ),Tline-mmb+ttt-1 (Tline- 
mmb+ttt+1))/9. (3*3 average peak 
amp=total(w)/pixels 
( average amplitude
(amplitude,duration and width measured as usual
w=rebin(imb((fix(Xcord-nnl+xxx-2.5/psize)>0):(fix(Xcord-nnl+xxx+2.5/psize)<nx-1),$ 
Tline-mmb+ttt-1 :Tline-mmb+ttt+1 ),(fix(Xcord-nnl+xxx+2.5/psize)<nx-1 )-(fix(Xcord- 
nnl+xxx-2.5/psize)>0)+1,1)(used to be 2
pw=max(w)
w50=n_elements(where(w ge (pw+1.)/2.))
w=rebin(imb((fix(Xcord-nnl+xxx-.4/psize)>0):(fix(Xcord-nnl+xxx+.4/psize)<nx-1),$ 
((Tline-mmb)<(fix(Tline-mmb+ttt-30./tscan)>0)):((Tline+mme)>(fix(Tline- 
mme+ttt+50./tscan)<ny-1 )))$ 
,1,((Tline+mme)>(fix(Tline-mmb+ttt+50./tscan)<ny-1))-((Tline-mmb)<(fix(Tline-mmb+ttt- 
30./tscan)>0))+1)
pk=max(w)
d50=n_elements(where(w ge (pw+1 .)/2.))
ii=skc
s(0,ii)=1
(Image # 
s(2,ii)=xpos 
(X pixel 
s(3,ii)=tpos
(Time pixel 
s(4,ii)=peak
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(Peak pixel 
s(5,ii)=averp
[Peak amplitude (3*3) 
s(6,ii)=amp
[Average amplitude in spark 
s(7,ii)=durmax 
[Max Duration 
s(8,ii)=averdur 
(Average duration 
s(9,ii)=breadthm
(Max breadth 
s(10,ii)=averwid
(Average width 
s(11,ii)=pixels 
(Sum of pixel values 
s(12,ii)=Xcord-nnl+bx 
[X co-ord of peak 
s(13,ii)=Xcord-nnl+ax 
(X co-ord
s(14,ii)=Tline-mmb+bt 
(Time of peak? 
s(15,ii)=Tline-mmb+at 
(Time 
s(16,ii)=pk
s(17,ii)=w50
(Width at 50% duration 
s(18,ii)=d50
(Duration at 50% height 
print,'ID#,P_max,P_33a,P_ave,D_max,D_ave, W_max,W_ave,pixels, P, W, □' 
print,format='(1l5, 7f7.3,1l5, 
3f7.3)',ii,peak,averp,amp,durmax,averdur,breadthm,averwid,pixels, pk,w50,d50
wset,0
z=tvrd(Xcord-nnl,Tline-mmb,nnl+nnr+1 ,mmb+mme+1 ) 
z1 =z*(1-(sk))
(make a block of image with spark area=0 
z2=z1 +sk*ired
(replicate the image block but spark image is coloured 
tv,z2,Xcord-nnl,Tline-mmb (
ytt=ym*0
ytt([bx,ax],bt(at)=1
ytt(bx:ax,[bt,at])=1
wset,0
z=tvrd(Xcord-nnl,Tline-mmb, nnl+nnr+1 ,mmb+mme+1 ) 
tv,z*(1 -(ytt))+(ytt)*(ired-1 ),Xcord-nnl,Tline-mmb 
endwhile
(Optional user interface
old_font = ! p.font (Use hdw font
Ip.font = 0
while human eq 1 do begin 
wset,0 (image window
print,'click left button at a spark to be discarded' 
print,'middle button to add a spark' 
print,'right button to exit' 
cursor,ix,iy,3,/dev
if (!Mouse.Button eq 4) then goto, jump4 
if (IMouse.Button eq 1) then begin
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repeat cursor,ix,iy,0,/dev until IMouse.Button eq 0 
for i=1,skc do begin
if ((ix le s(13,i)) and (ix ge s(12,i))) and ((iy le s(15,i)) and (iy ge s(14,i))) then begin
(update window by taking the image data from window 2 ......
wset,2
xu=tvrd(s(12,i),s(14,i),s(13,i)-s(12,i)+1 ,s(15,i)-s(14,i)+1 )
(... and use it in window 0 
wset,0
tv,xu,s(12,i),s(14,i)
(delete spark data
if i eq skc then s(*,i)=0
if i le skc-1 then s(*,i:skc-1)=s(*,i+1(skc) 
skc=skc-1
print, 'spark ',i,' deleted' 
end if
endfor
endif
if (I Mouse.Button eq 2)and(imf(ix,iy) eq 1) then begin 
im(ix,iy)=1
print,'spark',skc+1,' will be added' 
goto,jump1
endif
endwhile
jump4( if skc ne 0 then s=s(*,1 (skc) 
if skc ne 0 then s(1 ,*)=findgen(skc) 
print, 'total sparks ', skc
(data output to a file 
if run eq 1 then begin 
outfile=dialog_pickfile(/write,filter='*.txt') 
if outfile eq " then begin 
print,'No output filename?' 
goto, jump3 
endif else begin 
openw,2,outfile
for j=0,skc-1 do printf,2,format='(4l5,3f7.3,5i5,1f7.3,2i5)' $
,run,s(1 ,j),s(2,j),s(3,j),s(4,j),s(5,j),s(6,j),s(7,j),s(8,j),s(9,j),s(10,j) $ 
,s(11,j),s(16,j),s(17,j),s(18,j) 
close, 2 
jump3: 
endelse
endif else begin 
openu,2,outfile, /append
for j=0,skc-1 do printf,2,format='(4l5,3f7.3,5i5,1f7.3,2i5)' $
,run,s(1 ,j),s(2,j),s(3,j),s(4,j),s(5,j),s(6,j),s(7,j),s(8,j),s(9,j),s(10,j) $ 
,s(11,j),s(16,j),s(17,j),s(18,j) 
close, 2 
endelse
wdelete, 0,1,2,3
run=run+1
end
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Appendix 6.1
Sequence alignment of base pairs (6.1.1) and amino acids (6.1.2) for 
FKBP12.6, FKBP12.0 and the FKBP12.6 mutant, which cannot bind 
calcineurin.
Appendix 6.1.1 Base pair sequence
FKBP12 1
F K B P 12 .6  1
FK B P 12. 6G 89PV90K 1
t j L ' ■ J t l '
1 TiL I  jJ L  jJ L ' L  jL I  ‘ I
cBcHBcW BiW gfgc - cS
u a ' - j t ' j l I I '  l  .■.a ‘ » A A ‘
FKBP12 
FK B P 12.6
FK B P 12. 6G89PV9DK
FKBP12 
FK B P 12.6
FK B P 12. 6G89PV90K 121
FKBP12 
FK B P 12.6
FK B P 12 . 6G 89PV90K 181
FKBP12 
F K B P 12.6
FK B P 12. 6G89PV90K 2 41
FKBP12 
FK B P 12.6
FK B P 12. 6G89PV90K 3 01
TATA
AGGCBT
Where: a -  adenine, c -  cytosine, g -  guanine, and t -  thymine
Appendix 6.1.2 Amino acid sequence
FKBP12  
F K B P 1 2 .6  
FKBP12 . 6 '
H G V Ç P E T IS P G D G P T F P ^ lG O T C W H Y T G H L ig G K K F D S S P D F T J K P F K F p G K O E V liG
M G VÈlETISPG D G FTFPK K G Q TC W H YTG riLQ M G K K FD SSR D FH K PFP'FP IG K Q EVIK G F
IIG VEIET ISPG D G R TFPK K G Q TC VVH YTG H LO N G EK FD SSPD PIJEPFK FR IG K Q EVIK G F
FK B P12  
F K B P 1 2 .6  
F K B P 1 2 . 6 ' Si
279
Appendix
Appendix 6.1.3 Summary of construction of FKBP12.6 mutant
Below is a summary of the site directed mutagenesis, which enabled the 
production of the FKBP12.6 mutant virus (FKBP 12.6m). This virus cannot 
bind calcineurin (see section 6.1.12 for further details).
Amino Acid Sequence: FKBP12.6/ FKBP12.6m
MGVEIETISPGDGRTFPKKGQTCVVHYTGMLQNGKKFDSSRD
RNKPFKFRIGKQEVIKGFEEGAAQMSLGQRAKLTCTPDVAYGA
TGHP g g Z m  IPPNATLIFDVELLNLEiœ
Î
PasKs
Calcineurin binding site 
Amino acid (one-ietter code abbreviation)
Aspartate (D), Glutamate (E), cysteine (C), methionine (M), lysine (K), 
arginine (R), serine (S), threonine (Y), asparagine (N), glutamine (Q), 
glycine (G), isoleucine (I), leucine (L), valine (V), alanine (A), tryptophan 
(W), histidine (H), proline (P).
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